Yaushe ne wadannan alamun suka fara bayyana?
Kuma duk wani ciwon kirji da aka samu, ya kamata a magance shi ta wannan hanyar, musamman ma a lokacin da kake da shekaru.
Kuma tare da
Hakanan za a gwada cholesterol da hawan jini
Kuma kuna jin zafi a yanzu?
Kuma kuna da ciwon kirji a yanzu?
Kuma har ila yau, kuna jin wahalar numfashi?
Kuma za ku iya gaya mani abin da sauran alamomin da ke tattare da wannan ke nufi?
Kuma yaya girmanka yake?
Kuma ina shan ƙaya.
Ina da zazzabi da kuma zafin jiki.
Kuma a yau, na ji ciwo sosai a cikin kirji.
Kuma wannan ne lokacin da za a yi maka rashin lafiya?
Shin yana haifar da ciwon kirji?
Kuma ina jin ɗanɗanar ɗanɗano.
Kuma ina so in gaya muku inda ciwon kirji yake.
Kuma suna da ku.
Kuma da ciwon sukari na baya
Kuma ka san abin da yake ji kamar na ji kamar ƙirjina yana so ya yi girma.
Kuma ka san cewa mutane suna yawan zagin ni.
Shin kana da ciwon kirji a yanzu?
Kuma ka ce wannan yana kama da matsi a kan kirjinka.
Shin akwai wani a cikin iyalinku da ke da ciwon zuciya, ciwon zuciya, bugun zuciya, yawan kitse ko hawan jini?
Shin kuna jin wani ciwo ko alamun ciwo a cikin tsokoki?
Shin akwai wani a cikin gidanku da ke fama da rashin lafiya kuma yana da alamun da ke kama da naka?
Shin kuna da wasu alamun cutar?
Shin kana jin wahalar numfashi?
Har yanzu kana jin zafi a kirjinka?
Domin lokacin mura ne.
Amma bai kamata mu damu da cewa ciwon kirji yana iya haifar da cututtukan zuciya ba.
Amma abin da ya fi damunsa shi ne ciwon kirji.
Amma ina da numfashi mai wuya.
Amma na san mutane da yawa suna son ni.
Amma dole ne mu dauki duk wani ciwon kirji da muke ji da muhimmanci.
Amma yanzu kana samun numfashi mai kyau, ko ba haka ba?
Na manta da shi gaba ɗaya saboda wannan ciwon na tsokoki.
Shin yana da kamar wani ya taɓa kirjinka
Har yanzu kana jin wahalar numfashi?
Kuna da irin wannan rashin lafiya?
Kuna da wata cuta mai tsanani kamar hawan jini ko wata irin cuta?
Shin akwai wasu matsaloli na likita da ke tattare da wasu cututtuka na kullum kamar su ciwon suga?
Shin kuna da matsalar numfashi tare da ciwon kirji?
Shin kana da hawan jini?
Shin kana da matsalar numfashi?
Ka san menene alamun cutar?
Shin kuna ganin wannan hoton?
Ka sha ruwa mai yawa a yau.
Ina kuma gwada mata sukarin.
Alamar jikinsa daidai take da tawa.
Yaya yawan zafin jiki yake?
Mene ne karfin jininka?
Idan ka ci gaba da yin haka,
Idan zafin jiki ya kai 102°F
Idan ka yi tunanin cewa alamun ka ko matsalar ka sun inganta,
Yana da ɗanɗano mai kyau.
Kuma yana da ɗan ɗanɗano.
Na ji daɗin abin da na ji a jiya.
Ina da ciwo mai tsanani a cikin kirji na
Ina da ciwon numfashi.
Zan aika maka da hoton.
A yau ina jin ciwon kirji.
Yau da ɗan iska da kuma ɗanɗano.
Ina ganin yana da mura.
A ganina, wannan cuta ce mai saukin kamuwa da cuta.
Shin yana jin kamar wani mai nauyi yana zaune a kirjinka?
Na fara jin ciwon kai, kuma a lokaci guda, na ji kamar ana tauna ni.
Na ji ciwo a tsakiyar kirji na.
Matsi kamar ciwon kirji ne.
Yana cikin ƙirjina.
A tsakiyar ƙirjina.
A tsakiyar ƙirjinsa
Ina jin wani ciwo a kirji.
Na damu sosai game da ciwon baya.
Ina so ka kwatanta mini wannan ciwon ƙirjina.
kamar hawan jini ko hawan sukari
A daidai tsakiyar kirji
Yanzu za ka iya samun takwirar takwararka
Maryamu, kin yi fama da waɗannan alamun na 'yan kwanaki yanzu
Yanzu ka ce kana da ciwon kirji
Ina da ɗan ciwon kirji a wasu lokuta.
To, akwai wata alama a jikinka banda ciwo?
Ko kuma wani yana zaune a kan kirjinka?
Yana kama da ciwon kai, ciwon kai, ciwon kai da kuma ciwon tsoka.
A tsakiyar ƙirjina.
A wannan hoton, nuna mini inda nake jin zafi.
Domin akwai wani abu da ke da muhimmanci.
Kuna tsammanin wasu daga cikin wadannan alamun na iya alaƙa da ciki?
Shin yaranku suna da wasu alamun da suka dace?
Ka gaya mini game da ciwon da ke cikin zuciyarka.
Sai da dare ne kawai take tashi.
Na ji daɗin wannan a cikin kwanaki biyu da suka gabata.
Ya fara hawa ne a daren jiya.
Ni ne Dr. Porter na asibitin gaggawa na cibiyar ta.
"To, za ka iya gaya mini game da ciwon kirji na?"
"To, ina jin wani ciwo a gaba na, a cikin ƙirjina".
A'a, na ji wani irin ciwo a cikin kirji.
To, a lokacin da nake da ciwon a kirji
Wace irin ciwo kake ji a kirjinka?
Yaushe ne ciwon kirjin ya fara?
A wace yanki ne ciwon kirji yake?
Ba za mu iya yin hakan ba.
Shin kana jin wani nauyi a cikin kirji?
Ka sani, ina da ciwon sukari da kuma wasu cututtuka.
Ka ce kana da ciwon kirji
Saurin karuwar cutar COVID-19 a cikin EU/EEA da UK, 1 ga Janairu zuwa 15 ga Maris, 2020
Tsarin da ya yi daidai da karuwar adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da Burtaniya ya tabbatar da cewa, duk da cewa matakan sun bambanta a kowace ƙasa, yaduwar COVID-19 ta karu cikin sauri a cikin dukkan ƙasashe.
Kamar yadda aka nuna a cikin kwarewar Italiya, ƙasashe, asibitoci da kuma ɗakunan kulawa mai tsanani suna buƙatar haɓaka kasancewa don fuskantar karuwar masu cutar COVID-19 waɗanda ke buƙatar kulawa ta musamman da kulawa ta musamman.
A ranar 31 ga Disamba, 2019, an ba da rahoton wasu mutane da suka kamu da cutar SIDS da ba a san dalilin da ya haifar da ita ba a Wuhan, lardin Hubei na kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Cututtuka ta Sin ta bayyana cewa cutar ta samo asali ne daga sabon kwayar cutar da ake kira coronavirus 2 respiratory respiratory syndrome coronavirus 2-SARS-CoV.
Tun daga wannan lokacin, ana kiran cutar mai saurin kamuwa da cutar 2-SARS-CoV da cutar COVID-19.
Shaida ya nuna cewa har zuwa yau kashi 80% na masu cutar COVID-19 suna da rauni, watau, kamuwa da cutar huhu ba tare da cutar huhu ba ko tare da cutar huhu kuma yawancin suna warkewa.
14% na masu cutar COVID-19 sun buƙaci asibiti, kuma sauran 6% na marasa lafiya sun buƙaci kulawa mai mahimmanci.
Yawan mutuwar mutanen da suka kamu da cutar COVID-19 ya kai kusan kashi 4 cikin dari.
A cikin wannan binciken, mun bincika yanayin yanayin COVID-19 a cikin kowace EU / EEA da Burtaniya, da kuma kwatanta su da yanayin lardin Hubei na China.
Hakanan muna kwatanta adadin COVID-19 na yanzu a cikin ƙasashen EU/EEA da Burtaniya tare da adadin masu cutar a Italiya daga 31 ga Janairu-15 ga Maris, 2020.
COVID-19 a cikin EU / EEA da Burtaniya
Bayan China, COVID-19 ya bazu a wurare da yawa kuma ya haifar da irin wannan yanayin a sauran ƙasashe.
A ranar 11 ga Maris, 2020, Babban Daraktan Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annobar duniya.
A ranar 5 ga Maris, Spiteri da abokan aikinsa sun ba da sanarwar cutar COVID-19 ta farko da aka tabbatar a Turai, a cewar Eurosurveillance 2020.
A cikin ƙasashen EU/EAA, an ba da rahoton farkon kamuwa da cutar guda uku a ranar 24 ga Janairu 2020 tsakanin mutanen da suka dawo daga Wuhan, lardin Hubei na China.
A ranar 15 ga Maris, 2020, an sami karuwar COVID-19 a cikin dukkan ƙasashe 30 na EU/EAA da Burtaniya, wanda ya haifar da rahoton mutane 39,768 da suka kamu da cutar a tsakanin 31 ga Disamba, 2019 zuwa wannan shekarar, ciki har da mutuwar 1,727, wanda ya haɗa da kamuwa da cutar 17,750 da mutuwar 1,441 a Italiya.
Samun ƙididdigar ƙididdiga da ƙididdigar ƙididdigar COVID-19
A cikin Cibiyar Kula da Cututtuka ta Turai (ECDC), ana samun adadin rahoton COVID-19 a kowace ƙasa daga tushe na hukuma kamar ma'aikatun kiwon lafiya na ƙasa, hukumomin kiwon lafiya na yanki da WHO, kuma ana sabunta su kowace rana da karfe 8:00 na safe.
An yi amfani da wannan bayanan don tantance yanayin COVID-19 a cikin EU da Burtaniya da kuma kwatanta su da Italiya.
A matsayin mai kula da ci gaban COVID-19 mai aiki, mun lissafa jimlar jimlar kwanaki 14 na COVID-19 kuma mun yi la'akari da yanayin yanayin COVID-19 a kowace EU da UK a cikin Janairu-1 Maris 15, 2020.
Mun kuma gabatar da adadin wadanda aka ba da rahoton cutar a kowace ƙasa a karfe 8:00 na safiyar 15 ga Maris idan aka kwatanta da adadin a Italiya a ranar 31 ga Janairu zuwa 15 ga Maris.
Hanyar COVID-19 a cikin EU da Birtaniya
Jerin gajeren kwana 14 na rikodin COVID-19 a cikin EU da Burtaniya gabaɗaya suna bin tsarin lardin lardin Hubei na China (Figure 1.
A cikin EU da Burtaniya, adadin masu kamuwa da COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu, kuma ya ƙaru sosai a ranar 28 ga Fabrairu, 2020 (wanda ya nuna cewa ba a yi ba).
Wannan ya faru ne saboda karuwar yawan masu kamuwa da cutar a Italiya, amma duk sauran ƙasashen EU da Burtaniya sun nuna irin wannan karuwar a cikin adadin masu kamuwa da COVID-19 a cikin ƙasashensu.
Shafi na 2 ya nuna karuwar adadin masu cutar COVID-19 a cikin Tarayyar Turai da Burtaniya da Italiya tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Wannan yana nuna cewa a ranar 15 ga Maris da karfe 8:00 na safe, adadin mutanen da suka kamu a cikin wasu ƙasashen EU 15 da Burtaniya sun yi daidai da adadin mutanen da suka kamu a Italiya a cikin makonni uku ko ƙasa da haka a cikin wannan makon.
Sakamakon bincikenmu ya nuna cewa adadin wadanda suka kamu da cutar COVID-19 a kasashen EU da Birtaniya na karuwa cikin sauri.
Abubuwan da ake gani na ƙaruwar COVID-19 ya nuna cewa cutar ta yadu da sauri a cikin ƙasashe daban-daban.
Wannan ya faru ne duk da cewa ƙasashe suna cikin matakai daban-daban kuma ba su da daidaito a cikin matakan lafiyar jama'a na ƙasa, da kuma bambance-bambance a cikin ma'anar yanayi da kuma hanyoyin da ake amfani da su don gano marasa lafiya don gwaji don tabbatar da cutar COVID-19.
A farkon watan Maris na 2020, likitocin da ke yankin da aka kamu da cutar a Italiya sun bayyana cewa kusan kashi 10 cikin 100 na masu kamuwa da cutar COVID-19 na buƙatar kulawa mai tsanani, kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da rukunin kulawa da gaggawa a waɗannan yankuna sun kai iyakar ƙarfin su.
Bayanai na asibiti da na ICU na marasa lafiya da ke fama da COVID-19 a cikin EU/EEA sun kai kashi 6 cikin ɗari da 1 cikin ɗari na masu cutar a halin yanzu (ba a nuna bayanan ba).
Koyaya, dole ne a tattara waɗannan bayanan a cikin tsari mai kyau don kammala bayanan kulawa na yanzu wanda ke mai da hankali kan yawan shari'o'in da aka ruwaito da yawan mace-mace.
Wani bincike da aka gudanar a watan Nuwamba 2010 ya nuna bambancin da ke tsakanin adadin gadaje a cikin kulawar marasa lafiya da kuma cibiyoyin kulawa na likita a Turai, inda a Jamus adadin ya kai gadaje 29.2 da kuma a Portugal gadaje 4.2 ga kowane mutum 100,000.
Wannan yana nuna cewa ƙasashe na iya samun ƙasa ko sama da albarkatu fiye da Italiya (12.5 ICU gadoji a kowace 100,000 a cikin Nuwamba 2020).
Halin da ake ciki na yanayin da aka danganta da yawan ƙarfin kulawa da lafiya, tare da ƙididdigar cutar a cikin EU da Burtaniya game da yaduwar COVID-19 na rashin lafiya da ke da alaƙa da haɗarin fiye da 90% na ƙarfin ƙarfin kulawa da lafiya, an bayyana a cikin sabon sabuntawa na shida na ECDC Rapid COVID-19 Risk Assessment.
Saboda yawan adadin masu kamuwa da cutar a cikin EU da Birtaniya, da kuma asibitoci da dakunan kula da marasa lafiya da ke kula da mutanen da ke cikin wani yanki, ya fi dacewa a tattara bayanai kan yawan masu kamuwa da cutar da kuma yawan marasa lafiya a cikin rukunin ƙididdigar yanki na matakin 2 (2-NUTS).
Kwarewar Italiya da yanayin da ake ciki a wasu ƙasashe sun nuna cewa COVID-19 yana yaduwa cikin sauri a cikin EU da Burtaniya.
Kasashe, asibitoci da kuma sassan kula da masu cutar masu tsanani dole ne su shirya don yanayin da zai iya haifar da ci gaba da yaduwar SARS-CoV-2 a cikin al'umma da kuma karuwar masu cutar COVID-19 da ke buƙatar kulawa ta kiwon lafiya da kulawa ta musamman, kamar yadda ake gani a yanzu a yankunan da ke fama da cutar a Italiya.
A cewar sabon binciken ECDC na gaggawa, ana buƙatar hanzarta aiwatar da tsari mai mahimmanci don rage yaduwar cutar coronavirus 2-SARS-COV, tare da sauya tsarin daga riƙewa zuwa ragewa, saboda yawan saurin da ake tsammani na ƙididdigar lamura ba zai kasance da cikakken lokaci ga masu yanke shawara da asibitoci ba don fahimta, daidaitawa da daidaitawa idan ya cancanta kuma ba a kan lokaci ba.
Binciken haɗarin gaggawa ya kuma tsara matakan kiwon lafiyar jama'a don rage tasirin wannan annobar ta duniya.
Yanzu akwai wata dama ta musamman da ƙasashe za su iya ƙarawa don rage yaduwar cutar SARS-CoV-2 da rage matsin lamba kan kula da lafiya.
Idan hakan bai yi nasara ba, tsarin kiwon lafiya na sauran ƙasashen EU zai iya shiga cikin kwanaki ko makonni masu zuwa tare da yawan waɗanda ke buƙatar kulawa mai tsanani.
Cutar COVID-19, wanda ya haifar da cutar coronavirus 2 (2-SARS-CoV) ta haifar da cutar cututtukan huhu mai saurin kamuwa da cuta (SARS) ya kashe mutane sama da 3,000 kuma ya kamu da cutar fiye da 80,000 a China da sauran ƙasashe na duniya, wanda zai iya haifar da bala'i ga mutane.
Kamar kwayar cutar SARS-CoV, wanda ya kamu da dubban mutane a 2003, sabon kwayar cutar SARS-CoV-2 na iya zama mai saurin kamuwa da cutar a cikin ƙuda kuma yana haifar da alamun bayyanar cututtuka ta hanyar irin wannan tsari.
COVID-19 ba shi da haɗari da mutuwa fiye da SARS, amma yana da yawan watsawa kuma yana shafar tsofaffi da maza fiye da matasa da mata.
Wannan labarin ya fito ne saboda karuwar adadin cututtukan da ke da alaƙa da wannan sabuwar cuta, yana ba da cikakken bayani game da saurin ci gaban bincike.
Za mu tattauna muhimman al'amuran ilimin cututtuka, ilimin cututtuka, ilimin ƙwayoyin cuta, ganewar asali, magani, da kuma rigakafin cutar.
Duk da cewa har yanzu akwai tambayoyi da yawa da za a yi, muna fatan wannan binciken zai taimaka wajen fahimtar da kuma hana wannan mummunar cuta.
Bikin bazara na ranar 25 ga Janairu, 2020 ya zama abin tunawa ga jama'ar kasar Sin saboda an tilasta musu yin hutun hutunsu na tsawon makonni a gida bayan barkewar cutar.
Wannan kwayar cutar tana da kamanceceniya da kwayar cutar coronavirus (CoV) wacce ta haifar da cutar sankara mai saurin kamuwa da cutar sankara (SARS) a shekarar 2003; saboda haka Hukumar Lafiya ta Duniya (WHO) ta ba da sunan SARS-CoV-2 a ranar 11 ga Fabrairu 2020 da kuma cutar da ke haifar da ita COVID-19.
An gano cewa cutar ta fara ne a Wuhan, China, kuma ta yadu cikin sauri a duk faɗin ƙasar da kuma kusan ƙasashe 50 na duniya.
A ranar 2 ga Maris, 2020, cutar ta kai adadin mutane 80,000 da aka tabbatar sun kamu da cutar COVID-19, wanda ya kai 40,000 da suka warke, tare da mutuwar mutane fiye da 3,000.
WHO ta yi gargadin cewa COVID-19 shine "maƙiyi na farko na jama'a" kuma ya fi ta'addanci ƙarfi.
A cikin ƙasa da watanni biyu, an buga labarai sama da 200 game da COVID-19, wanda ya shafi ilimin ƙwayoyin cuta, ilimin halittu, ilimin halayya, ganewar asali da magani, tun bayan da aka ba da rahoton cutar ta farko a ranar 7 ga Janairu, 2020, kuma an gano jerin kwayoyin halittar kwayar cutar a cikin marasa lafiya da yawa, in ji PubMed.
Wannan bita na kokarin tattara yanayin bincike a cikin wannan sabon binciken da ake yi a cikin sauri.
Da zarar ya fara, muna ƙoƙarin kwatanta COVID-19 da SARS da sauran cututtukan coronavirus da cutar ta gabas ta tsakiya ta numfashi (MERS, 2012 pandemic).
Muna kuma tattauna abin da muka sani game da rigakafin cutar da kuma abin da za ta iya haifar da shi, da kuma wasu tambayoyi masu muhimmanci da ba a amsa ba.
Coronaviruses ana ɗaukarsu a matsayin masu cutarwa ga mutane kuma suna da alhakin kusan kashi 15% na mura na yau da kullun.
Duk da haka, a cikin wannan karni, mun fuskanci mutum-mai-mutu coronavirus sau biyu, SARS-CoV da MERS-CoV, wanda ya haifar da barkewar cutar a China a 2003 da Saudi Arabia a 2012, kuma da sauri ya bazu a cikin ƙasashe da yawa a duniya, yana haifar da mummunan kamuwa da cuta da mutuwa.
Wannan na nufin cewa COVID-19 ita ce cutar koronaviral ta uku da ta fi yawa a tarihin ɗan adam.
Hakanan an nuna a cikin adadi na 1.1.1, an fara samun kamuwa da cutar ta hanta da ba a san asalin ta ba a Wuhan a ranar 31 ga Disamba, 2019 a Hukumar Lafiya ta kasar Sin.
Bayan mako guda, an fitar da jerin kwayoyin halittar kwayar cutar corona.
A ranar 15 ga Janairu, 2020, an ba da rahoton mutuwar farko a Wuhan.
A wannan lokacin, cutar ta yadu cikin sauri a birane, larduna da kuma kasashe masu makwabtaka da su.
A ranar 20 ga Janairu, an ba da sanarwar kamuwa da cutar a tsakanin ma'aikatan kiwon lafiya, kuma an ba da sanarwar cewa cutar na iya yaduwa daga mutum zuwa mutum.
A ranar 23 ga Janairu, an kebe Wuhan kuma an dakatar da dukkan sassan sufuri.
A ranar 24 ga Disamba, wani bincike na farko ya nuna cewa daga cikin mutane 41 da aka tabbatar sun kamu da cutar, 21 ne kawai suka kamu da cutar daga kasuwannin abincin teku, wanda hakan ya sa aka gano asalin cutar daga wani dabbobin da ba a san asalinsa ba.
A ranar 30 ga Janairu, Hukumar Lafiya ta Duniya ta ayyana barkewar cutar a matsayin matsalar gaggawa ta duniya.
Ya zuwa lokacin wannan rahoton, cutar ta bazu a duk faɗin China da kusan ƙasashe 50 a duniya.
Saboda yanayin yana tasowa da sauri, tsawon lokaci da kuma tsananin cutar ta kasance a buɗe.
A ranar 11 ga Fabrairu, 2020, an gudanar da bincike mai zurfi a kan marasa lafiya 8,866 wanda ya nuna cewa 4,021 sun kamu da cutar COVID-19 wanda ya nuna sabon hoto na cutar a cikin al'umma (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana shafar mutane a cikin kowane zamani, amma mafi yawan mutane suna tsakanin shekaru 30-65.
Kusan rabin (47.7%) na masu kamuwa da cutar sun kasance sama da shekaru 50, kaɗan ne daga cikinsu suna ƙasa da shekaru 20, kuma 14 ne kawai ke ƙasa da shekaru 10.
Matsakaicin kamuwa da cutar SARS-CoV-2 ya kasance mafi girma a cikin maza (0.31/100,000) fiye da mata (0.27/100,000).
An samu karuwar masu cutar COVID-19 a Hubei da kewayenta.
COVID-19 yakan ɗauki matsakaicin kwanaki 5 (9-2) kafin a iya gano mutum.
A matsakaici, tsawon lokaci daga kamuwa zuwa bayyanar cutar shine kwanaki 4.8 (7.2-3.0).
Hakanan yana kashe mutum a cikin matsakaicin kwanaki 9.5 (13-4.8).
Matsakaicin farfadowa na farko (R0) na cutar shine 3.77 (95% CI:3.51-4.05), kuma daidaitaccen farfadowa na R0 shine 4.82-2.32.
Adadin masu kamuwa da cutar ya karu sosai kafin 23 ga Disamba, wanda ya zo daidai da yawan zirga-zirga da kuma jigilar mutane kafin bikin bazara na China.
Halin mutuwa a cikin tabbatattun lamura ya kai 1.44% (95% CI:1.10-1.86%) kuma daidaitaccen mutuwar a cikin dukkan masu kamuwa da cutar ya kai 3.06% (95% CI:2.02-4.59%).
Abubuwa uku da suka fi haifar da haɗarin kamuwa da COVID-19 sune jinsi (maza), shekaru (sama da 60), da cututtukan numfashi.
Coronaviruses suna cikin manyan, masu kama da juna, waɗanda ke ƙunshe da RNA.
Ana iya rarraba shi zuwa nau'i huɗu, wato, Alpha, Beta, Gamma, da Delta. Guda biyu na Alpha da Beta coronaviruses suna iya cutar da mutane.
A cikin SARS-CoV da MERS-CoV, kwayar glycoprotein spike (S) tana haɗuwa da enzyme mai canza angiotensin 2 (ACE2) da mai karɓar dipeptidyl peptidase 4 (DPP4) tare da haɗuwa da ƙwayar cuta.
Kwayar halittar RNA ta kwayar cutar tana cikin cytoplasm; bayan kwayar halittar kwayar cutar ta ninka, RNA na kwayar halitta tare da wasu glycoproteins da sunadarai na nucleosides na kwayar cutar sun yi amfani da su don yin kwayar cutar.
An sanar da jerin kwayoyin halittar farko na kwayar cutar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 coronavirus wani sabon nau'in coronavirus ne wanda ke da kashi 99.98% na bayanin kwayoyin halittar tsakanin samfuran 10 da aka tattara daga babban asalin cutar a kasuwar abincin teku ta Hunan da ke Wuhan.
SARS-CoV-2 yana da kamannin kwayoyin halitta na SARS-CoV-2 da MERS-CoV.
Ta hanyar microscopy na watsawa na lantarki, an gano SARS-CoV-2 coronavirus a cikin ɓangarorin ultrasound na ƙwayoyin cuta da ke rufe hanyoyin numfashi na mutum.
An gano ACE2 na ɗan adam a matsayin mai karɓar duka SARS-CoV-2 da SARS-CoV.
Koyaya, SARS-CoV-2 ba shi da ƙarfi sosai a kan mutum ACE2, wanda ya sa cutar ta SARS-CoV-2 ba ta da ƙarfi kamar ta SARS-CoV.
Hakanan, SARS-CoV-2 na iya samar da sabon kwayar halitta wanda aka sanya shi ta hanyar orf3b da kuma kwayar halitta da aka sanya ta hanyar orf8.
SARS-CoV-2 coronavirus orf3b na iya taka rawa a cikin kwayar cutar ta hanyar hana IFNβ bayyana; yayin da, orf8 ba shi da wani aikin da aka sani.
A ranar 18 ga Fabrairu, 2020, Xu da abokan aikinsa sun bayyana tsarin cryo-EM na cikakkiyar ACE2 na ɗan adam a cikin ƙayyadadden A 2.9 wanda aka haɗa tare da amino acid mai ƙarancin B0AT1.
Sun gano cewa wannan tsari na buɗewa da rufewa, kamar yadda aka haɗa da dimers, da kuma haɗin ACE2-B0AT1 zai iya haɗa sunadarin S guda biyu, yana ba da tabbaci ga ganowa da kuma hana coronavirus.
B0AT1 na iya zama makasudin magani don gwajin magunguna don hana kamuwa da cutar SARS-CoV-2
Gida da kuma makarantar sakandare
An gano cewa asalin SARS-CoV da MERS-CoV sun fito ne daga bat, kuma an ba da su ga mutane ta hanyar cats da al'amuran da ke cikin al'ada.
Ta hanyar kwatanta phylogenetics na SARS-CoV-2 coronavirus tare da sauran coronaviruses, an gano bat a matsayin asalin SARS-CoV-2 coronavirus host host saboda wannan sabon kwayar cutar yana da kashi 96% kama da sauran SARS-CoVs na bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, yadda kwayar cutar ta taimaka wa kwayar cutar ta tsallake shingen nau'in kuma ta wuce zuwa ga mutane har yanzu ba a gano ba kuma hanyar watsawa har yanzu tana buƙatar bayani.
Ji da abokan aikinsa, Mari sun bayyana shi a matsayin mai watsa kwayar cutar daga beraye zuwa mutane wanda ke haifar da haɗuwa da sunadarin sunadarai na S.
A cewar wani bincike, masu bincike a Guangzhou, China, sun bayyana cewa pangolin - wani dabba mai cin naman dabbobi da ake yawan amfani da shi a likitancin gargajiya na kasar Sin - na iya zama kwayar cutar SARS-CoV-2 saboda akwai daidaiton kwayar halitta tsakanin ƙwayoyin da aka gano a pangolin da SARS-CoV-2 coronavirus.
Duk da haka, bambancin kwayar halitta na 1% tsakanin ƙwayoyin cuta biyu har yanzu babban bambanci ne, don haka ana sa ran ƙarin shaida don yanke hukunci. (Fig.33.)
Har yanzu ba a gano cikakken ilimin kimiyyar jiki da na sinadarai na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV coronaviruses a cikin yanayin exotic na iya rayuwa har zuwa awanni 48 a cikin bushewar yanayi da har zuwa kwanaki 5 a zafin jiki ƙasa da digiri 20 da zafi mai zafi na 40% -50%.
Coronavirus SARS-CoV-2 na iya samun irin wannan yanayin.
An bayar da rahoton cewa SARS-CoV-2 coronavirus yana da tsananin haske, rashin ƙarfi, da zafi 56 ° C na tsawon minti 30; acetylcholine, 75% ethanol, chlorine idan akwai maganin rigakafin cutar, peroxyacetic acid, chloroform, da sauran abubuwan da ke haifar da ƙwayoyin cuta, ban da chlorhexidine, na iya kashe kwayar cutar sosai.
Mutane gabaɗaya ba su da rigakafi ga SARS-CoV-2 kuma suna iya kamuwa da wannan sabon ƙwayar cutar.
A halin yanzu, babu wani cikakken bincike da aka bayar game da rigakafin rigakafin SARS-CoV-2.
Saboda haka, zamu iya kawai yin la'akari da binciken da aka yi a baya game da coronaviruses, musamman SARS-CoV da MERS-CoV (Fig. 4).
Gabaɗaya, bayan kwayar cutar ta shiga cikin mahaifa, ana fara gano ta ta hanyar tsarin rigakafin ƙwayar cuta ta hanyar masu karɓar nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'i nau'in nau'i nau'i nau'i nau'in nau'in nau'in nau'i nau'in nau'in nau'in nau'in nau'in nau'i nau'i nau'in nau'i nau'i nau'i nau'i nau'i nau'i nau'in nau'i nau'i nau'i nau'in nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau nau'i nau'i nau'i nau'i nau nau'i nau nau'i nau'i nau nau'i nau'i nau'i nau'i nau nau'i nau'i nau'i nau'i nau nau nau'i nau'i nau nau'i nau'i nau nau'i nau nau'i nau'i nau nau nau'i nau nau nau nau'i nau nau nau nau nau nau nau nau'i nau nau'i nau nau'i nau nau nau nau'i nau nau nau nau nau nau nau nau nau'i nau nau'i nau nau nau nau nau nau nau nau nau nau nau nau nau nau nau nau nau nau nau'i
Ta hanyoyi daban-daban, kwayar cutar tana haifar da kamuwa da cuta, ƙwayoyin dendritic da kuma samar da ƙwayoyin cuta na I (IFNs) waɗanda ke iyakance yaduwar kwayar cutar da hanzarta fasositis na kwayar cutar ta kwayar cutar.
Hakanan, sunadarin N-type na SARS-CoV yana taimakawa kwayar cutar ta tsere daga amsawar garkuwar jiki.
Ba da daɗewa ba, rigakafin da ya dace zai yi daidai da ƙwayar cutar.
T lymphoma wanda ke da CD4+CD8+T yana taka muhimmiyar rawa a cikin rigakafin.
Kwayoyin CD4 + T suna motsa ƙwayoyin B don samar da ƙwayoyin ƙwayoyin cuta na musamman da ƙwayoyin cuta, kuma CD8 + T suna kashe ƙwayoyin cuta kai tsaye.
Kwayoyin T masu taimakawa suna samar da cytokines na pre-inflammatory don taimakawa ƙwayoyin rigakafi.
Hakanan, coronaviruses na iya hana aikin T-cell ta hanyar kashe T-cells.
Hakanan ana buƙatar rigakafin ruwa wanda ya haɗa da C3a da C5a da kuma masu kare jiki don yaƙar kamuwa da kwayar cutar.
Misali, kwayoyin cutar da aka samo daga mutanen da suka warke daga coronavirus suna kashe kwayar cutar MERS-CoV.
A wani bangaren kuma, rashin aiki na tsarin garkuwar jiki na haifar da yawan radicals na kyauta wanda ke haifar da mummunan lalacewar huhu da sauran gabobin jiki, kuma a cikin mafi munin yanayi, yana haifar da raunin jiki da yawa har ma da mutuwa.
Cutar kwayar cutar SARS-CoV-2 ta samo asali ne daga ƙwai, kuma yana iya kamuwa da tsofaffi da mata masu juna biyu.
Gabaɗaya, mutanen da ke fuskantar haɗarin kamuwa da ƙwayoyin cuta ko kuma ke fama da cututtukan rigakafi suna da haɗarin kamuwa da cutar fiye da sauran mutane.
Dangane da nazarin 425 na farko da aka gudanar a Wuhan, an kiyasta lokacin bayyanar SARS-CoV-2 na kwanaki 1-14 kuma mafi yawa daga kwanaki 3-7.
A wani binciken kuma, an nuna cewa matsakaicin lokacin bayyanar cutar a cikin mutane 1,099 ya kai kwanaki 3, kuma daga kwanaki 0 zuwa 24.
Binciken da aka yi kwanan nan, wanda aka ambata a sama, ya nuna cewa tsawon lokacin bayyanar cutar ya kai kwanaki 4.8 (7.2-3.0) a cikin yawan mutanen 8,866 da suka kamu da cutar.
Yana da mahimmanci ga hukumomin kiwon lafiya su tsara lokacin keɓewa mai inganci don daidaita lokacin bayyanar cutar, don haka hana yaduwar cutar daga wanda ba shi da alamun cutar zuwa wasu.
A matsayin al'ada, mutanen da suka kamu ko kuma suka kamu da wasu cututtuka, yawanci ana bukatar su killace su na tsawon kwanaki 14.
Shin ya kamata a tsawaita lokacin killacewa zuwa kwanaki 24?
Mafi yawan alamun farko na COVID-19 na iya faruwa a matsayin guda ko tare da alamun bayyanar cututtuka kamar tari mai bushewa, rashin numfashi, ciwon tsoka, ciwon kai, ciwon kai, ƙonewar hanci, hawan hanci, ciwon kirji, rashin ƙarfi, rikicewar zuciya, da kuma tashin hankali.
Wasu daga cikin wadanda suka kamu da cutar sun kamu da cutar numfashi/low oxygen a cikin jini mako guda bayan kamuwa da cutar.
A cikin matsanancin yanayi, cutar tana saurin ci gaba zuwa matsalar numfashi, hawan jini da kuma rashin ƙarfi, acidicity da kuma cututtukan jini.
An bukaci marasa lafiya da ke da alamun cutar ta huhu da kuma/ko kuma na ciwon hanci da na hanci, ko da kuwa ba a samu wani sabon abu ba a gwajin huhu, su yi gwajin cutar da wuri-wuri.
Wani bincike da aka yi a ƙarshen Disamba 2019 ya nuna cewa kashi 98% na marasa lafiya suna da tari, 76% na tari mai bushe, 55% na wahalar numfashi, 3% na tari, kuma 8% na buƙatar taimakon na'urar numfashi.
Bincike biyu da aka yi kwanan nan a kan wani nau'in kwayar cuta da kuma kwayar cuta mai yaduwa a cikin mutane marasa lafiya sun ba da irin wannan sakamakon.
A cikin kwatankwacin, ƙididdigar yawan jama'a a cikin 2012 ya nuna cewa MERS-CoV marasa lafiya kuma suna da alamun bayyanar cututtuka (98%), tari (47%), huhu (55%) da kuma cututtukan huhu (55%).
Duk da haka, kashi 80% na marasa lafiya sun buƙaci taimakon numfashi, wanda ya fi yawa fiye da marasa lafiya na COVID-19, wanda ya dace da yawan mutuwar MERS fiye da COVID-19.
An kuma lura da tashin zuciya (26%) da kuma konewa (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, an gano cewa kashi 100 zuwa 99 cikin 100 na masu cutar suna da tari mai tsanani (75 zuwa 29 cikin 100), rashin numfashi (42 zuwa 40 cikin dari), gudawa (25 zuwa 20 cikin dari), da kuma ciwon hanci (25 zuwa 13 cikin dari) sune manyan alamomi, kuma kimanin kashi 20 zuwa 14 cikin dari na masu cutar sun buƙaci a yi musu aikin numfashi.
Ya zuwa ranar 14 ga Fabrairu, yawan mutanen da suka mutu daga COVID-19 ya kasance 2% yayin da aka tabbatar da mutane 66,576 a duniya.
A kwatankwacinsa, yawan mutuwar SARS ya kai kashi 10% na 8,096 da aka tabbatar a watan Nuwamba na 2002.
Ga MERS, yawan mutuwar ya kasance 37% daga cikin 2,494 da aka tabbatar da su, a cewar wani binciken demographic a watan Yunin 2012.
Wani binciken da aka yi a baya ya nuna cewa R0 na SARS-CoV-2 coronavirus ya kai 6.47, wanda ya sa ya zama 95% CI na 7.23-5.71, yayin da R0 na SARS-CoV ya kasance tsakanin 2 da 4.
An kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da alamun bayyanar, yawan mutuwarsu, da R0 a cikin Tebur na 1.1.
Abubuwan da ke sama sun nuna cewa SARS-CoV-2 coronavirus yana da damar yaduwa fiye da MERS-CoV da SARS-CoV, amma ƙasa da sauran biyun.
Saboda haka, yana da wuya a sarrafa SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
A yawancin lokuta, ana yin bikin ne a gida ɗaya, a cikin taro ɗaya, ko a kan wani jirgin ruwa mai tafiya, kamar jirgin ruwa.
Yawancin lokaci, marasa lafiya suna da alaƙa da mutane da suka kamu da cutar, sun yi tafiya ko sun zauna a Wuhan ko wasu yankuna da cutar ta shafa, ko kuma sun yi hulɗa da mutane da suka kamu da cutar ko kuma marasa lafiya, a cikin makonni biyu da suka fara kamuwa da cutar.
Bugu da ƙari, an ba da rahoton cewa mutane na iya ɗaukar kwayar cutar fiye da makonni biyu ba tare da bayyanar da alamun cutar ba, kuma marasa lafiya da suka warke bayan an sallame su daga asibiti na iya sake kamuwa da cutar, wanda hakan ya zama abin ƙyama ga tsawaita lokacin keɓewa.
A cikin marasa lafiya da ke cikin farkon matakan, ƙwayoyin ƙwayoyin cuta na waje (musamman lymphocytes) suna da yawa ko ƙananan.
Misali, an sami lymphopenia tare da adadin farin kwayar cutar < 4x109/L kuma an sami adadin lymphocyte na < 1x109/L kuma an sami karuwar matakan aminotransferase aspartate da kuma kwayar cutar kwayar cutar kwayar cutar a cikin marasa lafiya 1,099 na COVID-19.
An sami karuwar matakan enzymes na musculoskeletal da na ciki da myoglobin a cikin jinin wasu marasa lafiya, kuma sun sami karuwar amfanin C-reactive protein da kwayar halitta mai ɗauke da jini a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya da ke da cutar, matakan D-dimer, wani sinadarin plasmid na fibrin, da ke cikin jini, ya tashi kuma adadin ƙwayoyin lymphocytes ya ragu sosai.
An lura da rashin daidaito na radiation na nono a cikin yawancin marasa lafiya na COVID-19 kuma ya bayyana a matsayin inuwa mai haske mai haske a kowane gefe ko duhu mai kama da gilashin da ke cikin huhu.
Marasa lafiya galibi suna nuna cututtukan huhu na rashin lafiya, mummunan rauni na huhu, da kuma ciwon huhu mai tsanani (ARDS).
Lokacin da ARDS ta faru, rashin kulawar kumburi, tarin ruwa, da kuma ci gaba da fibrosis, yana haifar da haɗarin musayar gas.
Rashin aiki na kwayoyin cutar pneumocytes na 1 da na 2 yana rage matakan sulfafacyanate kuma yana ƙara yawan ƙwayar ƙwayar cuta, don haka rage ikon huhu don fadadawa, kuma yana ƙara haɗarin kamuwa da cutar huhu.
Saboda haka, idan an nuna cewa cutar ta daɗa muni, za a iya cewa cutar ta daɗa muni.
A ranar 18 ga Fabrairu, 2020, bincike na farko na ilimin cututtuka na COVID-19 ya nuna cewa mutuwar ƙwayoyin cuta, ƙwayoyin cuta, da kuma ƙwaƙwalwar ƙwayar cuta, da kuma ƙwayoyin cuta masu haɗuwa a cikin huhu na marasa lafiya da suka mutu daga wannan cutar, sun yi daidai da cututtukan cututtukan ƙwayar cuta da ARDS kuma sun yi kama da na marasa lafiya da SARS da MERS.
Gano RNA na SARS-CoV-2 coronavirus ta hanyar aikin RT-PCR ya zama babban ma'auni don gano COVID-19 a cikin cutar.
Ko da yake farashin maganganun ƙarya na iya saurin yaduwar cutar, an fara amfani da alamar cututtuka don gano cutar a China a ranar 13 ga Fabrairu 2020 (saboda ba a ƙara dogaro da RT-PCR).
Hakanan, an sami irin wannan yanayin don gano SARS.
A sakamakon haka, haɗuwa da tarihin cutar, alamun cututtuka, gwajin gwaji, da kuma binciken bincike don samun ingantaccen ganewar asali.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana wata yarjejeniya ta amfani da SHERLOCK ko CRISPR-based technique don gano SARS-CoV-2 coronavirus, wanda ke gano RNA na SARS-CoV-2 a cikin 20x10-18mol/L zuwa 200x10-18mol/L (10-100 kofe na kowane microliter da aka fitar) ta hanyar karɓar ƙwayar cuta a cikin ƙwanƙwasa ɗaya a cikin ƙasa da sa'a ɗaya ba tare da buƙatar kayan aiki mai mahimmanci ba.
Muna fatan cewa wannan sabuwar hanyar, idan an tabbatar da ita, za ta iya ƙara ƙwarewa da sauƙin gwajin asibiti.
Saboda rashin ƙwarewa a cikin sabon coronavirus, likitoci na iya ba da kulawa ga marasa lafiya da COVID-19, duk da haka suna iya amfani da hanyoyin da aka saba amfani da su ga marasa lafiya da SARS-CoV, MERS-CoV da sauran cututtukan ƙwayoyin cuta.
Wadannan jiyya sun hada da magungunan antiviral da ake amfani da su a yanzu da magungunan ɓoye, masu hana garkuwar jiki, steroids, plasma na marasa lafiya, magungunan gargajiya, da kuma taimakon tunani.
An ba da shawarar yin amfani da plasma daga marasa lafiya da suka warke don magani.
Kamfanonin ƙwayoyi suna cikin tsere don samar da maganin rigakafi da allurar rigakafi ga cutar.
SARS-CoV-2 coronavirus yana kaiwa ga tsarin numfashi ne kuma yana iya, har ma da ƙananan, kaiwa ga gabobin da ke ɗauke da ACE2, kamar tsarin narkewa da ƙoda.
Bugu da ƙari, rashin aiki da rashin lafiyar tsarin numfashi shine babban haɗarin marasa lafiya da kuma babban dalilin mutuwar masu fama da cutar.
Saboda haka, taimakon numfashi yana da mahimmanci don rage bayyanar cututtuka da ceton rayuka, wanda ya haɗa da maganin oxygen na yau da kullun, maganin oxygen na hyperbaric, ba da iska mai iska, iska mai iska, iska mai iska, gwargwadon yanayin cutar.
Marasa lafiya da ke da alamun cutar huhu mai tsanani za a ba su maganin ECMO, wata hanyar bugun zuciya da kuma gyaran numfashi don magance cututtukan numfashi ko kuma na zuciya.
Bugu da ƙari, kula da daidaiton electrolyte, rigakafi da magani na ƙananan ƙwayoyin cuta da damuwa na septic, da kuma kiyaye aikin gabobin jiki na da mahimmanci ga marasa lafiya na SARS-CoV-2 coronavirus.
An kuma gano cewa cytocan cyclone sakamakon sakamakon sakamakon amsawar rigakafin rigakafi na SARS da MERS.
Tsoron cytokine wani nau'i ne na amsar kumburi na tsarin da ake yi ta hanyar sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Waɗannan cytokines suna tilasta ƙwayoyin rigakafi su saki babban adadin free radicals, wanda shine babban dalilin ARDS da rashin aiki na gabobin daban-daban.
An yi amfani da maganin rigakafin rigakafi don magance cutar cytokine, musamman a cikin marasa lafiya.
An yi amfani da corticosteroids da tosylisumab, da kuma anti-IL6 monoclonal antibody, don magance hadari na cytokine.
Sauran hanyoyin magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na cututtukan cututtuka na cututtuka na cututtuka na cututtukan cututtukan cututtukan cututtukan cututtuka na cututtukan cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka.
Ana amfani da steroid a matsayin maganin rigakafi don magance SARS, wanda aka tsara don rage girman cutar.
Bugu da ƙari, yawan shan steroid ba zai iya taimakawa ba a cikin SARS da COVID-19 idan an sha shi da yawa.
Maimakon haka, zai iya haifar da sakamako masu illa, musamman neurosyncosis, wanda zai iya shafar ganewar asali.
Bugu da ƙari, an ba da shawarar yin amfani da gajerun hanyoyin maganin steroid a cikin ƙananan zuwa matsakaici don amfani da marasa lafiya na COVID-19 waɗanda ba su da lafiya.
A lokacin wannan rubutun, ba a tabbatar da ingancin maganin antiviral ba.
Koyaya, allurar rigakafin ƙwayar cuta ta remdesivir, wani analog na nucleotide, ya nuna tasiri a kan wani mai cutar COVID-19 na Amurka.
Remdesivir wani sabon magani ne na maganin rigakafi wanda Gilead ta fara samarwa don magance cututtukan da suka haifar da cutar ta Ebola da cutar ta Malburg.
Daga baya, Remdesivir ya kuma nuna tasirinsa a kan hana kwayoyin RNA na mutum, ciki har da SARS da MERS.
A cewar su, Gilead ya ba da wannan kayan aikin don yin gwajin cutar SARS-CoV-2 ga China kuma sakamakon ya kasance mai hasashe.
Bugu da ƙari, barisitinib, interferon alfa, lopinavir/ritonavir, da ribavirin, an ba da shawarar su zama magunguna masu mahimmanci ga marasa lafiya da ke da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka.
Cutar ciki, ciwon zuciya, zubar da jini, rashin aiki na hanta, da sauran cututtukan da ke tattare da cututtukan hanta na iya faruwa bayan maganin ritonavir / lopinavir.
Dole ne a kula da hulɗar waɗannan magunguna tare da sauran magunguna a cikin marasa lafiya.
Plasma daga marasa lafiya da aka warkar da kuma samar da antibodies
Tattara jinin mutane da suka tsira daga wata annoba da amfani da shi don warkar da wasu da suka kamu da cutar ko don kare lafiyar mutane daga kamuwa da cutar yana da tarihi mai tsawo.
A gaskiya, marasa lafiya da suka warke sukan sami adadi mai yawa na ƙwayoyin rigakafi don yaƙar ƙwayoyin cuta a cikin jinin su.
Antibodies sune immunoglobulin (lg) da aka samar da ƙwayoyin cuta na B na lymphocytes don yaƙi da pathogens da sauran maƙasudin waje kuma suna gano ƙwayoyin cuta na musamman a cikin pathogen kuma suna daidaita su kai tsaye.
An yi amfani da wannan don haɗa plasma na jini daga ƙungiyar marasa lafiya da suka warke daga COVID-19 zuwa jini na marasa lafiya 10.
Alamar ta dawo cikin su bayan sa'o'i 24, kuma sun rage kamuwa da cuta da ƙwayoyin cuta, da kuma inganta haɓakar oxygen a cikin jini.
Duk da haka, ana buƙatar tabbatarwa da bayani don bayar da shawarar tsari da amfani a kan sikelin kafin ci gaba da magunguna na musamman.
Bugu da ƙari, tare da la'akari da tasirin magani, wasu haɗari masu alaƙa da plasma ya kamata a yi la'akari da su sosai.
Alal misali, ƙwayoyin rigakafi na iya haifar da amsawar da ta wuce kima kuma ta haifar da cutar fitowar cytokine wanda zai iya zama mai barazanar rai.
Antibodies a cikin jini sun fi ƙarancin al'ada, kuma ana buƙatar plasma don kula da marasa lafiya.
Samun da kuma gina maganin rigakafi na musamman wanda ke da sauri don yaƙi cutar ta duniya yana da wuya.
Saboda haka, gano ƙwayoyin B daga marasa lafiya da suka warke da gano lambar halittarsu da kuma ɓoye magungunan rigakafi masu tasiri, ko kuma bincika magungunan da ke shafar sunadarai na kwayar cutar, yana da mahimmanci.
Idan za a iya yin haka, za a iya samar da maganin rigakafi da sauƙi.
An yi amfani da TCM don magance cututtuka daban-daban a kasar Sin shekaru dubbai.
Duk da haka, tasirinsa ya dogara ne akan haɗuwa da abubuwa da yawa a cikin wani tsari wanda ya bambanta dangane da ganewar cutar bisa ga ka'idojin TCM.
Yawancin abubuwan da ke da tasiri sun kasance ba a sani ba ko kuma ba a sani ba saboda yana da wuya a gano da kuma tabbatar da irin wannan tsari ko kuma haɗuwa.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin madadin magani ga marasa lafiya tare da laushi zuwa matsakaici ko waɗanda suka kamu da cutar kuma suka warke.
Misali, maganin Shu Feng Jie Du da Lian Hua Qing Wen sun yi tasiri a kan COVID-19.
Babban adadin marasa lafiya na COVID-19 an lura da shi a larduna da yawa na China tare da 87% na marasa lafiya da suka karɓi TCM, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da a lardin Hubei, TCM ya kasance kawai 30% na marasa lafiya na COVID-19, kuma yana da ƙarancin ƙimar dawowa (13%).
Duk da haka, wannan ƙaramin abu ne, saboda yawancin abubuwan da ke da tasiri kamar yawan marasa lafiya da kuma tsananin cutar dole ne a yi la'akari da su a cikin kimantawa.
A ranar 18 ga Fabrairun 2020, Boli ZHang da abokan aikinsa sun gudanar da bincike kan kwatancen maganin maganin yamma (WM) da kansa.
Sun gano cewa lokacin da ake buƙata don dawo da zazzabi, bayyanar cututtuka, da kuma buƙatar asibiti a cikin ƙungiyar WM + TCM ya fi ƙasa da na ƙungiyar WM kawai.
Mafi mahimmanci, yawan cututtuka (daga mara kyau zuwa mai tsanani) a cikin ƙungiyar WM+TCM ya kasance ƙasa da ƙungiyar WM kawai (7.4% vs 46.2%) kuma yawan mutuwar a cikin ƙungiyar WM+TCM ya kasance ƙasa da ƙungiyar WM kawai (8.8% vs 39%).
Bugu da ƙari, inganci da amincin TCM har yanzu suna buƙatar ƙarin gwaji mai kyau a cikin manyan-sikelin, ƙarin-cibiyar gwaji.
Hakanan, bayyana yadda aikin yake da kuma bayanin abubuwan da ke cikin maganin TCM ko abubuwan da ke ciki idan ya yiwu.
Marasa lafiya da ake zargi da COVID-19 ko kuma an tabbatar da cutar sau da yawa suna fuskantar babban fargabar cutar ko annoba, kuma waɗanda aka keɓe suna fuskantar damuwa, keɓewa, da tashin hankali.
Bugu da ƙari, alamun bayyanar cututtuka kamar su tashin hankali, hypoxia da tari, da kuma cututtukan magani na cututtuka kamar rashin barci daga amfani da corticosteroids na iya haifar da damuwa da damuwa.
A farkon farkon barkewar SARS, an ba da rahoton yawancin cututtukan ƙwaƙwalwa da suka haɗa da ciwon ciki, damuwa, tashin hankali, tashin hankali, alamun rashin hankali, rashin hankali, har ma da kashe kansa.
Binciken haɗuwa da keɓaɓɓen keɓewa, a matsayin ɓangare na amsar kiwon lafiyar jama'a ga COVID-19, na iya sa mutane su zama masu damuwa da damuwa game da tasirin cutar, keɓewa, da kuma tasirin ta ga iyalansu da abokan su.
Saboda haka, kula da lafiyar hankali ya zama dole ga marasa lafiya na COVID-19, waɗanda ake zargi da waɗanda suka kamu da cutar, da kuma jama'a gaba ɗaya.
Wannan ya kamata ya haɗa da tallafi na tunani, ƙirƙirar ƙungiyoyin kula da lafiyar kwakwalwa, sadarwa mai kyau tare da sabuntawa na yau da kullun da kuma cikakkun bayanai game da yaduwar SARS-CoV-2, shirye-shiryen magani da amfani da na'urorin lantarki da takardun aiki don hana kusanci da mutane.
Ana buƙatar allurar rigakafi mai inganci don katse sarkar watsawa daga dabbobi da mutane da suka kamu da cutar zuwa ƙwayoyin cuta masu saurin kamuwa da cutar, kuma galibi ana amfani da maganin antiviral don sarrafa cutar gama gari ta sabon kwayar cuta.
An sa ido sosai ga ƙoƙarin yin allurar rigakafi bisa ga furotin na S don samar da rigakafin rigakafin rigakafi na dogon lokaci da / ko rigakafin rigakafin rigakafin cutar SARS-CoV.
An gwada allurar rigakafin SARS na kwayoyin halitta a cikin ƙirar dabbobi.
Bugu da ƙari, ba a ƙayyade tasirin in vivo na waɗannan allurar rigakafin rigakafi a cikin mutane masu tsufa da ƙirar ƙira ba kuma ba a ƙayyade kariya daga yaduwar cutar tsakanin mutane da dabbobi ba kafin a fara binciken asibiti.
Wannan na iya zama saboda SARS ya bayyana shekaru 17 da suka wuce kuma ba a sami wani sabon labari ba tun lokacin.
Akasin haka, har yanzu ana samun kamuwa da cutar MERS a Gabas ta Tsakiya kuma tana yaduwa a wasu yankuna saboda ci gaba da samun tushen da aka samu tsakanin mutane da dabbobi a yankunan da cutar ta fi karuwa.
An haɓaka dabarun kwantar da hankali na MERS ta hanyar amfani da ƙwayoyin cuta marasa ƙwayoyin cuta, DNA plasmids, masu ɗaukar hoto, nanoparticles, kwayoyin halittar kwayar halitta, da kuma ƙananan ƙananan sunadarai na recombinant, wasu kuma an kimanta su a cikin dabbobi.
Samar da ingantaccen maganin rigakafin cutar coronavirus SARS-CoV-2 ga mutanen da ba su da rigakafi, ya zama wani gaggawa kuma muhimmin aiki na kula da cutar.
Bugu da ƙari, yana da wuya a shawo kan wannan matsalar saboda tsananin lokacin da ake buƙata don samar da allurar rigakafi (kusan watanni 18) da kuma sauye-sauye a cikin kwayar cutar coronavirus.
A matsayin sabon cutar, COVID-19 ya fara nunawa a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya suna samun lafiya ba tare da wata illa ba.
Koyaya, kamar SARS da MERS, COVID-19 yana haifar da rashin lafiya da mutuwa a cikin marasa lafiya.
Saboda haka, gina samfurin tsinkayen cutar yana da mahimmanci ga hukumomin kiwon lafiya don fifita sabis, musamman a wuraren da albarkatu suke da iyaka.
Dangane da binciken asibiti da aka bayar da rahoto, abubuwan da ke gaba na iya tasiri ko alaƙa da hangen nesa na masu cutar COVID-19 (tebur, tebur na 33):
Shekaru: Shekaru shine mafi mahimmanci a lokacin dawowa daga SARS, kamar yadda yake a COVID-19.
COVID-19 ya fi yawa faruwa a tsakanin shekaru 65 zuwa 30, kuma a cikin binciken da aka yi na mutane 8,866, kashi 47.7 cikin ɗari na masu cutar sun kasance sama da shekaru 50, kamar yadda aka ambata a sama.
Marasa lafiya da ke buƙatar kulawa da lafiya sun fi dacewa da rashin lafiya kuma sun fi tsufa (shekaru na matsakaici na 66 da 51), yana ba da shawarar shekaru a matsayin abin da ke haifar da sakamakon marasa lafiya na COVID-19.
Jinsina: SARS-Cov-2 ya fi kamuwa da maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka ambata a baya.
Sauran cututtukan: marasa lafiya da ke da COVID-19 da ke buƙatar kulawa mai kyau na iya samun cututtukan zuciya ko kuma rashin ƙarfi.
Har ila yau, cututtukan zuciya sun kasance babban dalilin mutuwar marasa lafiya na SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya kamuwa da kwayar cutar ACE2 mai cutarwa ta hanyar kwayar cutar ta ACE2 mai yiwuwa ta haifar da cutar a cikin marasa lafiya na COVID-19.
Dole ne a ce cewa tsufa da cututtukan asali suna da alaƙa sosai kuma suna iya shafar juna.
Sakamakon gwaje-gwaje na ban mamaki: matakin ƙwayar C-type mai amsawa (CRP) a cikin jini yana nuna tsananin ƙonewa ko lalacewar nama kuma yana da mahimmin abin da ke haifar da cutar, amsa magani, da kuma dawo da lafiya.
Hakanan an ba da shawarar haɗi tsakanin matakan CRP tare da tsananin COVID-19 da tsinkaye.
Bugu da ƙari, haɓakar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT) da kuma creatine kinase (CK) na iya taimakawa wajen hasashen sakamakon.
Wadannan enzymes suna da yawa a cikin gabobin jiki, musamman a cikin zuciya da hanta, kuma ana sakin su yayin lalacewar nama.
Saboda haka, waɗannan su ne alamun farko na cututtukan zuciya.
Babban alamun asibiti: Ana la'akari da allurar rigakafi da ci gaba na ɗan lokaci na alamun asibiti tare da sauran batutuwa don hasashen sakamako da rikitarwa na COVID-19.
Amfani da steroid: Kamar yadda aka ambata a baya, steroids suna da tasiri a kan tsarin rigakafi kuma ana amfani da su sau da yawa a matsayin magani na taimako don cututtukan cututtukan cututtuka don rage haɗarin cututtuka.
Saboda yawan amfani da corticosteroids a cikin matsanancin SARS, yawancin waɗanda suka tsira sun kamu da rashin ƙwayoyin ƙwayoyin cuta da rashin ƙwayoyin jini tare da rashin ƙarfi da kuma yanayin rayuwa.
Don haka, idan ya cancanta, ana iya cire shi daga abinci mai ƙarancin steroid kuma a ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Tashin hankali: Kamar yadda aka ambata a baya, yayin barkewar cutar COVID-19, yawancin marasa lafiya suna fuskantar damuwa mai ban mamaki saboda yawancin sun fuskanci tsawan lokacin keɓewa da rashin tabbas da kuma fuskantar mutuwar dangi da abokai.
Dole ne a samar da jagoranci na tunani da kuma taimako na dogon lokaci ga waɗannan marasa lafiya don taimaka musu su shawo kan damuwa kuma su koma rayuwa ta yau da kullun.
Dangane da binciken da aka gudanar a yanzu, COVID-19 yana da nau'ikan watsawa daban-daban fiye da SARS.
Ban da sakewa a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya sakewa a cikin hanyoyin numfashi na sama kuma ya zama mai sauƙi ko rashin bayyanar cututtuka a farkon matakan kamuwa da cuta, kamar sauran coronaviruses da ke haifar da mura.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon matakan cutar ko kuma a lokacin da cutar ba ta bayyana ba, suna iya samar da kwayar cutar a cikin rayuwarsu ta yau da kullun, wanda hakan ke haifar da babban kalubale wajen shawo kan cutar.
Bugu da kari, SARS-CoV yana yaduwa yayin da cutar ta kasance mai saukin kamuwa, yayin da mafi yawan watsawa ba ya faruwa a farkon lokacin.
Saboda wannan, cutar ta COVID-19 da ke faruwa yanzu ta fi ta SARS tsanani da kuma wahalar sarrafawa.
A halin yanzu ana yin ƙoƙari sosai a cikin Sin, gami da rufe Wuhan da biranen da ke kewaye da kuma keɓe kusan dukkan mutane, a cikin fatan dakatar da sarkar watsa SARS-CoV-2.
Duk da cewa wadannan ayyukan sun yi mummunan tasiri ga tattalin arzikin da sauran sassan kasar, yawan sabbin masu kamuwa da cutar ya ragu, wanda ke nuna cewa annobar ta ragu.
Hasashen da aka yi na da tabbaci cewa za a iya kawo karshen annobar a cikin watan Maris, kuma za a iya samun koma baya na tsawon watanni 4 zuwa 3.
Duk da haka, wasu masana ba su da kyakkyawan fata.
Paul Hunter da abokan aikinsa sun yi hasashen cewa COVID-19, wanda ya bayyana yana da saurin kamuwa da cutar fiye da SARS, ba zai ƙare ba a cikin 2020.
Ira Longini da abokan aikinsa sun yi samfurin da ke nuna yiwuwar cutar ta SARS-CoV-2 da ke iya cutar da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 coronavirus a cikin yankuna biyu na tsakiyar turbinate da kuma swabs na ƙaho na marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, yana nuna cewa sabon kwayar cutar za ta iya zama abin da ya faru kamar mura.
A lokaci guda, an samu raguwar sabbin masu kamuwa da cutar a China, wanda ke nuna cewa dabarun na iya yin tasiri.
An yi hasashen cewa cutar Ebola za ta iya kamuwa da mutane miliyan daya da kuma kashe mutane miliyan daya da rabi.
Duk da haka, tare da keɓewa da kuma keɓewar jama'a, cutar za ta iya samun iko.
Wataƙila, kamar SARS-CoV, SARS-CoV-2 zai iya zama mai rauni a cikin iyawar kamuwa da cuta kuma a ƙarshe ya mutu ko ya canza zuwa cutar da ba ta da cuta da ta rage yawan mutane.
An kwatanta yanayin COVID-19 da SARS da MERS a ƙasa (Hotuna. Hotuna.55).
SARS-CoV-2 ana yaduwa ta hanyar kumfa ko farfajiya, kuma wataƙila ta hanyar hulɗa kai tsaye da abubuwan da ke da ƙwayoyin cuta.
An kuma gano wannan cutar a cikin shara, wanda ya ba da damar sabon yiwuwar watsawa daga shara zuwa baki.
Wani sabon bincike na mutane 138 ya nuna cewa kashi 41 cikin 100 na masu cutar sun kamu ne a asibiti, inda mutum 17 daga cikinsu suka kamu da cutar kuma 40 daga cikinsu ma'aikatan kiwon lafiya ne.
Don haka, ya kamata a yi ƙoƙari sosai don kare mutane, musamman ma ma'aikatan kiwon lafiya, masu ba da agaji, membobin dangi, abokan aiki, har ma da matafiya da ke hulɗa da marasa lafiya da waɗanda ke da cutar.
Mataki na farko na kariya wanda za'a iya ɗauka don rage haɗarin kamuwa da cuta shine amfani da abin rufe fuska; amfani da nau'ikan nau'ikan abin rufe fuska na N95 da abin rufe numfashi na N1860 (jerin 1860) na iya taimakawa wajen sarrafa yaduwar cutar.
Abun rufe fuska na likitanci yana hana yaduwar kwayar daga mutum mai cutar ta hanyar iska ko kuma ta hanyar tuntuɓar fuskar wani abu wanda za a iya yadawa zuwa wasu.
Duk da haka, abin rufe fuska na N95 (nau'in lamba 1860) ne kawai zai iya karewa daga ƙwayoyin cuta masu ƙanƙanta daga 10 zuwa 80 nanometers, kuma kawai 5% na ƙwayoyin cuta za su iya yaduwa gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoVH a girma da kusan 85 nanometers.
Saboda ƙwayoyin cuta na iya yaduwa ko da an sanya 5 a jere, masu ba da lafiya waɗanda ke hulɗa kai tsaye da marasa lafiya suna amfani da N95 (nau'in 1860) ba don rufe fuska ba.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya dole ne su sanya abin rufe fuska mai keɓewa don rage haɗarin kamuwa da cutar.
Ƙwayoyin cuta kuma za su iya kamuwa da mutum ta hanyar idanu.
A cikin Janairu 2020, likita ya kamu da SARS-CoV-2 duk da cewa yana amfani da abin rufe fuska na N95; cutar na iya shiga cikin jikinsa ta hanyar kamuwa da cutar ido.
Saboda haka, ma'aikatan kiwon lafiya ya kamata su sa rigar kare fuska da tabarau yayin aiki tare da marasa lafiya.
A cikin yankunan da aka kamu da cutar, an ba da shawarar cewa kowa ya wanke hannayensa da sabulu fiye da yadda ya saba, ya kasance a gida don keɓe kansa, kuma ya rage hulɗa da mutanen da suka kamu da cutar.
Aƙalla ƙafa uku ne ya kamata ka yi nesa da wanda yake rashin lafiya.
Waɗannan ayyuka sune hanyoyin da za a iya amfani da su don rage haɗarin kamuwa da cutar da kuma hana yaduwar cutar.
Kodayake SARS-2 coronavirus ya zama sabon abu ga mutane, akwai wasu kamance da SARS coronavirus da aka ambata a cikin 7/1/2020 wanda zai iya zama babban dalilin sauye-sauye na China dangane da bayanan da aka samu game da barkewar SARS a 2003
Koyaya, har zuwa 19 ga Janairu 2020, Cibiyar Kula da Cututtuka ta Wuhan ba ta gamsar da masu bincike ba cewa cutar ba ta da saurin yaduwa daga mutum zuwa mutum, kuma babu wata matsala game da hanawa da kawar da cutar.
Wannan sakon ya kwantar da hankulan mutane, musamman yayin da duk kasar ke shirin bikin bazara, lokacin da aka rasa himma don sarrafawa da kuma iyakance cutar a cikin mafi ƙarancin yanayi a Wuhan.
Hukumomin kula da lafiya na kasar Sin na iya daukar darasi daga wannan kuma su inganta shi a nan gaba.
Misali, irin waɗannan hukumomi da cibiyoyin dole ne (1) su kasance masu hankali yayin da suke ba da sanarwar jama'a, saboda kowane kalma ga al'ummarsu na iya canza yanke shawara da halayyarsu; (2) zama masu saurin amsawa da amsawa ga bayanan Noring na yau da kullun, maimakon jiran rahotannin likita na hukuma; (3) zama masu ƙwazo wajen iyakance da sarrafa cutar a farkon matakansa maimakon sa mutane su ji daɗi; da kuma (4) zama mafi ƙwarewa da aiki da horo don haɓaka wayar da kan jama'a game da cututtukan cututtuka da kuma tsarin amsawa da amsawa na al'umma. gwada da inganta.
An bayyana cewa cutar ta COVID-19 ta samo asali ne daga wata sabuwar cuta da ake kira SARS-CoV-2 da ta ɓarke a watan Disamba na 2019.
A cikin ƙasa da watanni biyu, ya bazu a duk faɗin China da kusan ƙasashe 50 a duniya, kamar yadda aka rubuta wannan labarin.
Saboda kwayar cutar ta SARS-CoV-CoV mai kama da juna da kuma alamun bayyanar da ke kama da juna tsakanin SARS da COVID-19, yaɗuwar COVID-19 ya sa an ji cewa SARS na dawowa.
Koyaya, akwai wasu bambance-bambance masu ban mamaki tsakanin COVID-19 da SARS, waɗanda sune manyan bambance-bambance a cikin rigakafin cutar da kula da marasa lafiya.
COVID-19 ya fi kamuwa da tsofaffi fiye da matasa, maza fiye da mata, kuma yana da ƙimar cutar da mutuwa a cikin tsofaffi fiye da matasa.
SARS ya fi COVID-19 mutuwa da kashi 10.91% da kashi 1.44.
Marasa lafiya na COVID-19 suna iya yada cutar koda kuwa ba su da alamun cutar, yayin da marasa lafiya na SARS suma suna iya kamuwa da cutar bayan sun kamu da cutar, wanda ke haifar da matsaloli masu yawa wajen hana da kuma iyakance yaduwar COVID-19 kamar SARS.
Wannan ya bayyana, a wani bangare, dalilin da ya sa SARS-CoV-2 ke yaduwa da sauri fiye da SARS-CoV-2.
Gwajin RNA na yau da kullun na SARS-CoV-2 na iya zama mara kyau ga wasu marasa lafiya na COVID-19.
A gefe guda, marasa lafiya da suka warke na iya sake kamuwa da cutar.
Wadannan binciken sun kara hadarin kamuwa da cutar.
Tare da ci gaba mai sauri a cikin binciken COVID-19, wasu batutuwa da aka warware sun kasance, kamar:
Daga ina ne SARS-CoV-2 ya fito?
Kodayake kashi 96% na kwayar halitta tsakanin SARS-CoV-2 da SARS-CoV-2 sun fito ne daga bat, ba za a iya cewa SARS-CoV-2 ya fito ne daga bat ba.
Wace dabba ce ta yi aiki a matsayin matsakaiciyar hanyar watsa kwayar cutar daga wani da ya kamu da cutar, wato, daga barkonon zuwa mutum?
Ba tare da amsa tambayoyin #1 da 2 ba, ba za mu iya dakatar da tasirin da kuma tasirin watsawa ba, kuma cutar na iya sake bayyana a kowane lokaci.
Kodayake binciken kwayoyin halitta da gwajin zinad-kimya sun nuna cewa SARS-CoV-2 ya haɗu da ACE2, ta yaya kwayar cutar ta shiga cikin ƙwayoyin cuta kuma daga baya ta haifar da canje-canje masu alaƙa da cuta?
Shin kwayar cutar za ta iya haɗuwa da ƙwayoyin cuta masu alaƙa da ACE2 a cikin sauran kwayoyin?
Ba tare da amsoshi masu ma'ana ga waɗannan tambayoyin ba, ba za mu iya samun saurin ganewar asali da kuma ingantaccen magani ba.
Har yaushe cutar za ta yi?
Ta yaya kwayar cutar ke samun yawaitar kwayoyin halitta a yayin da ake yaduwa tsakanin mutane?
Shin zai zama annoba mai yaduwa kamar SARS ko kuma zai sake bullowa kamar mura?
Yana da mahimmanci kuma yana iya ɗaukar lokaci don bincika waɗannan tambayoyin da yawa.
Duk da haka, duk da irin wannan amsa da kuma amsa, ba mu da wani zaɓi sai dai mu kawo ƙarshen annobar da wuri-wuri kuma mu dawo da rayuwarmu ta yau da kullun.
Kwayar halittar dabba ta mutum coronavirus
Canji da kuma juyin halitta sun jagoranci ci gaban kwayar cutar corona da kwayoyin halitta, gami da mutane, tsawon dubban shekaru.
Kafin shekara ta 2003, an san kwayar cutar coronaviruses guda biyu da ke haifar da cututtukan yau da kullun, kamar su sanyi da kuma mura.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka, wanda aka fi sani da SARS da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na Mideast, wanda aka fi sani da MERS, sun kasance a matsayin alamar da ke nuna yadda kamuwa da HCoVs ke iya zama mai haɗari da haɗari ga rai.
Cutar SARS-CoV-2 ta sake bullowa a tsakiyar China a ƙarshen 2019 kuma ta yi mamakin yawan kwayar cutar, amma ta rage yawan kamuwa da cuta idan aka kwatanta da SARS-CoV-2 na asali.
HCoVs ana daukar nauyin dabbobi zuwa ga mutane, kuma fahimtar asalin dabba na nau'in HCoV na iya zama mai amfani.
Yawancin nau'ikan HCoVs sun fito ne daga ƙuda, yayin da ba su da cutarwa.
An san matsakaiciyar mahaukaciyar HCoV.
Gano dabbobi masu cin naman dabbobi na taimakawa kai tsaye wajen hana cututtukan mutane.
Nazarin haɗuwa da dabbobi da ke dauke da kwayar cutar corona na iya samar da muhimman bayanai game da cututtukan coronavirus a cikin mutane.
A cikin wannan binciken, za mu gabatar da bayanai game da nau'ikan kwayar cutar corona guda bakwai, tare da yin la'akari da tarihin gano su da kuma abubuwan da suka shafi dabbobi da kuma yadda suke yaduwa tsakanin nau'in.
Abu mai mahimmanci, zamu gano nau'ikan kwayar cutar corona da kuma bambance-bambance a cikin yanayin haɓakar kwayar cutar da kuma tsarin halittar jini.
An tattauna cutar ta kwayar cutar coronavirus (COVID-19) a cikin wannan labarin.
Duk da haka, bukatun don samun nasarar yin amfani da shi ya bambanta kuma an gano abubuwan da ke taimakawa ci gaban kwayar cutar a cikin yanayin cutar.
Kwayoyin cutar corona (CoVs), suna cikin iyali Coronaviridae, wanda ya ƙunshi nau'in ƙwayoyin RNA guda ɗaya da ƙwayoyin cuta masu banƙyama.
Wadannan sun kasance mafi girma a cikin nau'ikan 26 zuwa 32 kilobase na RNA da ake kira "CoVs", saboda suna kama da kambi a ƙarƙashin rufi.
Ainihin, nau'ikan corona suna da nau'ikan ƙwayoyin cuta da aka rarraba da kuma abubuwan da suka dace waɗanda ke da irin wannan tsari.
Kusan kashi biyu cikin uku na kwayoyin halitta suna dauke da manyan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'i nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'i nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'i nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'i nau'i nau'i nau'i nau'ikan nau'i nau nau'ikan nau'i nau'ikan nau'i nau'i nau'ikan nau'i nau'i nau'i nau'i nau nau'ikan nau'i nau'i nau'ikan nau'ikan nau'i nau'i nau'ikan nau'i nau'i nau'i nau'i nau'i nau'ikan nau'i nau'i nau'ikan nau'i nau'
Sunadarai masu yawa suna amfani da sunadarai marasa tsari na 16, wanda aka ƙayyade a matsayin nsp1 ~ 16.
Sauran kwayoyin sun ƙunshi ORFs don sunadarai masu gina jiki, wanda ya haɗa da kaifi (S), murfin (E), membrane (M) da nucleoproteins (N).
An canza wasu sunadarai masu kama da na asali, ta hanyar bambancin ƙwayoyin CoVs.
Dangane da bambancin tsari na furotin, coronaviruses sun kasu kashi 4: alpha-coronaviruses, beta-coronaviruses, gamma-coronaviruses da delta-coronaviruses, daga cikinsu beta-coronaviruses shine mafi yawan adadin coronaviruses kuma an rarraba shi zuwa 4 subtypes (C , B , A , da D).
Shaidar da aka samu ta hanyar nazarin halittu ta nuna cewa, dabbobi masu cin naman kaza da masu cin naman alade suna da irin wannan aiki a matsayin tushen kwayoyin halittar yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune tushen asalin gamma-CoVs da delta-CoVs.
Shekaru da yawa, nau'ikan coronaviruses sun ci gaba da ƙetare shingen nau'ikan su kuma sun haɗu da juna a matsayin masu cutarwa ga mutane.
A halin yanzu, an gano CoVs HCoV guda bakwai na ɗan adam.
HCoV-229E da HCoV2NL63 sune alpha-CoVs, waɗanda suka haɗa da su.
Sauran beta-CoVs 5 sun haɗa da HCoV-OC43, HCoV-HKU1, SARS-CoV, MERS-CoV da SARS-CoV-2.[1]
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da alamun bayyanar cututtuka masu laushi, kamar sanyi da farfaɗiya da / ko tashin zuciya.
Sabanin haka, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano kwanan nan suna da saurin kamuwa da cuta, suna haifar da cututtukan numfashi a cikin yawancin marasa lafiya kuma suna iya haifar da cututtukan numfashi na numfashi (ARDS) da kuma bayyanar cututtukan huhu.
An fara gano cutar HCoV-229E, B814, a cikin numfashi na mutanen da ke da cutar a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bayani ta hanyar bincike mai zurfi game da HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun bayyanar cututtuka.
Tabbas, an yarda da cewa kamuwa da nau'ikan kwayar cutar Corona gaba ɗaya sun fi kamuwa da cutar SARS.
Cutar SARS ta 2003 ta kasance daya daga cikin mafi muni a tarihi, inda ta kama mutane fiye da 8,000, kuma ta kashe kusan kashi 10 cikin ɗari na masu kamuwa da cutar.
Bayan shekaru 10, cutar ta "Middle East respiratory syndrome" ta haifar da cutar da ta mamaye yankin Arabiya tare da yaduwa a duniya.
Coronavirus na 2019 (2019-nCoV), wanda aka sake suna SARS-CoV-2, shine asalin dalilin cutar ta COVID-19 ta 2019 da ke ci gaba, wanda ya kashe mutane 3,120 kuma ya kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
An yi kira kuma duniya dole ne ta shirya don barkewar SARS-CoV-2 mai zuwa.
Dukkanin nau'ikan HCoVs 7 suna da asali na dabba a cikin bats, mice ko dabbobin gida.
Akwai shaidu da yawa da ke goyan bayan ci gaban asalin dukkanin nau'in HCoVs na bat, waɗanda ƙwayoyin cuta ba su da kyau kuma ba su da cuta, amma suna da bambancin ƙwayoyin halitta.
Cutar ta COVID-19 ta haifar da babban ƙalubalen kiwon lafiya, kimiyya, zamantakewa, da ɗabi'a ga China da duniya.
Binciken asalin kwayoyin halittar HCoVs na dabbobi yana ba da tsarin fahimtar tarihin halitta, ikon gudanarwa da kuma dalilan da ke haifar da tsalle-tsalle da kuma sauye-sauye na jinsuna.
Wannan na iya zama mai tasiri ga masu ɗaukar SARS-CoV-2 masu matsakaici da masu haɓaka tare da mahimman taimako don hana yaduwar cutar a nan gaba.
A cikin wannan bincike, za mu yi nazarin asalin halittar dabbobi, yaduwar nau'in, da kuma cutar H-type na coronaviruses.
Musamman, muna ganowa da kuma bayyana nau'i na kwayar cutar corona, wanda ba shi da cutar a cikin kwayar halitta, amma bayan an canza shi zuwa sabon kwayar halitta, ya zama mai cutarwa.
Hakanan muna magana ne game da yanayin coronavirus, inda yawan watsawa koyaushe yana tafiya tare da raguwar yawan asibiti.
Sakamakon ci gaba da yaduwar SARS-CoV-2 an kuma tattauna shi a cikin rubutun.
An gano CoVs na dabbobi a ƙarshen 1930s.
Kafin ware masu kamuwa da B814 HCoV-229E daga numfashi da iska na waɗanda suka kamu da cutar, an ware nau'ikan coronaviruses daga nau'ikan da dama, ciki har da mice, beraye, aladu, dabbobin gida da karnuka.
A cikin 'yan shekarun da suka gabata, an gano nau'o'in coronavirus guda bakwai.
Takaitaccen tarihin gano cutar coronavirus a cikin tsari na zamani, Shafi na 1 yana ba da bayani da kuma jagora.
An fara gano HCoV-229E a cikin 1966 daga masu fama da cutar huhu, kuma daga baya ya samo asali ne daga ƙwayoyin WI-38.
HCoV-229E ya kamu da cututtukan cututtuka na yau da kullun, ciki har da ciwon kai, tashin zuciya, gajiya da maƙarƙashiya, tare da tari da tari wanda aka lura a cikin 10 ~ 20% na masu kamuwa da cutar.
Daga baya a 1967, an ware HCov-OC43 daga ƙwayoyin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta.
Alamomin da bayyanar cututtuka na waɗanda ke da HCoV-OC43 sun yi kama da waɗanda ke haifar da HCoV-229E, wanda aka bambanta da alamomi daga waɗanda ke da cututtukan cututtukan cututtukan cututtukan numfashi, kamar su Influenza A da Rhinovirus.
HCoV-229E da HCoV-OC43 suna rarraba a duniya, ana watsa su ne a cikin hunturu a cikin yanayin sanyi.
Yawanci, rayuwar waɗannan ƙwayoyin cuta ba ta wuce mako guda ba, wanda kusan makonni biyu ke biyo bayan rashin lafiya.
A cewar binciken da aka yi na masu sa kai, mutane masu lafiya sun kamu da cutar HCoV-229E mai ciwo wanda ya kamu da mura
Wasu marasa lafiya da ke da ƙarancin rigakafi ne kawai ke da matsalar rashin numfashi.
SARS, wanda aka fi sani da SARS-CoV, an fara rubuta shi sosai cewa HCoV shine asalin asalin cutar a cikin tarihin ɗan adam kuma SARS-CoV shine mai haifar da kamuwa da cuta, HCoV na uku da aka gano.
An gano farkon SARS a ƙarshen 2002 a lardin Guangdong na China.
Cutar SARS ta haifar da mutane 8,096 da suka kamu da cutar, 774 daga cikinsu suka mutu, kuma wannan ya bazu zuwa ƙasashe da nahiyoyi da dama.
Duk da saurin yaduwar cutar, an yi hasashen cewa kowace cutar za ta iya ninka zuwa biyu, za a iya yin rayuwa tsawon kwanaki 4 zuwa 7, kuma ana iya samun mafi yawan masu dauke da cutar a rana ta 10 na cutar.
Masu cutar SARS-CoV sun fara nuna alamun ciwon tsoka da ciwon kai da rashin jin daɗi da rashin jin daɗi, sannan kuma ana samun rashin jin daɗi da rashin jin daɗi da rashin jin daɗi a matsayin alamun ƙarshe.
Lymphopenia, wanda ke haifar da gwajin gwajin hanta da kuma haɓakar nitrogen a cikin urea, yana haifar da matsala ta rashin lafiyar SARS.
Ciwon huhu da kuma yaduwar kwayar halitta da kuma karuwar macrophages a cikin marasa lafiya na SARS na faruwa.
Kusan kashi 20 zuwa 30% na marasa lafiya daga baya suna buƙatar kulawa mai zurfi da aikin numfashi.
Baya ga ƙananan hanyoyin numfashi, gabobin jiki da yawa, ciki har da tsarin ƙanshi da hanta da ƙwayoyin ƙwayoyin cuta suna fama da matsi mai tsanani wanda ke haifar da ƙwayar cytokine wanda zai iya haifar da mutuwa a cikin marasa lafiya marasa lafiya.
An fara gano cutar ne daga gwajin huhu da aka yi wa wani dangin mai cutar da ya ziyarci Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai a cikin binciken HCoVs.
An cire HCoV-NL63 daga jariri ɗan wata bakwai a Netherlands a ƙarshen 2004.
Da farko an gano cewa yana da yawa a cikin yara da manya da kuma marasa lafiya da ke da rauni da kuma cututtukan cututtuka.
Halin hawan jini, hawan jini a cikin ido, da hawan jini a cikin hanyoyin numfashi na yau da kullun suna faruwa ne saboda HCoV-NL63.
Wani bincike na daban ya bayyana cewa an sami kwayar cutar a cikin kwayar halittar wani jariri mai wata 8 da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a cikin Netherlands, ya zama sananne a duniya.
An kiyasta cewa HCoV-NL63 ya kai kusan 4.7% na cututtukan cututtukan numfashi, tare da faruwar abubuwa a farkon bazara, bazara, da kuma hunturu.
HCoV-NL63 yana da alaƙa da kamuwa da cutar sankara wanda kuma aka sani da cutar sankara.
A wannan shekarar, an cire HCoV-HKU1 daga wani mutum mai shekaru 71 da haihuwa wanda ke kwance a asibiti saboda cutar huhu da kuma cutar huhu a Hong Kong.
Duk da haka, an gano cewa an yi amfani da maganin huhu da kuma maganin huhu na al'umma da HCoV-HKU1 wanda ke da alaƙa da cutar ta Ebola.
HCoV-NL63 da HCoV-229E da HCoV-OC43 da HCoV-HKU1 an gano su a duk duniya kuma sun haifar da cututtukan huhu na huhu.
Dukkanin nau'ikan HCoVs guda huɗu da aka karɓa ta hanyar jama'a suna da kyau a cikin ɗan adam kuma galibi ba su da wataƙila su canza zuwa manyan cututtuka, kodayake abubuwan da suka faru sun faru ne saboda dalilai marasa tabbas kamar yadda ake samun su a cikin ƙananan cututtukan HCoV-NL63 da aka gano kwanan nan suna haifar da ciwon huhu a China.
Gabaɗaya, idan waɗannan HCoVs suka sami damar shiga cikin jikin mutum kuma suka sami damar warkewa a cikin jikin mutum, ba su da haɗari ko haifar da cuta.
An fara gano MERs-CoV a Saudiyya a 2012 daga huhu na wani mai shekaru 60 da haihuwa wanda ya kamu da cutar huhu mai tsanani da kuma rashin lafiya na koda.
Duk da yake yawancin lokuta da aka tabbatar da su a cikin lab suna a Gabas ta Tsakiya, ana samun karuwar karuwar cutar ta hanyar hulɗa ta kusa a ƙasashen Turai da Tunisia.
A cikin 2015, an sake samun barkewar cutar a Koriya ta Kudu inda aka tabbatar da mutane 186 da suka kamu da cutar.
Halin asibiti na MERS ya yi kama da SARS, wanda aka bambanta da ci gaban ciwon huhu na huhu.
Ba kamar SARS ba, yawancin marasa lafiyar MERS suna fama da cututtukan cututtukan ƙwayar cuta, wanda ya bambanta MERS daga masu haddasa cutar HCoV.
Fiye da 30% na marasa lafiya suna da alamun cututtukan tsarin tsarin tsarin, ciki har da haushi da kuma rashes.
A ranar 14 ga Fabrairu, 2020, akwai fiye da mutane 2,500 da aka tabbatar sun kamu da cutar, tare da babban adadin mutuwar da aka samu a kashi 34.4 cikin dari na MERS-CoV, wanda ya kasance daya daga cikin manyan ƙwayoyin cuta da aka sani ga 'yan adam.
A cikin rabin rabin Disamba na 2019, an gano wasu cututtukan huhu masu alaƙa da SARS-CoV-2 da aka gano a Wuhan, lardin Hubei na China.
Hukumar Lafiya ta Duniya ta sanar da cewa cutar SARS-CoV-2 ta haifar da cutar sankarar huhu da kuma zama babbar matsalar kiwon lafiya ta duniya da ake kira COVID-19.
A ranar 3 ga Maris 2020, an tabbatar da mutane 90053 a duniya, wanda ya kai ga mutuwar mutane 3.4.
A cikin Hubei, China, adadin mutuwar ya kai kashi 4.2, yayin da a waje ya kai kashi 1.2 cikin dari.
SARS-CoV-2 kamar SARS-CoV da MERS-CoV suna haifar da cututtukan huhu mai tsanani tare da kamuwa da cuta da kuma rashin ƙarfi na numfashi.
Wasu marasa lafiya suna samun saurin tashin zuciya.
Cutar huhu tana ɗaya daga cikin alamomi masu haɗari kuma tana iya haɓaka cikin sauri zuwa rashin lafiya na numfashi.
Ko da yake SARS-CoV-2 da SARS-CoV-2 suna da alaƙa sosai saboda girman jerin kwayoyin hormonal na 82% a cikin nau'i daban-daban na phylogenetic.
SARS-CoV-2 ya bayyana a matsayin mai saurin kamuwa da cuta amma ya fi yaduwa fiye da SARS-CoV-2 da SARS-CoV-2.
Rahotanni sun ce wadanda ke dauke da SARS-CoV-2 ba su da alamun cutar kuma hakan na iya haifar da saurin yaduwar cutar a duniya.
Ta hanyar kwatanta da kuma juyawa SARS-CoV-2 tare da sauran COVID-19 guda shida, da yawa daga cikin kamance da bambance-bambance sun bayyana a fili.
Na farko, rayuwar rayuwa da tsawon lokacin rayuwa na HCoVs suna da alaƙa.
A wannan ma'anar, SARS-CoV-2 ya bi bayanan da aka samu na sauran HCoV guda shida.
Na biyu, alamun bayyanar COVID-19 sun haɗa da SARS-CoV da HCoVs huɗu da aka karɓa daga al'umma (misali HCoV-229E da HCoV-OC43 da HCoV-HKU1 da HCoV-NL63)
A gefe guda, masu kamuwa da SARS-CoV-2 suna nuna alamun da ake samu a sakamakon kamuwa da HCoVs, ciki har da rashin bayyanar cututtuka, rashin ƙarfi, da rashin lafiya.
A gefe guda, ƙananan ƙananan COVID-19 na iya haɗuwa da SARS-CoV-2 har ma da ƙananan ƙananan ƙananan.
Na uku, SARS-CoV-2 na nuna misalai masu ban sha'awa na halaye na HCoVs da SARS-CoV da ke cikin al'umma.
A gefe guda, yaduwar SARS-CoV-2 ya yi yawa kamar yadda yawan HCoVs ke samun karbuwa a cikin al'umma.
A gefe guda, ya rage a tantance ko yaduwar SARS-CoV-2 zai rage saurin yaduwar cutar zuwa mutum kamar yadda ya faru a SARS-CoV da Mars-CoV.
A ƙarshe, ana iya gano HCoVs da SARS-CoV-2 a cikin samfuran datti.
Ko watsawar SARS-CoV ta hanci yana da muhimmiyar rawa a cikin SARS-CoV, aƙalla a wasu yanayi, ya rage a gani a binciken da ke zuwa.
Hakanan yana da mahimmanci a bincika ko SARS-2 na iya sake bayyanawa a cikin yanayi kamar yadda ake samun HCoVs da aka karɓa a cikin al'umma.
Abubuwan da ke cikin SARS-CoV-2 da ke da alaƙa da yiwuwar watsawa, kamuwa da cuta, da kuma ci gaba da yaduwa bayan shigar da kwayoyin halittar mutum na iya yin tasiri ga maganin ƙarshe na COVID-19 na yanzu.
Kowane HCoVs huɗu da aka gano a cikin jama'a suna haifar da alamun matsakaici wanda ɗan adam ya saba da shi sosai.
A wata hanya kuma, yana iya zama gaskiya cewa ɗan adam yana da ƙwarewa sosai tare da waɗannan nau'ikan HCoVs guda huɗu.
A wasu kalmomin, duka biyun sun tsira daga HCoVs na asali.
HCoVs da ke haifar da cutar mutum sun ɓace, kuma HCoVs masu ɗauke da su sun ɓace.
Don yin wannan, HCoVs dole ne su yi girma a cikin mutane kuma su isa matakin da zai ba da damar yin amfani da kwayar cutar don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka.
A cikin wannan yanayin, ya fi dacewa da SARS-CoV-2 ya ci gaba da yaduwa, saboda haka yawancin kwayoyin cutar za su iya shiga cikin mutane, kuma yawancin za su iya samun damar shiga cikin mutane.
Idan ya daidaita, baza a iya hana yaduwar cutar ga mutane ba ta hanyar yin amfani da allurar rigakafi ko wasu hanyoyin hana yaduwar cutar.
Shekaru da dama, dukkanin nau'o'i hudu na cutar da aka samu a cikin al'umma sun fito ne daga al'amuran yau da kullum da aka ba da su ga jama'a.
Wadannan kwayoyin ba sa bukatar ajiyar bayanai.
Amma a sakamakon sakamakon SARS-CoV da MERS-CoV, ba a iya samun daidaito ga mutane ba, kuma ba za a iya samun damar watsawa ga mutane ba.
Suna buƙatar su zauna kuma su yada a cikin ɗakunan da suke zaune kuma suna neman su yada motsin zuciyar su a cikin manufofin mutum, wanda zai iya zama ta hanyar matsakaici ko kuma mafi girma na gidaje.
Halin SARS-CoV-2 ya yi kama da SARS-CoV da SARS-CoV da kuma dukkanin nau'ikan HCoV guda huɗu da aka karɓa a cikin al'umma.
An yi imanin cewa yana da alaƙa da HCoV da aka samu a cikin ƙananan ƙananan al'ummomi a halin yanzu.
Koyaya, HCoVs da ke shiga cikin al'umma sun fi haifar da rashin lafiya.
Ya rage a ga ko zai iya daidaitawa da mutum kuma ya iya yadawa a cikin jikin mutum ba tare da ajiya ko matsakaicin matsakaici ba.
Kafin tattauna asalin kwayoyin HCoV, yana da kyau muyi la'akari da ma'anar da halayyar masu haɓaka da na halitta da na matsakaici da kuma bunkasa HCoVs.
Kwayar halitta za ta iya haifar da ci gaban kwayar halitta don HCoV idan ta haɗu da wani kwayar halittar da ke kusa da ita ta hanyar musayar homologues a matakin sarkar nucleotide.
Kakanninmu na asali sun saba da yanayin kuma ba sa shiga cikin wannan kwayar cutar.
Hakanan, ruwan da ke cikin gidan zai iya zama mai kare H coronavirus na dindindin kuma na dogon lokaci.
A cikin waɗannan lokuta, masu karɓar baƙi suna da haɗari kuma suna da haɗari ga HCoV ko kwayar cutar.
Hakazalika, idan HCoV ya kamu da cutar kafin ko kuma kusan lokacin da ya kamu da mutane, ba zai iya kamuwa da cutar ba.
Wannan matsakaiciyar salwar salwar tana iya zama tushen tushen rayuwa a cikin cututtukan mutum kuma tana taimakawa wajen haɓaka salwar ta hanyar barin kwayar cutar ta girma cikin ɗan lokaci sannan ta wuce zuwa ga mutum don haɓaka yawan kamuwa da cutar mutum.
HCoVs na iya shiga cikin hanyar kullewar kamuwa da cuta idan ba za su iya tallafawa kansu ba a cikin kwayoyin cuta.
Sabanin haka, HCoVs na iya daidaitawa da ƙwayoyin cuta masu matsakaici, har ma da zama a cikin wani wuri na dogon lokaci.
A wannan yanayin, ƙwayoyin gishiri na tsakiya za su zama ƙwayoyin gishiri na halitta.
Bayanan da aka samu daga sama zuwa kasa sun nuna cewa akwai alamun SARS da ke da alaƙa da tarihin rayuwa.
Binciken da aka yi na yawan masu kamuwa da cutar ya nuna cewa kwayar halittar anti-SARS-CoV lgG ta fi yaduwa fiye da yadda take a cikin jama'a.
Cats masu rufe fuska (Paguma larvatta) da karnuka masu rarrafe da ke zaune a cikin manyan kasuwanni sun fara nuna cewa suna ɗaukar SARS-CoV kamar ƙwayoyin cuta waɗanda ke da alaƙa da SARS-CoV.
Wannan ya ba da tabbaci kai tsaye cewa babu wani labarin SARS da aka samu bayan an kawar da duk kuliyoyin P. larvae daga kasuwanni.
Ko da yake an nuna cewa kuliyoyin P. paguma larvata da ke cikin daji ko waɗanda ke cikin gonaki ba su da alaƙa da rikice-rikicen kasuwa, akwai yiwuwar SARS-CoV ba. Wannan ya ba da shawarar cewa kuliyoyin P. paguma larvata ne kawai ke haifar da haɓakar gida amma ba a cikin ajiyar SARS-CoV ba.
Wannan ya nuna cewa kashi 80 cikin dari na masu cinikin da ke kasuwar Guangzhou sun riga sun sami maganin SARS-CoV, kuma ba za a iya watsi da yiwuwar samun nau'in ƙwayoyin halittar dabbobi masu ƙarancin dabbobi ba.
Duk waɗannan suna nuna ƙarshen SARS-CoV.
Abin da binciken ya gano shi ne cewa sararin samaniya na SARS-CoV-2 yana da alaƙa da Cove bat, kalmar SARS tana nufin bat-bat Rhinolophus Cove HKU3 (SARSr-RH-BatCoV HKU3) wanda ke rayuwa a cikin batunan Hersu na China.
Wadannan batir suna da kyau ga maganin rigakafin SARS-CoV da jerin kwayoyin SARS-RH-BatCoV HKU3
Wannan da sauran masu kwayar cutar C.ov sun raba 88-92% na sarkar daidaitaccen kwayar nucleotide tare da SARS-CoV.
Waɗannan binciken kimiyya sun ba da sabuwar ma'anar cewa ƙwayoyin ƙwayoyin cuta suna haifar da cututtukan mutum.
An gano SARS-like CoVs (SL-CoVs) da yawa a cikin bat, amma wanda aka sani da WIV1 ne kawai za'a iya gano shi azaman kwayar cutar mai rai.
An enzyme na angiotensin-converting enzyme 2 (ACE2) an san shi da mai karɓar SARS-CoV.
WIV1 an cire shi daga samfurin ƙwayoyin bat, wanda ya nuna cewa ACE2 na bat ne kuma yana amfani da cat P. larvae da larvae a matsayin mai karɓa don shiga cikin kwayar halitta.
Mafi mahimmanci, shine cewa ƙwayar SARS da aka warke ta iya kawar da tasirin WIV1.
Saboda haka, WIV1 ya nuna mafi kusantar dangantaka tsakanin SARS da coronavirus a cikin beyar, tare da yaduwar kashi 95% na nucleotides a cikin jerin masu jituwa.
Amma, yawan daidaito tsakanin waɗannan ƙwayoyin cuta biyu ya sa mun yarda cewa WIV1 ba ainihin asalin SARS-CoV ba ne kuma baƙon kwari ba ne ainihin mai karɓar SARS-CoV ba.
Nazarin nazarin halittar jini na MERS-CoV ya haɗa da CoV-HKU4 mai cutar sankara da CoV-HKU5 mai cutar sankara.
HCoV-HKU4 yana da cutar sankara kuma MERS-CoV yana amfani da mai karɓar kwayar halitta ɗaya, mai karɓar kwayar cutar (DPP4) don shigar da cutar.
RNA mai zaman kanta RNA mai sarkar polymerase daga Mars-Cov ya fi kusa da tarihin rayuwarsu fiye da irin wannan corona a cikin tauraron tauraron da aka gano a Turai da Afirka.
Har yanzu, babu wani ɗan adam na Mars da ya taɓa samun damar gano shi a cikin daji.
Mars-Kov da kuma masu kama da shi suna da alaƙa da Kov-HKU25 tare da kashi 87 cikin ɗari na jerin abubuwan da ke faruwa a cikin kwayar halitta.
Duk da haka, makãho na yau da kullum ba za su iya samun Mars-Kov ta hanyar gaggawa ba.
A wani bangaren kuma, bincike a Gabas ta Tsakiya ya nuna cewa raƙuman raƙuman raƙuman da ke da ƙwayoyin cuta guda ɗaya suna da ƙwayoyin cuta na musamman ga Mars-Cov, kamar raƙuman da ke Gabas ta Tsakiya kuma sun fito ne daga wasu yankuna na Afirka.
An gano asalin cutar SARS-CoV-2 yanzu kuma an ware shi daga ƙwararrun ƙwayoyin cuta guda ɗaya da ke da alaƙa da cutar ta hanyar numfashi, kuma ya nuna cewa wannan ƙwayoyin cuta na ɗaya ne na SARS-CoV-2.
An kuma lura cewa bayyanar cututtuka a gaba ɗaya suna da sauƙi amma a cikin ƙwayoyin cuta an lura da cutar a cikin tumaki ta hanyar kamuwa da cutar Mars-Cov.
An gano cewa raƙuman da ke da cutar suna watsa kwayar cutar ba ta hanyar hanyoyin numfashi ba, amma ta hanyar hanyar hanci, wanda shine hanyar da ake yada cutar ga al'ummomin da ba su da lafiya.
Ko da yake, akwai sauran mutane da yawa da aka rubuta a cikin Mars kuma ba su da wata hulɗa da dabbobi masu rarrafe da suka riga sun nuna alamun, wannan yana nuna cewa tushen ya kasance ne ta hanyar mutum-zuwa-mutum ko kuma hanyar jiki ta hanyar ƙananan dabbobi da ba a sani ba da suka sami Mars-Covid.
SARS-CoV-2 yana da 96.2% na nucleotide da ke hade da COV-RaTG13 wanda aka ware daga Rhinozoos monoclonal.
Kamar yadda yake a SARS-CoV da MERS-CoV, daidaita bambancin tsakanin SARS-CoV-2 da RaTG13 yana da kyau ga alaƙar dangi.
Kamar yadda kuka ambata, akwai yiwuwar cewa ba za a sami makamai na gaggawa ba ga SARS-CoV-2 har sai an gano wasu sanannun makamai a nan gaba.
An yi imanin cewa, a matakin da ya ci gaba, ana sayar da dabbobin da ke da kwari na SARS-CoV-2 a tsakanin dabbobin da ke zaune a cikin kogin ko kuma a kashe su a kasuwar sayar da kayan kifin teku ta Huanan, tare da karuwar karuwar COVID-19 da aka samu, wanda ke haifar da duk abin da ke faruwa na watsawa daga dabba zuwa mutum.
Wasu daga cikin binciken da suka yi kan tsarin metagenomic (wanda ke da alaƙa da kwayoyin halitta) sun ba da shawarar cewa akwai wani rukuni na dabbobi masu shayarwa da aka sani da pangolin (ƙananan dabbobi) kuma yana iya kasancewa a cikin jerin Jovolan da ke da alaƙa da SARS-CoV-2.
Kwayoyin Covi na Penguin na kwanan nan sun nuna daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaitattun daidaituwa.
Ko da yake suna da alaƙa da RATG13 a cikin kashi 90 cikin 100 na ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙira.
Sun ba da damar yin amfani da kwayoyin halitta guda biyu don yin amfani da SARS-CoV-2 a matsayin kwayar cutar a cikin bishiyar kwayoyin halitta, ɗaya daga cikinsu yana ba da ƙarin mai karɓar mai karɓar mai karɓa (RBD) tare da SARS-CoV-2, tare da kashi 97 cikin ɗari na amino acid mai mahimmanci.
A matsayin cikakkiyar kishiyar, SARS-CoV-2 da RaTG13 RBDs sun bambanta sosai, kodayake akwai babban adadin daidaitattun daidaitattun kwayoyin halitta.
Binciken da aka yi a baya kan cutar pangolin ya kuma nuna yiwuwar kamuwa da wani yanki na kwayar cutar DNA daga samfuran huhu, wanda ya bayyana yana da alaƙa da SARS-CoV-2.
Wannan binciken ya haɗa da hanyoyi daban-daban da kuma kulawa da mutum don ƙirƙirar jerin kwayoyin halittar da ke riƙe da kashi 86.3 cikin dari na cikakkiyar ƙwayar ƙwayar cuta.
Ba za mu iya watsi da cewa Penguin yana ɗaya daga cikin gidajen SARS-CoV-2 masu kyau ba.
Duk da haka, babu wata shaida da ta nuna ainihin asalin SARS-CoV-2 na pangolin, duk da cewa akwai alamun SARS-CoV-2 da SARS-CoV-2 na pangolin da ke kama da COVID-19.
Duk da haka, nisan tsakanin SARS-CoV-2 da RaTG13 ya fi ƙasa da tsakanin SARS-CoV-2 da kuma SARS-CoV-2 masu kama da juna.
An yi watsi da ci gaban SARS-CoV-2 a cikin ƙudaje, pangolins da sauran nau'in dabbobi masu shayarwa.
Mafi girman daidaiton jerin da aka samo a cikin RBDs tsakanin SARS-CoV-2 da pangolin, SARS-CoV-2 beta-CoVs masu alaƙa, SARS-CoV-2 da RaTG13 suna ba da mafi girman girman ƙwayar genome-matter daidaito.
An yi imani cewa babban daidaituwa tsakanin SARS-CoV-2 da beta-SARS-CoV-2 da ke da alaƙa da RBDs na pangolin an ƙaddara su ne a cikin zaɓin-haɓaka haɓaka.
Reverse-claiming a cikin haɗin haɗin haɗin tsakanin pangolin SARS-CoV-2 da Beta-CoV da RaTG13 a cikin nau'in dabba na uku.
A matsayin mai haɓaka, haɗuwa ta zama gama gari tsakanin Beta-Cov.
Kungiyoyin masu tantancewa har yanzu suna waje da yankin SARS-CoV-2.
A gefe guda, an kuma gwada HCoVs masu saurin kamuwa da cutar, HCoV-229 na asali, HCo43, HC0V-NL63 da HCoV-HKU1.
Shaidar tarihin juyin halitta ya nuna cewa duka HCoV-NL63 da HCOv-229E an samo su daga bat-coronaviruses, yayin da aka gano HCoV-OC43 da HCoV-HKU1 a cikin dabbobi masu rarrafe.
An gano cewa an gano ARCoV.2 (Abubuwan da ke haifar da Corona) a cikin North America a cikin nau'in bat da ke da alaƙa da HCoV-NL63.
A gefe guda, HCo-229E ya kasance cikin dangantaka da wani kwayar halitta mai suna Kove, mai suna Hipposidors/Kanakwan/19/2008. An gano shi a Ghana lokacin da ake zargin cewa yana da matsakaiciyar matsakaici.
Don ƙarin bayani, an taƙaita bayanan kwanan nan game da asalin kwayar cutar da aka sani da HCoV a cikin nau'i na 1 da na 2 na jadawalin.
Binciken tarihin juyin halitta ya nuna yiwuwar yiwuwar watsawa na HCoVs a cikin tarihi.
Lokacin da HCo-OC43 ya wuce daga dabbobi zuwa mutane ta hanyar gurbatacciyar hanyar gida a cikin shekarun 1890, an yi rahoton cutar ta numfashi mai tsanani.
Tarihin watsawar iska na HCoV-229E ba shi da cikakken bayani
Alpha-Covs bats suna da alaƙa da HCO-229E da aka gano.
Daga cikinsu akwai Covey-Alpa Alpa.
Wasu dalilai na iya tabbatar da cewa cutar ba ta iya wucewa kai tsaye daga barkonon zuwa mutum.
Na farko, mutane ba kamar alpacas ba (dabbacin dabba kamar tumaki amma ya fi girma) na iya saduwa da bat da aka haifa a cikin wani yanayi mai kama da juna.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, HCoV-229E ya bambanta da kwayar cutar bat-coronaviruses kuma ba ya haifar da cutar a cikin bat, yayin da kwayar cutar ta alpha-coronaviruses ke haifar da cutar numfashi a cikin dabbobin da suka kamu da cutar.
A ƙarshe, ba a gano alpha-coronavirus na alpine ba a cikin dabbobi masu shayarwa.
Saboda haka, ba za a iya kawar da yiwuwar cewa algae suna iya samun HCoV-299E daga alpha-coronaviruses na mutane ba.
A gaskiya, ƙwayoyin cuta sune tushen kai tsaye na cututtukan ɗan adam kamar su rabies, Ebola, Nepah, da Hantavirus.
Saboda haka, ba abin mamaki ba ne cewa an gano cewa bat yana iya kaiwa ga mutum kai tsaye ta hanyar kwayar cutar HCoV-229E.
A gefe guda, yayin da alpha-coronavirus na bat ke aiki a matsayin mai ɗaukar kwayar halittar H-coronavirus-299E, algae da algae na iya zama babban kwayar halitta mai ɗaukar hoto wanda ke ɗaukar ƙwayoyin cuta zuwa ga mutane, kamar yadda yake a cikin yanayin MERS-COV.
MERS-CoV ya zama misali mafi kyau na ƙaura daga ƙuda zuwa ƙuda, daga ɗan maraƙi zuwa ɗan maraƙi, daga ɗan maraƙi zuwa ɗan adam.
An samo asalin MERS-COV daga kwayar cutar coronavirus a farkon ganowa kuma an ƙarfafa shi ta hanyar binciken da aka samu a cikin ɓoye.
A bayyane yake cewa, raƙuman ruwan da ke da nau'ikan ƙwayoyin cuta masu yawa suna da nau'in ƙwayoyin cuta don canzawa daga nau'in zuwa nau'in kuma suna canzawa tsakanin nau'in.
Yawan shekaru, yawan mamayar kwayar halitta, da kuma kusancin samun damar tashi sama duk sun bada damar da kwayar cutar ke da shi na zama "mai yada cutar".
A cikin al'ada, MERS-COV ya kasance sananne ne ga kwari guda ɗaya na shekaru da yawa.
Wannan ya dace da raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra raƙuman raƙuman raƙuman raƙuman raƙuman ra raƙuman ra ra ra ra ra ra ra ra rauman ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra
MERS-COV yana haifar da cututtuka masu saurin gaske, wanda ke haifar da ƙananan canjin DNA a cikin waɗannan dabbobin.
Hatsarin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka.
Ba kamar raƙuman da ke da alhakin watsa MERS-COV ba, raƙuman da ke da alhakin watsa SARS-COV-2 sun bambanta, idan akwai.
Musamman, beta-cove penguins suna haifar da cututtuka a cikin penguins.
Daga ƙarshe, za su iya zama mahalarta masu mutuwa ga SARS-CoV-related beta-CoVs, kamar su Sivits a cikin yanayin SARS-CoV.
Za a iya samun ƙarin hanyoyin da za a iya ɗaukar SARS-CoV-2 daga dabbobi zuwa mutane a cikin bincike na gaba.
Na farko, kwari suna iya zama masu ɗaukar SARS-CoV-2 da suka danganci ƙwayoyin cuta da suka danganci SARS-CoV-2 .
Mutane na iya raba muhalli tare da kunkuru ta hanyar sayar da nama ko kuma ta hanyar sayar da kwal.
Na biyu, mutanen Pongoles za su iya zama cibiyar cibiyar cibiyar cutar SARS-CoV-2 da aka gano kwanan nan.
Mutane sun kamu da ƙwayoyin cuta ta hanyar sayar da naman da kuma farauta.
Dukkanin dabbobi masu shayarwa, musamman dabbobi masu gida, na iya zama masu saukin kamuwa da SARS-CoV-2.
An yi gwajin dabbobi na gida da na daji don gano kwayoyin antibody.
Na uku, kamar yadda aka ambata a sama, ana iya samun sake haɗuwa da daidaitawar SARS-CoV-2 a cikin nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau.
Binciken asalin SARS-CoV-2 na ci gaba.
Baya ga nau'ikan dabbobi masu ƙwayoyin cuta, akwai manyan abubuwa guda uku a cikin ƙwayoyin cuta waɗanda suke da mahimmanci don sauƙaƙa ƙetare iyakar ƙwayoyin halitta.
Da farko, matsakaicin saurin RNA ya yi yawa.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar ƙirar ƙirar COVs ana ɗaukar su a matsayin "matsakaici" zuwa "manyan" tare da matsakaicin matsakaicin matsakaici - 10-4 maye gurbin kowace shekara a kowane shafi 2.
Cove yana da shaida - karanta exoribonuclease (enzyme mai lalata RNA), cire duk wani sakamako daga cikin abubuwan da ke da tasiri sosai kuma yana da rauni, ya ragu ko kuma ba ya aiki.
Musamman, an san nucleotide mai kama da mai karɓar don hana kwayar cutar corona ta hanyar hana shi shiga cikin ƙwayoyin ƙwayoyin cuta da RNA mai karɓar RNA da RNA mai haɓaka.
Remdesivir yana ɗaya daga cikin magungunan rigakafin ƙwayar cuta na SARS-CoV-2 da aka gwada a cikin rukunin gwajin gwaji.
Duk da haka, matsakaicin tsallake-tsallake na COVID ya ninka na masu cutar ta kusan sau miliyan.
Bugu da ƙari, yawancin lokuta matsakaicin tsalle-tsalle ya fi girma lokacin da COVIDs ba su dace da gidaje ba.
Idan aka kwatanta da SARS-CoV-2 wanda ke da matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaici, an bada shawarar cewa matakin daidaitawa ya fi girma.
An yi imanin cewa, wata ƙwayoyin halitta da ke kusa da mutum, ta yi kama da ita.
Duk da haka, ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da raƙuman raƙumi guda ɗaya.
A ka'ida, wani nau'in kwayoyin halitta da ke motsa kwayoyin halitta don samar da maganin rigakafi da rigakafi ga SARS-CoV-2 ba shi da tasiri.
Na biyu, babban RNA na kwayar cutar corona yana da matukar dacewa wajen canzawa da kuma sake haɗawa, kuma hakan yana da matukar dacewa da haɗuwa da juna. Wannan yana da amfani ga haɗuwa da sabon kwayar cutar yayin da yanayin ya inganta.
Wannan yana da goyan bayan da aka yi amfani da shi a cikin tsarin karatun da aka yi da kuma yadda ake amfani da shi a cikin tsarin rubutun na uku na ƙarshe na kwayar halitta, wanda ya haɗa da ƙididdigar ƙididdigar ƙididdigar ƙididdiga na ƙididdigar ƙididdiga na ƙididdiga na ƙididdiga na ƙididdigar ƙididdiga.
Na uku, kovids suna canzawa a cikin lokaci-lokaci a yayin da RNA ke rarraba ta hanyar zaɓin-sake-sake-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da-da.
A cikin wani kwayar halitta da ke aiki a matsayin matattarar matattarar RNA, ana samun saurin tsalle-tsalle a cikin ƙwayoyin RNA yayin da ake kwafa.
RNAs masu kama da juna suna da tsayi mai yawa kuma suna iya yin kwafi don samar da sabon kwayar halitta.
An sami shaidar phylogenetic game da yanayin sake haɗuwa a cikin duka HCOV-HKU1 da HCOV-OC43, kamar yadda a cikin coronaviruses na dabbobi kamar bat SL-COV da bat COV-HKU9.
Kwayar cutar ta haɗu da juna ta hanyar haɗuwa da juna.
Baya ga dalilai uku na kamuwa da kwayar cutar da aka tattauna a sama, haɗuwa da kwayar cutar ta hanyar kwayar cuta wata hanya ce da ke shafar yaduwar cutar tsakanin halittu.
A cikin wannan, an ɗauki tsarin SARS-CoV a matsayin misali, wanda kuma ya nuna shaidar zabin mai kyau a cikin aikin watsawa.
Ganin nazarin kwatancen tsakanin bambancin ɗan adam da SARS-CoV, SARS-CoV an yi tsammani zai iya yin saurin gwaji a cikin ƙwayoyin cuta daban-daban, musamman tare da tsalle-tsalle a cikin RBD na furotin S.
Gabaɗaya, RBD yana haɗuwa da furotin S na COVID a cikin ƙofar sel kuma an zaɓi shi ta hanyar amsawar antibody na mai karɓar.
A SARS-CoV, RBD yana da amino acid 318 zuwa 510 a kan S1 sashin. wanda ya haɗu da ACE2 na mutum a matsayin mai shiga cikin ƙwayar cutar.
SARS-CoV-2 RBD zai iya gano nau'in ACE2 na nau'ikan dabbobi daban-daban, gami da bat, civet, mice da kuma rakon, yana hana watsa kwayar cutar ta hanyar da ta dace.
A gaskiya, kawai 6 amino acid residues da aka gano cewa sun bambanta da na mutum da kuma na kwayar cutar HIV sun rabu da RBD kuma 4 daga cikinsu sun kasance a kan mai karɓar mai karɓa don hulɗa tare da mai karɓar ACE2.
C. SARS-CoV yana da saurin saurin K479N da S487T na RBD, wanda zai iya inganta haɓakar haɓakar haɓakar spike tare da mai karɓar ACE2 na mutum.
A wata hanya, maye gurbin waɗannan amino acid ɗin na iya zama mahimmanci ga ingancin kwayar cutar a cikin mutane.
An yi imanin cewa SARS-CoV-2 yana da nau'ikan ƙwayoyin cuta iri ɗaya da SARS-CoV.
Akwai bambanci tsakanin SARS-CoV-2 da SARS-CoV-1 na kashi 30 cikin dari na S1 na S-protein wanda ya haɗa da haɗin S-protein tare da ACE2 na mutum wanda aka canza.
A zahiri, binciken EM cryo yana nuna yiwuwar 10 zuwa 20 na wannan haɗin ya fi na ACE2 na ɗan adam da S ARS-KOVS protein.
Hakanan yana da mahimmanci ko ana buƙatar kowane mai karɓa don ɗaukar SARS-CoV-2
Abin mamaki, kwayar cutar NL63 ta haɗu da ACE2 amma tare da wani ɓangaren S daban.
Akwai wasu masu karɓar H-coronaviruses, kamar su N aminoepidase enzyme na H-coronavirus 229E, da kuma 9-O acidic acid na sialic acid na H-coronavirus OC43.
Wannan na iya haifar da nasarar kwayar cutar CoVs a cikin mutane bayan wannan yaduwar tsakanin jinsunan da suka karɓa daga dabbobin da ke dauke da cutar.
Duk da waɗannan masu karɓar masu karɓa, sakamakon watsawa tsakanin nau'ikan coronaviruses ana sarrafa shi ta wasu dalilai masu zaman kansu da kuma takamaiman ƙwayoyin halitta.
Rarraba sunadarai sunadarai tsakanin mutane da kuma wuraren da coronavirus ke zama a cikin gida kamar amphibians, camels, da dabbobi masu rarrafe na iya haifar da cikas ga wannan hanyar ta hanyar wucewa.
Kwayar cutar corona dole ne ta kunna yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin yanayin
A wannan yanayin, ana iya gano da kuma bayyana abubuwan da ke da nasaba da cutar a cikin yankin da cutar ta fi dacewa.
Tsarin kwayoyin halitta mai zurfi da ke haifar da ƙuntataccen ƙuntatawa na ƙwayoyin cuta na SARS-CoV-2 ta amfani da fasahar fasaha ta CRISPR na iya zama mai amfani.
Jituwa ta coronavirus: Komawa zuwa farkon
Bambancin da kuma bambancin bat-CoVs na ba da damar haɗuwa da HCoVs.
Ta haka, bat-CoVs suna yin irin aikin CoVs.
Duk da haka, saurin canzawa da kuma tsara kwayoyin halitta suna jagorantar ci gaban kwayar cutar corona kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin tsari.
Alal misali, samun ko rasa wani kwayar halitta mai cike da furotin yana iya canza yanayin da ake gani a cikin al'ada.
Daga cikin nau'ikan sunadarai na SARS-CoV, an bar ORF8 a cikin canji zuwa ga mutane, wanda ya haɗa da SARS-CoV, wanda aka gano, amma an gano cewa ya canza zuwa furotin ORF8.
An gano ɓoyayyen ɓoyayyen ɓoyayyen kwayar cutar SARS-CoV-29, a cikin ɓoyayyun abubuwa, a farkon barkewar cutar.
Wannan shi ne, ORF8 ya rabu zuwa ORF8a da ORF8b kuma an bar shi ya zama canjin da zai inganta musayar ƙwayoyin cuta.
Bugu da ƙari, SARS-CoVs suna da tarihin da ya dace da alpha- and gamma-CoVs, waɗanda ke da ƙarin adadin RNA-linked RNA polymorphism.
An gano wuraren da aka yi wannan gyare-gyare a cikin nsp9, yawancin nsp10, da kuma wani ɓangare na nsp14.
Hakanan, an nuna cewa cutar MERS-CoV ta sami daidaituwa a lokuta daban-daban, kamar yadda ya faru a raƙuman raƙuman Saudiyya.
Baya ga SARS-CoV-2 da MERS-CoV-2 , an kuma gano wannan tsari a cikin coronavirus, wanda aka tsara a cikin yanayin rashin jituwa na coronavirus tare da sauran ƙwayoyin coronavirus.
Ya kamata a lura cewa binciken na wucin gadi na iya haifar da canji mara kyau a cikin kwayoyin halitta, wanda zai iya haifar da yaduwar kwayar cutar a cikin wani yanki da aka gano, kamar tsarin garkuwar jiki.
Misali na irin wannan tasirin shine asarar ORF4 na kwayar cutar coronavirus-229E na farko, wanda ke haifar da ɓarna da haɗuwa da 2-nucleotide.
Yayin da ORF4 mai rikitarwa za a iya gani a cikin bat da kuma kwayar cutar HCoV-229E, ƙwanƙolin alpha na kwayar cutar coronavirus yana nuna wani mai cike da enucleotide, wanda ya haifar da kamuwa da cuta.
Na ƙarshe, haɓakar kwayar cutar corona ta hanyar nazarin ƙwayoyin cuta.
An gano rashin bayyanar cututtuka ko bayyanar cututtuka masu sauƙi lokacin da jemage suka kamu da coronavirus, wanda ke nuna yiwuwar kamuwa da cutar coronavirus daga jemage.
Ya bayyana cewa, a zahiri, da kuma ilimin halittu, tururuwa sun dace da kwayar cutar corona.
Misali, rashin aikin maganin cutar sankara a cikin jemagu, ya rage cutar ta kwayar cutar corona.
Bugu da ƙari, an kashe kashewar halitta na aikin kwayar halitta, wanda ya haifar da rage yawan mai karɓar kwayar halitta na NKG2/CD94 da kuma rashin daidaituwa na ƙananan ƙananan I.
Hakanan, yawan adadin Oxygen-Reactive Type (ROS), wanda aka nuna a cikin yawan aikin Metabolic activity na bat, na iya rage yaduwar kwayar cutar corona da kuma yin tasiri a kan enzyme na acrybonuclease, don haka yana haifar da ƙarancin ƙwayar ƙwayar ƙwayar cuta, wanda cutar ta zama mai saurin kamuwa da cuta yayin da ta shiga cikin sabon kwayar halitta.
Sauran nau'ikan coronavirus na marasa lafiya, waɗanda ke cikin tsari, suna haifar da ƙaruwa a cikin furotin, ko kuma ƙwarewar furotin a cikin jigilar zuwa ƙwayoyin cuta.
Ta haka ne, ba daidaituwa ba ne cewa nau'ikan coronaviruses guda uku sun haɗu a cikin shekaru ashirin da suka gabata.
Coronaviruses ba cuta ba ce, suna haifar da ƙananan alamomi a cikin dabbobi kamar jemagu da raƙumi.
Suna ƙarawa da kuma lalacewa ba tare da wani amsa mai ƙarfi na rigakafin kwayar halitta ba.
Asirin abin da ke sa mutum ya kamu da cutar ba tare da wata alama ba, yana nan; da abin da ke sa mutum ya kamu da cutar.
Kwayoyin cuta na yau da kullum suna haifar da amsawar rigakafi mai karfi da kuma yawan ƙwayar cuta na furotin, kuma mafi yawan tsarin rigakafi, mafi yawan cutar da ke fama da cutar.
Akasin haka, a cikin marasa lafiya, an raba amsawar rigakafin daga haɓakar CoV da kwayar cutar.
Wannan dabarar na hana garkuwar jiki amsawa na iya zama da amfani wajen maganin SARS-CoV-2 (SARS-2).
Yawan amsawar da ƙwayoyin halitta ke bayarwa ga ƙwayoyin cuta, sun fi ƙarfin ƙwayoyin cuta.
Don haka, gudanar da furotin na sel, aƙalla a farkon matakan SARS-CoV-2 a cikin mutane, ya kamata ya zama mai amfani.
Duk da haka, aikin NLRP3 mai banbanci ya ɓace a cikin ƙwayoyin cuta.
A bisa ga ka'ida, kasancewar furotin mai rikitarwa NLRP3 tare da MCC950 na iya zama da amfani ga maganin coronavirus.
Hadin SARS-CoV-2 ya kawo sabon tsari, wanda ya haifar da SARS-CoV da MERS-CoV.
Yayin da aka gano beta-CoVs tare da 95% nucleotide-combination zuwa SARS-CoV, akwai kuma coronavirus-CoVs tare da 96% nucleotide-combination zuwa SARS-CoV-2.
Duk da yake an gano cewa dabbobin da aka yi wa kiwon dabbobin da aka yi wa kiwon dabbobin da ke da kwayar cutar SARS-CoV-2, ba a gano cewa akwai kwayar cutar SARS-CoV-2 ba.
An gano haɗuwa da beta-coronavirus a cikin dabbar pangolin tare da SARS-CoV-2, yana nuna cewa dabbar pangolin na iya zama mai haɗuwa da matsakaiciyar ƙwayoyin cuta, ko kuma kwayar cutar ta pangolin na iya ɗaukar wani yanki na kwayar halitta don watsa kwayar cutar SARS-CoV-2 na ƙarshe.
Ko da yake akwai tambayoyi, babu wata shaida da ta nuna cewa SARS-CoV-2 ta samo asali ne daga mutum, ko ta hanyar ganganci ko kuma ta hanyar haɗari.
Coronavirus ta taso ne sakamakon barkewar cutar SARS-CoV-2 a kwanan nan.
Nazarin coronavirus a cikin bats da sauran dabbobi ya canza ra'ayoyinmu game da mahimmancin asalin dabbobi da kuma kwayar cutar coronavirus daga dabbobi zuwa mutane.
Shaidar da aka samu ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da asalin bat kuma an haife su ne ta hanyar kwayoyin halittar da ke cikin matsakaici zuwa mutane.
Kamar yadda cutar SARS-CoV ta taso ne daga hulɗar mutane da dabbobin SIVET a cikin kasuwanni, rufe waɗannan kasuwanni da kuma kashe SIVETs sun kawo ƙarshen cutar SARS.
Saboda wannan dalili, da kuma dabaru, dabbobin da ke cikin gida dole ne su daina cin kasuwa, don hana yaduwar cutar daga dabbobi, saboda gano kwayar cutar beta-CoV da ke da alaƙa da SARS-CoV-2.
Koyaya, ko da kuma yadda SARS-CoV-2 ke iya wucewa ta hanyar dabbobi masu rarrafe da sauran dabbobi masu shayarwa zai kasance a cikin binciken da ke zuwa.
A gefe guda, MERS-CoV ya kasance a cikin iska na dogon lokaci.
Rakuma na da amfani a matsayin hanyar sufuri, saboda ita ce tushen nama, madara, fata da abinci ga mazaunan yankin.
An fi samunsu a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a kashe duk rakuman ba a madadin sarrafa MERS, kamar yadda aka yi a kasuwannin dabbobi na kasar Sin, don hana yaduwar SARS-CoV-2 da SARS-CoV-2.
Don dakatar da yaduwar cutar MERS, dole ne a yi ƙoƙari na duniya don haɓaka ingantaccen maganin rigakafin cutar MERS-CoV don raƙuman raƙuman raƙumi, tare da matakan sarrafa kamuwa da cuta.
Duk da cewa ba za a iya kawar da cutar ba, sabon nau'in kwayar halitta na iya haifar da yaduwar cutar.
Yawancin nau'ikan coronavirus na asali na dabba sun bazu a cikin yankunan tsaunuka.
Musamman, nau'ikan coronavirus na asali na dabba sun bambanta.
Akwai yiwuwar cewa wannan kwayar cutar ta zobe za ta iya zama mai saukin kamuwa da cutar coronavirus, wanda hakan zai sa sabon kwayar cutar ta zobe ta zama mai saukin kamuwa da cutar da kuma / ko kuma cutarwa ga mutane a nan gaba.
A wasu sassan kasar Sin, ya kamata a hana cin naman dabbobin daji domin a rage yawan cin zarafin da mutane ke yi da dabbobi.
Tare da annoba kamar SARS, MERS da COVID-19, ana buƙatar mafi kyawun shiri da shirye-shiryen amsawa.
A gaskiya, yawancin ƙwayoyin cuta sun kasance a nan na dogon lokaci.
Suna zama a cikin mazauninsu na asali, har sai sun sami damar yin amfani da su.
Kodayake akwai wasu bat-da-kumburi da ke taimakawa wajen yaduwar ƙwayoyin cuta, amma yiwuwar saduwa da mutane da bat-da-kumburi da sauran dabbobin daji za a iya ragewa idan aka koya wa mutane su guje su.
Ana buƙatar ci gaba da lura da dabbobi masu shayarwa don samun kyakkyawar fahimta game da yanayin CoVs da wuraren da suke da zama, wanda ke nuna fa'idar hana yiwuwar watsawa da kuma yiwuwar yaduwar cutar.
A ƙarshe, hanya mafi inganci don hana dabbobi masu ɗauke da cutar ita ce nisantar da mutane daga yanayin da dabbobi masu ɗauke da cutar ke rayuwa.
Wasu daga cikin abubuwan da ke tattare da SARS-CoV-2 na dabbobi har yanzu ba a gano su ba.
Da farko, idan batir ya ba da SARS-CoV-2 na CoV zuwa pangolin, zai zama da kyau a ga wane yanayi batir da pangolin suke da irin wannan yanayin.
Na biyu, idan ana ganin akwai wasu abubuwa da ake son yi wa namomin kaza fiye da kai wa mutane kwayar cutar, to ya kamata a yi bincike a kan yadda mutane da namomin kaza suke da alaƙa.
Na uku, idan dabba mai shayarwa ta uku ta zama kamar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwar ƙwararriyar ƙwar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwararriyar ƙwarriyar ƙwararriyar ƙwar ƙwararriyar ƙwar ƙwararriyar ƙwar ƙwararriyar ƙwarriyar ƙwarriyar ƙwar ƙwararriyar ƙwar ƙwararriyar ƙwararriyar ƙwar ƙwararriyar ƙwararriyar ƙwar ƙwarriyar ƙwar ƙwarƙwar ƙwar ƙwarƙwar ƙwarƙwar ƙwar ƙwarƙwarƙwarƙwar ƙwarƙwar ƙwar ƙwar ƙwarƙwar ƙwar ƙwarƙwarƙwarƙwarƙwar ƙwar ƙwar ƙwarƙwar ƙwar ƙwarƙwarƙwarƙwar ƙwarƙwar ƙwar ƙwarƙwarƙwarƙwar ƙwarƙwar ƙwarƙwarƙwarƙwar ƙwarƙwarƙwar ƙwarƙwarƙwar ƙwar ƙwarƙwarƙwar ƙwar ƙwar ƙwar ƙwarƙwar ƙwar ƙwar ƙwar ƙwarƙwar ƙwar ƙwarƙwar ƙwar ƙwar ƙwarƙwarƙwar ƙwarƙwarƙwar ƙwar ƙwarƙwar ƙwarƙwarƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwarƙwar ƙwar ƙwar ƙwar ƙwarƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwarƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙ
A ƙarshe, tun da yawancin dabbobi masu shayarwa suna ɗaukar dabbobi na gida, ana iya sa su a cikin haɗari ga SARS-CoV-2, ana buƙatar kulawa da gwaji don kamuwa da cuta.
Idan kun kasance kunkuru, pangolin ko wata dabba mai shayarwa, ana sa ran SARS-CoV-2 ko kuma wani nau'in da ya yi kama da shi, za a iya gano shi a cikin yanayin sel a nan gaba.
Bincike na ci gaba da ke gudana kan yadda SARS-CoV-2 ke bunkasa a cikin dabbobi yana ci gaba a wannan fannin, tare da ƙoƙarin da ake yi na kawar da cutar a cikin mutane.
Ana buƙatar sabunta sigogin gano cutar COVID-19 "abin da ake zargi" da "abin da aka tabbatar".
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta ba da umarnin gaggawa don ganowa da magance cutar Coronavirus 2019 (2019-nCoV), wannan jagorar ta ba da damar kwarewarmu da kuma ba da shawara ga masu fama da cutar a duniya.
Koyaya, cutar Coronavirus ta 2019 (COVID-19) sabon cuta ne, wanda ke ci gaba da haɓaka ƙwarewarmu da iliminmu dangane da ci gaba da binciken bincike da ƙwarewar aikin asibiti; saboda haka, ana ci gaba da sabunta hanyoyin ganowa da hanyoyin magani.
A cikin wannan labarin, mun amsa wata tambaya game da jagororinmu kuma mun gabatar da sabon ƙirar ganewar asali don "ainihin hali" da "ainihin hali" bisa ga sabon jagorar ganewar asali da magani don COVID-19 (bugu na bakwai) wanda Kwamitin Lafiya na Kasa na Jamhuriyar Jama'ar Sin ya wallafa.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya fara yaduwa, wanda yanzu ake kira da sunan cutar coronavirus 2019 (COVID-2019) kuma an kira cutar da sunan SARS-CoV-2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya.
Don yaƙi da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagorar shawarwari na gaggawa wanda aka buga akan layi a cikin Nazarin Likita na Soja a ranar 6 ga Fabrairu, 2020.
Tun lokacin da aka buga shi, ya jawo hankali sosai.
lura: Kodayake COVID-19 sabon cuta ne, iliminmu yana ƙaruwa bisa ga ci gaba da binciken bincike da ƙwarewar aikin asibiti; saboda haka, ana sabunta hanyoyin bincike da magani.
Misali, umarnin ganowa da magani don COVID-19 wanda Kwamitin Lafiya na Kasa na Jamhuriyar Jama'ar Sin ya wallafa (http://www.nhc.gov.cn/), ya buga jimlar lambobi bakwai tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, tare da wasu abubuwan da suka canza sosai.
Yanzu, a cikin wannan jagorar, mun sami wani bayani daga Zhou et al. wanda ya ba da shawarar yin amfani da ƙididdigar ƙididdiga mai sauƙi daga gwajin asibiti.
Ayyukan su sun ba da sabon tabbaci ga umarninmu kuma sun ba da babbar alama ga wannan annoba ta duniya.
Muna goyon bayan su kuma muna godiya da su saboda wannan gagarumin aiki.
Koyaya, aikin su yana buƙatar sabuntawa tare da sabbin hanyoyin bincike da magani na COVID-19 (sashi na gwaji na 7) da kuma sababbin bincike.
Dangane da fitowar ta bakwai (Maris 3, 2020), don tabbatar da cewa ana tsammanin akwai buƙatar haɗa kowane ɗayan abubuwan da ke cikin tarihin cutar tare da abubuwa biyu na alamar asibiti don yin cikakken bincike, ko kuma dole ne a haɗa abubuwa uku na asibiti idan tarihin cutar ba shi da kyau:
Tarihin cututtukan: (1) Tarihin tafiya ko zama a Wuhan da kewayen birni, ko kuma sauran al'ummomi inda aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin saduwa da wanda ya kamu da cutar SARS-CoV-2 (tare da gwajin kwayar nucleic acid mai kyau); (3) Tarihin saduwa da marasa lafiya da ke da alamomin cutar ta numfashi a Wuhan da kewayen birni, ko kuma sauran al'ummomi inda aka ba da rahoton cutar ta COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin saduwa da tarin lamuran da aka tabbatar (>= 2 lamuran da ke da alamomin cutar ta numfashi da suka faru a cikin makonni 2 a cikin ƙananan wurare, kamar gidaje, ofisoshi, makarantu, da sauransu).
Alamar asibiti: (1) alamun rashin lafiya na numfashi da/ko; (2) tare da alamun COVID-19 na cutar ta radiation; (3) ƙarancin adadin ƙwayoyin farin jini wanda ke nuna ƙimar al'ada, ƙarancin, ko kuma raguwar ƙwayoyin lymphocyte a farkon matakin.
Ya kamata a tantance tabbataccen yanayin bisa ga yanayin da ake zargi da cutar ko kuma hujjojin siru: (1) gwajin lokaci na PCR na SARS-CoV-2 mai kyau; (2) cikakken kwayar halittar kwayar halitta wanda ke nuna asalin asalin kwayar cutar coronavirus; (3) tabbatacce ga IgM antigen da IgG antigen na SARS-CoV-2 a cikin gwajin kwayar; ko canji a cikin IgG antigen na SARS-CoV-2 daga mara kyau zuwa tabbatacce, ko kuma =>4 sau da yawa a cikin lokacin dawowa bayan cutar ta tashi.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihi don nucleic acid a cikin hanyoyin numfashi ko samfurin jini zuwa na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An ƙara gano cututtukan cututtuka a cikin samfurin jini a cikin juzu'i na huɗu (Janairu 27, 2020) da juzu'i na biyar (Fabrairu 8, 2020); sannan kuma an ƙara hujja ta serological a cikin juzu'i na bakwai.
Waɗannan gyare-gyare sun dogara ne akan ci gaba da aikin masu bincike na neman kayan gano nucleic acid don saurin ganewa, tare da samfurin numfashi wanda ya haɗa da samfurin jini, wanda ya inganta wadatar samfurori daban-daban, kuma ya ba da damar samar da sakamako mai kyau na maganin rigakafi na musamman a cikin iyakokin da aka tabbatar.
Duk da haka, akwai ƙarin tabbaci da ke nuna cewa ya kamata mu mai da hankali ga cututtukan cututtuka da cututtuka marasa cututtuka.
Saboda haka, dole ne a sabunta jadawalin Zhou et al., saboda sun yi la'akari da mutumin da ba shi da alamun cutar a matsayin "mai ƙarancin haɗari".
Hakanan ana buƙatar yin amfani da tsarin kulawa don ƙarin bincike da aikin asibiti.
A sakamakon haka, muna fatan za a sami ƙarin shaidu kai tsaye kuma muna roƙon masu karatu su ba da ra'ayoyinsu.
Don gano "al'amuran da ake zargi" da "al'amuran da aka tabbatar", muna ba da shawarar bin diddigin da kuma bin ƙa'idodin da aka sabunta don ƙasashen su.
Ƙungiyarmu za ta sabunta jagororinmu na bayar da taimako a lokaci-lokaci.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19 guda biyar, mafi yawan adadin yau da kullun
A ranar Litinin, Bangladesh ta tabbatar da mutuwar mutum biyar daga COVID-19 a ranar.
Wannan shi ne adadi mafi yawa na mutuwar da aka samu a cikin rana guda sakamakon cutar.
A jiya, Hukumar Kula da Cututtuka da Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton adadin masu kamuwa da cutar, wanda ya haɗa da 114 masu aiki da 33 da suka warke a gida.
An yi rahoton mutuwar mutane 17.
A cikin wani bayani na kokarin da aka yi a kan layi, mai kula da IEDCR, Mista Mirjai Sabrina Flora, ya ce mutuwar ta kasance maza hudu da mace daya.
A cewar Dr. Mirjdar, shari'o'i biyu sun kasance sama da shekaru 60, biyu tsakanin 51 da 60 da kuma shari'a daya tsakanin 41 da 50.
Ya kuma ce wadanda aka kashe 'yan Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba ta duniya a ranar 11 ga Maris.
Wani jami'in kiwon lafiya ya shaida wa kamfanin dillancin labarai na Anadolu, cewa daya daga cikin wadanda suka mutu Jalal Sayfur Rahman, shugaban kwamitin Bangladesh don magance rashawa, wanda ke jinya a asibitin Kuwait Matter.
A ranar Asabar, a cikin sanarwar bidiyo ta kan layi, Ministan Wayoyi da Bridges, Ubaidul Qader ya ce za a dakatar da zirga-zirgar jama'a na tsawon lokaci fiye da yadda aka tsara, har zuwa wannan maraice.
An fara dakatar da zirga-zirgar jama'a a ranar 26 ga Maris, kuma an shirya za a ƙare a ranar Asabar, 4 ga Afrilu.
Jiragen da suka isa wurin da kayan aikin da ake bukata - magani, mai da abinci - har yanzu suna nan.
An fara samun mutum biyu da suka kamu da COVID-19 a Bangladesh a ranar 8 ga Maris, biyu daga cikinsu sun dawo daga Italiya tare da matar ɗaya daga cikinsu.
A ranar 19 ga Maris, an dawo da su uku.
SARS-CoV-2 ya wuce miliyan daya a duniya
A ranar Alhamis, jimlar adadin wadanda suka kamu da cutar coronavirus SARS-CoV-2 a duniya ya zarce miliyan daya, a cewar bayanan Jami'ar Johns Hopkins.
Akalla mutane dubu 52 ne suka mutu sanadiyyar COVID-19, cutar da ke haifar da kwayar cutar corona.
Wannan babban canji ya faru ne a ranar da Malawi ta ba da sanarwar farkon kamuwa da cutar coronavirus da Zambia ta ba da sanarwar mutuwar farko da ke da alaƙa da cutar.
A ranar Alhamis, Koriya ta Arewa ta ba da sanarwar cewa tana ɗaya daga cikin ƙananan ƙasashe da ba su da cutar coronavirus.
Har zuwa jiya, Hukumar Lafiya ta Duniya ta ba da rahoton 1,051,635 da aka tabbatar da cutar, ciki har da 79,332 a cikin awanni ashirin da huɗu kafin karfe 10 na safe agogon Turai ta Tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an sami fiye da 244,000 da suka kamu da cutar coronavirus, tare da aƙalla mutuwar 5,900.
CBS ta ba da rahoton cewa, bisa ga bayanan da Jami'ar Johns Hopkins ta bayar, an samu mutuwar fiye da 1,000 a Amurka a ranar Laraba saboda kamuwa da kwayar cutar coronavirus.
A duk duniya, ƙasashe sun ba da sanarwar tsaurara matakan da za a ɗauka don dakatar da yaduwar cutar.
A ranar Alhamis, Sarga Sobiyan, mai mulkin Moscow, ya tsawaita dokar hana fita har zuwa 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya ba da sanarwar cewa za a ba wa mutanen Rasha albashi ba tare da sun je aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'a don tsawaita dokar ta baci ta ƙasa har zuwa kwanaki 15; kuri'ar ta amince da kuri'u 215, saɓani 10, da ƙuri'a ɗaya.
Saudi Arabia ta kara tsawaita dokar hana zirga-zirga a cikin biranen Makkah da Madina har zuwa ranar; a baya, dokar hana zirga-zirga ta kasance daga 3 na yamma zuwa 6 na safe.
Thailand ta shirya aiwatar da dokar hana zirga-zirga daga 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike Dwayne, ya ba da sanarwar cewa jihar ta tsawaita dokar hana fita daga gida har zuwa 1 ga Mayu.
Shagunan a Ostiraliya suna rage adadin kayan wanki a kowane ma'amala
A ranar Juma'a da yammacin Juma'a, manyan kantin sayar da kayayyaki na Woolworths da Coles na Australiya sun rage iyakokin sayan kayan wanka na Clinkx zuwa fakiti biyu da fakiti ɗaya a kowane ma'amala a duk shagunan da ke cikin ƙasa.
A ranar Litinin, ALDI ya kuma sanya takunkumin takarda guda.
An sanya waɗannan ƙuntatawa a matsayin sanarwa a kan tashoshin da kuma shafin Facebook na jerin.
An sanar da cewa masu siye suna yin sayayya da yawa saboda tsoron COVID-19 idan ana buƙatar keɓance kai.
A ranar Laraba, Wolverse ya taƙaita sayen kayan aikin gidan wanka don isar da kaya zuwa gida ɗaya kawai a cikin oda.
Waɗannan canje-canjen sun biyo bayan ƙuntatawa na kunshin huɗu da Wolverines da Coles suka sanar a ranar 4 da 5 ga Maris.
Coles, a cikin sanarwar da aka fitar a ranar 8 ga Maris, ya ba da sanarwar cewa ingancin ƙuntatawar kunshin huɗu, "har yanzu yawancin shaguna suna siyarwa a cikin sa'o'i ɗaya na isarwa", kuma ya kira buƙatar "ba a sani ba", yayin da ALDI, a cikin wani sakon Facebook a ranar Talata, ya kira shi "ba a sani ba".
A makon da ya gabata, tallace-tallace sun sami "mafi girman tashin hankali", a cewar mai magana da yawun Wolverines.
A makon da ya gabata, wani kantin sayar da kayayyaki na Costco a Canberra ya sauya adadin da aka ba shi zuwa fakiti biyu.
Don daidaita ƙarancin, Coles ya nemi ƙarin fakiti daga masu samarwa kuma ya ƙara lokutan isarwa, WollorSez ya nemi ƙarin kayan, yayin da ALDI ta ba da umarnin kayan don farkon isar da aka tsara a ranar Laraba.
Russell Zimmerman, babban darektan kungiyar masu sayar da kayayyaki ta Australiya, ya ce masu sayar da kayayyaki suna kokarin kara yawan kayayyaki, amma takunkumin da majalisar ke sanyawa kan lokacin isar da motocin da ke da wuya.
Ana sa ran farashin kayayyaki zai ƙaru, saboda masu samar da kayayyaki za su yi ƙoƙari su cika buƙatun, kuma ba tare da ƙarancin kayayyaki ba.
A ranar Talata, ALDI ta sanar da cewa bayan da aka fara samar da kayan aiki, wasu shagunan ba za su iya ba da kayayyaki na musamman a ranar Laraba ba.
A wani rahoto da News.com.au ya fitar, Dr. Gary Mortimer, masanin sayar da kaya a Queensland University of Technology, ya ce ana cika shagunan da kayayyaki a kowane dare.
Ya yi nuni da cewa, kayan wanka na wanka abu ne mai ban tsoro, wanda ke haifar da karancin kayan aiki a cikin adadi, kuma, lokacin da aka sayar, yana haifar da ɗakunan ajiya da yawa, yana da wahalar rashin ƙarancin.
A cewar ABC News, Russell Zimmerman ya ce Coles da Woolworths suna da ra'ayi cewa idan akwai wadata a kan ɗakunan ajiya, idan samfurori kamar wanka na wanka da tsabtace [an saya] kuma an keɓe su, to, za ku iya rage tsoro.
Kamfanin da ke kera kayayyakin da aka sake amfani da su na toilet, wanda ya ba da Crap, ya ce a ranar Laraba cewa kayan sun lalace.
Kimberly-Clark, wanda ke kera kayan wanka na Kleenex da Solaris, wanda ke kera kayan wanka na Sorbent, ya yi iƙirarin cewa suna aiki 24/7 don kare wadatar, a cewar News.com.au.
Domain.com, wani gidan yanar gizon gidaje, ya ba da rahoton cewa wasu dillalan gidaje na Clynx sun ba da gidan wanka kyauta ga masu ba da tallafi na farko a Melbourne, yayin da aka yi ƙarancin tallafi saboda dillalai suna da lokaci mai yawa a lokacin hutun hutun hutun ranar ma'aikata.
Buga na biyar na NT News, wata jaridar da ake bugawa a Darwin a kullum, ta yi amfani da shafuka takwas don a yanka ta a matsayin kayan wanka.
Shagunan sun yi jinkirin aiwatar da takunkumin, kamar yadda ABC Australia ta ruwaito a ranar 3 ga Maris, inda suka ce ba su da shirin sanya takunkumin sayen.
Russell Zimmerman ya kara da cewa akwai wasu kayayyaki da ake bukata sosai, kamar su masks, masu tsabtace gida, kayan wanki, sabulu mai ruwa da kuma jakar.
A Australia, an lura da wani babban kanti na Burtaniya da ke sayar da kayayyaki a kan layi na Ukado a ranar Lahadi da yamma cewa ya iyakance sayar da kayan wanka na Andres zuwa fakiti na 12 na biyu.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana ci gaba da yaduwar COVID-19 - cutar da ke haifar da kwayar cutar coronavirus SARS-CoV-2 - a matsayin annoba ta duniya.
Kodayake kalmar "annoba" tana nuna yadda cutar ta yadu, ba yadda wasu cututtuka ke da haɗari ba, WHO ta yi nuni da cewa gwamnatoci na buƙatar ɗaukar mataki:
Babban Daraktan Hukumar Lafiya ta Duniya, Dr. Tedros Adhanom Ghebreyesus, ya ce har yanzu ba a bar dukkan ƙasashe su canza yanayin cutar ba.
Idan ƙasashe za su iya tantance, bincika, warkar, ware, kuma su bi mutane da su, za su iya ba da amsa.
Muna cikin damuwa sosai game da yawan masu cutar da kuma rashin kulawarsu.
A cewar Dr. Tom Friedman, tsohon darektan Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, cutar ta "ba ta da tabbas".
A wani rahoto da CNN ya fitar a watan Fabrairu, ya ce, "Baya ga mura, babu wata cutar da ke shiga cikin iska da aka gano tun daga lokacin da ta fara fitowa har zuwa yau da kullum".
Ghibrisus ya yi magana game da ra'ayi mai kama da juna, yana cewa "Ba mu taɓa ganin annobar da ke haifar da kwayar cutar ta corona ba".
Ya kara da cewa, "Kuma ba mu taba ganin wata annoba da za a iya sarrafawa a lokaci guda ba".
Sabuwar cutar ta zama annoba ta duniya bayan da WHO ta yanke shawarar a watan Janairu don ayyana gaggawar matsalar lafiyar jama'a mai matukar damuwa ta duniya.
Daraktan Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, Dr. Anthony Fauci, ya ce game da barkewar cutar, "A takaice dai, yana kara ta'azzara".
A ranar Alhamis, Associated Press ta ba da rahoton cewa akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya haifar da mutuwar sama da 4,600.
Cutar annobar coronavirus ta 2019-20 annoba ce mai ci gaba ta cutar coronavirus (COVID-19) wanda ke haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan coronavirus 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China a watan Janairun 2019, an ayyana ta a matsayin gaggawa ta lafiyar jama'a ta kasa da kasa a ranar 30 ga Janairun 2020, kuma an ayyana ta a matsayin cutar ta duniya a ranar 11 ga Maris, 2020.
Ya zuwa 10 ga Afrilu 2020, an ba da rahoton kusan mutane miliyan 1.61 na COVID-19 a cikin ƙasashe da yankuna 210, wanda ya haifar da mutuwar kusan mutane 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta mutuwar ta kai kashi 4 cikin 100 a China, yayin da a duniya ta kai 13.04 bisa ɗari a Algeria da kuma kashi 0.08 cikin ɗari a New Zealand.
Alamun da ake yawan gani sun hada da tari, tari, da rashin numfashi.
Matsaloli na iya haɗawa da ciwon huhu da alamun cututtukan cututtukan cututtukan cututtukan numfashi.
Lokacin kamuwa da cutar zuwa lokacin bayyanar cututtuka shine kwanaki biyar, amma yana iya zama daga kwana biyu zuwa goma sha huɗu.
Babu wani maganin alurar riga kafi ko maganin rigakafi da aka sani.
Farkon magani shine bayyanar cututtuka da magani mai mahimmanci. Shawarwarin da aka ba da shawarar na farfadowa sun haɗa da wanke hannaye, rufe baki yayin da ake hauka, kiyaye nesa da wasu, da kuma sa ido da kuma keɓewa ga waɗanda ake zargin suna da cutar.
A duk duniya, hukumomi sun mayar da martani ta hanyar aiwatar da takunkumin tafiye-tafiye, keɓewa, takunkumin zirga-zirga, kula da haɗarin haɗari, da rufe wuraren.
Cutar ta haifar da rikicewar zamantakewar al'umma da tattalin arziki a duniya, jinkirta ko soke wasanni, addini, siyasa da al'adu, da kuma raguwar kayayyaki da aka yi amfani da su.
An rufe makarantu da jami'o'i a matakin ƙasa ko na gida a cikin ƙasashe 193, wanda ya shafi kusan kashi 99.4 na yawan ɗaliban ɗaliban duniya.
Rashin bayanai game da kwayar cutar ya bazu a yanar gizo, tare da nuna tsoron baƙi da nuna bambanci ga 'yan ƙasar Sin, da sauran mutanen da ke da asali daga gabashin da kuma kudu maso gabashin China, da kuma wasu da ke cikin yankin da cutar ta fi yawa.
An rage gurbataccen iska da iskar carbon ta hanyar rage tafiye-tafiye da rufe manyan masana'antu.
Jami'an kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton wasu kamuwa da cutar huhu a ranar 31 ga Janairu, 2019, kuma sun fara bincike a farkon Janairu, 2020.
Yawancin waɗannan cututtukan sun shafi kasuwar sayar da abincin teku ta Havana, saboda haka ana tsammanin kwayar cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da barkewar cutar, wacce aka fi sani da SARS-CoV-2, wata sabuwar cuta ce da aka gano mai alaƙa da kwayar cutar coronavirus, kwayar cutar coronavirus, SARS-CoV. Mutumin da aka fara sanin cewa yana da alamun bayyanar cutar kuma ya kamu da cutar a ranar 1 ga Disamba, 2019, mutumin da ba shi da wata alaƙa da sabon rukunin kasuwar nama.
Daga cikin shari'o'in da aka fara bayar da rahoto a cikin watan Janairun 2019, kashi biyu bisa uku suna da alaƙa da kasuwar naman alade.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba a cikin South China Morning Post ya ba da shawarar cewa wani lamari da ya faru a ranar 17 ga Nuwamba, 2019, a cikin wani mutum mai shekaru 55 a lardin Hubei, na iya zama na farko.A ranar 26 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya ta ce, tare da raguwar sabbin cututtukan da ke faruwa a China, amma kwatsam ya tashi a Italiya, Iran, da Koriya ta Kudu, a karon farko yawan sabbin cututtukan da ke faruwa a wajen China ya zarce na cikin kasar Sin.
Yawancin lokuta na iya wucewa ba tare da an ba da rahoto ba, musamman a tsakanin waɗanda ke da alamun bayyanar cututtuka.
A ranar 26 ga Fabrairu, an ba da rahoton ƙananan ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran
Lamarin na nuni da adadin mutanen da suka kamu da COVID-19, wadanda aka tabbatar sun kamu da cutar a cewar ka'idojin gudanarwa.
Har zuwa ranar 23 ga Maris, babu wata ƙasa da ta yi gwajin fiye da kashi 3% na yawan jama'arta, kuma yawancin ƙasashe suna da manufofin rufe waɗanda ke da alamun bayyanar cututtuka, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani bincike da aka fitar a ranar 16 ga Maris ya kammala da cewa a cikin Sin, ya zuwa ranar 23 ga Janairu, an yi hasashen cewa kashi 86% na masu kamuwa da COVID-19 ba a gano su ba, kuma waɗannan cututtukan da ba a ba da rahoton ba sun kai kashi 79% na shari'o'in da aka ba da rahoton.
Wani bincike da aka fitar a ranar 30 ga Maris ya yi hasashen cewa adadin wadanda suka kamu da cutar a Italiya ya zarce adadin da aka ba da rahoto.
Hasashen farko na R0 na COVID-19 ya kasance 1.4 zuwa 2.4
Wani binciken da Cibiyar Kula da Cututtuka ta Amurka ta wallafa ya nuna cewa cutar ta kamu da cutar ta 5.7.
Yawancin mutanen da ke da COVID-19 sun warke.
Ga wadanda ba su warke ba, lokacin da suka fara nuna alamun cutar zuwa lokacin mutuwar ya kasance tsakanin kwanaki 6 zuwa 41, wanda ya fi dacewa da kwanaki 14.
Ya zuwa 10 ga Afrilu, 2020, kusan mutuwar 97,000 sun faru sakamakon COVID-19.
A China, zuwa ranar 5 ga Fabrairu, kashi 80% na mutanen da suka mutu sun kasance sama da shekaru 60, kuma kashi 75% suna da wasu matsalolin lafiya kamar su cututtukan zuciya da ciwon sukari. jimlar mutuwar hukuma daga COVID-19 yawanci yana nuna mutanen da suka mutu waɗanda suka gwada tabbatacce ga COVID-19 bisa ga ƙa'idodin hukuma.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, saboda yana iya ƙunsar mutanen da suka mutu a cikin bincike - misali, a cikin gidajen tsofaffi, da sauransu.
Bayanai na ɓangaren Italiya sun nuna cewa yawan mutuwar a lokacin annobar ya ninka na COVID-19 sau 4-5 fiye da yadda ake tsammani.
Wani mai magana da yawun Cibiyar Kula da Cututtuka ta Amurka (CDC) ya ce "Mun san cewa [kimanin mutuwar da aka ruwaito] ya kasance ƙaramin zato", in ji sanarwar tare da rahoton rashin ƙididdigar mutum ɗaya a Amurka.
Mutuwar farko da aka samu a wajen China ta faru ne a Philippines a ranar 1 ga Fabrairu, kuma mutuwar farko a Asiya ta faru ne a Faransa a ranar 14 ga Fabrairu.
Ya zuwa 28 ga Fabrairu, a wajen China, fiye da mutane goma sha biyu sun mutu, ɗaya a Iran, ɗaya a Koriya ta Kudu, ɗaya a Italiya.
Ya zuwa 13 ga Maris, fiye da kasashe da yankuna arba'in sun ba da rahoton mutuwar, a kowace nahiyar ban da Antarctica.
Waɗannan lambobin sun bambanta bisa ga yanki da lokaci, kuma ana iya shafar adadin gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da aka fara kamuwa da cuta, da kuma halayen jama'a kamar shekaru, jinsi da lafiyar jama'a. Adadin mutuwar ya nuna yawan mutuwar da aka rarraba zuwa yawan mutanen da aka gano a cikin wani lokaci.
Dangane da bayanan Jami'ar Johns Hopkins, yawan mace-macen duniya ya kai 6.0% (97,039/1,617,204) har zuwa 10 ga Afrilu, 2020.
Adadin ya bambanta dangane da yankin.
A China, ƙididdigar mutuwar mutum ya ragu daga 17.3 (ga waɗanda suka fara nuna alamun daga 1 zuwa 10 ga Janairu, 2020) * zuwa 0.7% (ga waɗanda suka fara nuna alamun bayan 1 ga Fabrairu, 2020).Sauran ma'aunai sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan adadin mutanen da aka gano da ke mutuwa daga cutar, da yawan mutuwar cutar (IFR), wanda ke nuna yawan adadin mutanen da suka kamu da cutar (da aka gano da kuma marasa cutar) da ke mutuwa daga cutar.
Bayanai ba su da lokaci kuma suna bin wasu ƙididdigar al'umma ta hanyar maganin cutar.
Yawancin masana kimiyya sun yi ƙoƙari su lissafa waɗannan ƙididdigar don ƙididdigar yawan jama'a.
Cibiyar Nazarin Magunguna ta Oxford ta tabbatar da cewa yawan mutuwar da cutar ke haifarwa ya kasance tsakanin 0.1% da 0.39%.
Hasashen da ke sama da wannan adadin ya yi daidai da sakamakon gwajin COVID-19 na farko da aka yi a Jamus, da kuma nazarin ƙididdiga wanda ke nazarin tasirin gwajin akan hasashen CFR.
Hukumar Lafiya ta Duniya ta tabbatar da cewa za a iya shawo kan annobar.
Lokacin da cutar ta ɓarke da kuma inda ta ƙare ba a sani ba kuma yana iya bambanta dangane da wurin.
"Ba tare da gwaji ba, yaduwar cutar a cikin al'ada tana da yawa, sannan ta fara raguwa lokacin da cutar ta zama ba ta da wata hanyar da za a iya ganowa", in ji masanin kifi na Penn State University.
Amma yanzu ba za ku iya yin hasashen ko hakan zai faru ba".
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin China Zhong Nanshan ya yi amannar cewa "zai yiwu a kawo karshen watan Yuni" idan dukkan kasashe sun shirya don bin shawarar Hukumar Lafiya ta Duniya kan matakan da za a dauka don dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kocharsky na Jami'ar Kula da Lafiyar Lafiya da Tropical na Landan ya ce SARS-CoV-2 "za ta ɓace cikin shekara ɗaya ko biyu".
A cewar binciken da Neil Ferguson ya gudanar a Imperial College, nisantar da jama'a da sauran matakan da ake bukata "za su kasance har sai an sami allurar rigakafi (ko da yaushe watanni 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin cewa wannan kwayar cutar ba za ta iya ɓacewa gaba ɗaya ba, saboda tana da saurin yaduwa", kuma "mai yiwuwa ya zama cuta ce ta yanayi, da ke sake dawowa kowace shekara".
Rashin dawowa ya dogara ne akan juriya da yawan tsalle.
Alamun COVID-19 na iya zama ba a iya gano su ba, kuma mutanen da ke da cutar na iya zama ba su da alamun cutar.
Abubuwan da suka fi faruwa a cikin mutane sune: saurin hauka (88%) da kuma tari (68%).
Sauran alamun da ba a saba gani ba sun haɗa da ciwon sukari, ciwon hanci, rashin jin ɗanɗano, ƙanƙan numfashi, ciwon tsoka da haɗin gwiwa, ciwon hanci, ciwon kai, sanyi, tari, jini tare da tari, maƙarƙashiya, ko kuma fata mai launin fata. Hukumar Lafiya ta Duniya ta ce kusan mutum ɗaya cikin shida na iya samun zazzabi da matsalar numfashi.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta bayyana alamun cututtuka na gaggawa kamar wahalar numfashi, ciwo ko ci gaba da ciwon huhu, saurin zubar da jini, wahalar tafiya, da kuma fuska ko hanci; ya kamata a nemi kulawar likita nan da nan idan akwai waɗannan alamun. Ci gaba da cutar na iya haifar da kumburi na huhu, matsin lamba na numfashi na yau da kullun, cutar hawan jini da mutuwa.
Wasu daga cikin wadanda ke dauke da cutar ba su da alamun cutar, ba su da alamun cutar amma sakamakon gwajin ya tabbatar da cewa suna dauke da cutar, don haka masu binciken sun ba da shawarar cewa a sanya wa mutanen da suka yi mu'amala da wadanda aka tabbatar da cewa suna dauke da cutar ido sosai, sannan a yi musu allurar rigakafin cutar.
An yi hasashen cewa yawan mutanen da ba su da alamun cutar za su iya kaiwa kashi 44 cikin 100.
Lokacin rayuwa (lokacin tsakanin kamuwa da cutar da bayyanar cututtuka) ya kasance daga kwana 1 zuwa 14; mafi yawanci kwanaki 5. A matsayin misali na rashin tabbas, ƙididdigar yawan mutanen da ke da COVID-19 da suka rasa ƙanshin ƙanshi da ƙanshi ya kasance 30% a farkon amma daga baya ya ragu zuwa 15%
Ba a san cikakken bayani game da yadda cutar ta samo asali ba.
Ana tsammanin cutar ta samo asali ne daga kusanci da ƙananan ƙwayoyin cuta da aka samu yayin yin kuka, yin kuka ko magana; kusanci yana tsakanin mita 1 zuwa 2 (mita 3 zuwa 6).
Bincike ya gano cewa cocaine mai saurin motsawa yana sa tsinkaye su kai tsawon mita 4.5 (ƙafa 15) zuwa 8.2 (ƙafa 27).
Wasu sun ba da shawarar cewa ana iya yada cutar ta hanyar ƙananan ɗigon ruwa da ke cikin iska na dogon lokaci, wanda za'a iya haifar da shi yayin magana. Za'a iya haifar da ɗigon ruwa na numfashi ta hanyar numfashi, ciki har da magana, kodayake cutar ba ta da iska.
Za a iya amfani da digo daga bakin ko hanci na mutanen da ke kusa da su ko kuma a jawo su cikin huhu.
Wasu hanyoyin kiwon lafiya kamar su inhaling da cardiopulmonary resuscitation (CPR) na iya haifar da saurin fitar da iska daga cikin huhu, wanda ke haifar da yaduwar iska.
Hakanan yana iya yaduwa lokacin da mutum ya taɓa ƙazantar tufafi, ya taɓa fata, sannan ya taɓa idanu, hanci ko baki.
Duk da yake akwai damuwa cewa za a iya yada shi ta hanyar sharar gida, amma ana ganin cewa wannan haɗarin yana da ƙananan.
Gwamnatin China ta musanta yiwuwar yiwuwar watsa SARS-CoV-2 ta hanyar kwayoyin cutar. Kwayar cutar ta fi yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya samun yaduwa kafin bayyanar cututtuka da kuma a cikin matakan da suka gabata na cutar.
Wasu mutane sun gwada inganci har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ya nuna cewa cutar za ta iya tashi kafin bayyanar cututtuka.
Akwai ƙananan rahotanni na tabbataccen yanayin rashin bayyanar cututtuka, amma an gano bazuwar watsawa a cikin ƙasashe da yawa a cikin binciken bin diddigin.
Cibiyar Kula da Cututtuka da Cututtuka ta Turai (ECDC) ta ce yayin da ba a san yadda cutar ke yaduwa da sauri ba, yawanci mutum ɗaya zai iya kamuwa da mutum biyu zuwa uku.
Musamman, an gano kwayar cutar a kan filastik (polypropylene) da 304 na tsawon kwana uku, a kan kwalba na tsawon kwana ɗaya, da kuma tagulla har tsawon kwanaki huɗu.
Koyaya, wannan ya dogara da yanayin zafi da zafi. dabbobin gida da sauran dabbobi sun kamu da COVID-19.
Babu tabbacin cewa dabbobi na iya yada cutar zuwa ga mutane, kodayake hukumomin Burtaniya sun ba da shawarar wanke hannu bayan sun taɓa dabbobi, kamar bayan sun taɓa tufafin da waɗanda suka kamu da cutar suka iya taɓawa.
SARS-CoV-2 wani sabon kwayar cuta ne, wanda aka fara rarrabe shi daga mutane uku da suka kamu da cutar sankara mai tsanani zuwa wasu mutane da suka kamu da cutar huhu a Wuhan.
Dukkanin abubuwan da ke cikin SARS-CoV-2 sun fito ne daga yanayin yanayin coronavirus. A waje da jikin mutum, ana kashe kwayar cutar da sabulun gida, wanda ke narkar da rigar kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
An yi imani da cewa akwai dabba da ke da asali.
Nazarin bincike ya nuna cewa coronavirus yana da nasaba ta hanyar kwayar halitta tare da betacoronavirus, tare da subgenic sarbicoronavirus (B-line) tare da nau'i biyu da aka samo daga bat.
Yana da kashi 96% na kwayar halitta da ta yi kama da na sauran batCov TaTG13 coronavirus.
A cikin watan Fabrairun 2020, masu binciken China sun kammala cewa akwai bambancin amino acid guda ɗaya kawai a cikin wasu sassan jerin kwayoyin tsakanin ƙwayoyin cuta a cikin penguin da na ɗan adam.
A halin yanzu, jimlar kwatancen kwayoyin halitta ya kai kusan kashi 92% na abubuwan da ke tattare da kwayoyin halitta tsakanin kwayar cutar kwayar cutar kwayar cutar kwayar cutar SARS-CoV-2, wanda ba lallai ba ne ya zama dole don tabbatar da cewa kwayar cutar kwayar cutar kwayar cutar kwayar cuta ce.
Ana iya tabbatar da cutar ta hanyar bayyanar cututtuka, kodayake tabbatarwa ta ƙarshe ta hanyar juyawa ta hanyar polymerase chain reaction (rRT-PCR) na ƙwayoyin cuta masu cutar ko CT.
Wani bincike da aka yi a Wuhan ya kwatanta PCR da CT ya nuna cewa CT yana da saurin ganewa fiye da PCR, yana da ƙarancin ganewa, kuma yana da alaƙa da ƙarancin radiation da sauran hanyoyin ciwon huhu da sauran cututtuka.
A cikin Maris 2020, Cibiyar Nazarin Radiology ta Amurka ta ba da shawarar cewa "kada a yi amfani da CT don gwaji ko a matsayin gwajin farko don gano COVID-19".
Hukumar Lafiya ta Duniya ta wallafa wasu ladabi na gwajin RNA don SARS-CoV-2, wanda aka fara bugawa a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin reverse polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin ta hanyar samfurin numfashi ko jini.
A mafi yawan lokuta ana samun sakamakon a cikin sa'o'i zuwa kwanaki.
Ana yin gwajin ne a kan hanci ko hanci, ko da yake ana iya amfani da hancin hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna yin gwajin ƙwayar cuta, wanda ke gano antibodies.
Har zuwa 6 ga Afrilu, 2020, babu ɗayan waɗannan da aka ƙaddamar da su don a ba su izinin amfani da su.
A Amurka, Cellex ya haɓaka gwajin kwayar cutar kuma an yarda da shi don amfani da gaggawa kawai ta hanyar ɗakunan bincike masu aminci.
Abubuwan da ke tattare da hasken rana na musamman a kan radiography da CT na mutanen da ke da alamun cutar sun haɗa da hasken gilashin baya da rashin fitowar gefe.
Ƙungiyar Radiology ta Italiya tana tattara bayanan yanar gizo na sakamakon radiation na waɗanda aka tabbatar da cutar.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, PCR na nuna rashin tabbaci yana da iyakancewar ƙwarewa a cikin gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT da PCR kuma ya nuna cewa, kodayake hasken yana da ƙarancin kamuwa da cuta, amma ya fi sauri da ƙwarewa, yana ba da shawarar a yi amfani da shi a matsayin hanyar bincike a yankunan da ke fama da cutar.
An kirkiro cibiyar sadarwa ta jijiyoyin jiki ta AI don gano halaye na radiation tare da radiographs da CTs.
Dabaru don hana yaduwar cutar sun haɗa da kiyaye tsabtar jiki, wanke hannu, gujewa taɓa idanu, hanci ko baki da hannaye marasa wanka, yin amfani da clenx ko clenx, da kuma zubar da clenx a cikin ruwan najasa kai tsaye.
An shawarci waɗanda ke da cutar su sanya abin rufe fuska a cikin jama'a.
An kuma ba da shawarar matakan nesantawa ta jiki don hana yaduwar cutar. Yawancin gwamnatoci sun ba da umarnin ko ba da shawara game da duk wani balaguron da ba shi da mahimmanci kuma guji shiga cikin ƙasar ko yankin da cutar ta ɓarke.
Koyaya, cutar ta kai matakin yaduwar al'umma a wurare da yawa na duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'umma, kuma membobin wasu al'ummomin ba su san inda ko yadda suka kamu da cutar ba. Masu ba da lafiya suna kula da mutumin da zai iya kamuwa da cutar wanda aka umurce su da su yi amfani da sanarwa da kuma kula da hulɗa da kuma amfani da kariya ta ido.
Yin amfani da bayanan wuri daga wayoyin salula ta hannu ta hanyar gwamnatoci don wannan dalili ya haifar da damuwar sirri, tare da Amnesty International da fiye da 100 kungiyoyi suna ba da shawara da kuma neman a hana irin wannan sa ido.
An aiwatar da aikace-aikacen wayar hannu da yawa ko kuma an ba da shawarar don amfani da kai tsaye, kuma a ranar 7 ga Janairu, 2020, ƙungiyoyi masu ƙwarewa sama da dozin biyu suna aiki akan mafita masu dacewa da sirri, kamar amfani da Bluetooth don yin rikodin mai amfani da ke kusa da sauran wayoyin hannu.
Masu amfani za su karɓi wasiƙa idan sun kasance cikin kusanci da wani wanda ya gwada tabbatacce ga COVID-19. Akwai ra'ayoyin da ba daidai ba game da yadda za a guji kamuwa da cutar; alal misali, wanke hanci da kuma yin amfani da maganin wanke baki ba shi da amfani.
Babu wani maganin rigakafin COVID-19, kodayake kungiyoyi na iya aiki don samar da guda.
Ana bada shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa a kalla na tsawon dakika 20 da wuri, musamman bayan sun je banɗaki ko kuma idan hannayensu sun ƙazantu; kafin su ci abinci; da kuma bayan sun yi hanci, da kuma wanka.
Wannan saboda a waje da jikin mutum, ana kashe kwayar cutar da sabulu na gida, wanda ke lalata kumfa mai aiki.
CDC ta kuma ba da shawarar yin amfani da sabulun wanka wanda ya ƙunshi aƙalla kashi 60% na ruwa mai wanka idan sabulu da ruwa ba su samuwa.
WHO ta ba da shawarar cewa mutane su guji taɓa idanu, hanci, ko baki da hannaye marasa wanki.
Za a iya tsabtace yadudduka tare da wasu abubuwa (a cikin minti 1 daga saduwa da mai tsabtace kayan zuwa yadudduka na karfe), wanda ya ƙunshi 62-71% na ethanol, 50-100% na isopropanol, 0.1% na sodium hydrochloride, 0.5% na hydrogen peroxide da 0.2-7.5% na iodine-povoyodin.
Sauran sunadarai, kamar su benzalkonium chloride da gluconate chromium oxide, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan ana zargin ko tabbatar da cutar COVID-19 a cikin ofishi ko wurin kulawa, duk wuraren da aka saba da su kamar ofisoshin, dakunan wanka, wuraren da ake amfani da su, na'urorin lantarki da aka raba kamar su allunan, allon taɓawa, makullin, na'urar sarrafawa ta nesa, da na'urar ATM da mutum mai cutar ya yi amfani da ita ya kamata a yi masa allurar rigakafin cutar.
Kungiyoyin lafiya sun ba da shawarar rufe bakin da hanci da anishki ko kuma wani abu mai laushi yayin shan cocaine ko pythons, da kuma zubar da abin da ke ciki nan da nan.
An ba da shawarar sanya abin rufe fuska ga mutanen da suka kamu da cutar, saboda sanya abin rufe fuska na iya rage girman da kuma iyakar saurin saurin saurin saurin saurin numfashi yayin magana, tari, da tari.
Hukumar Lafiya ta Duniya ta ba da jagora kan lokacin da yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin ƙwayoyin cuta a Jami'ar Leeds, "saka abin rufe fuska zai iya rage yawan sharar da mutane ke yi a fuska, wanda shine babban tushen kamuwa da cuta ba tare da tsabtace hannu ba".
Hukumar Lafiya ta Duniya ta ba da shawarar sanya abin rufe fuska ga mutanen da ke cikin koshin lafiya idan suna cikin haɗari, kamar waɗanda ke kula da wanda ke da COVID-19, kodayake sun yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskarsu.
Kasashe da yawa sun fara ƙarfafa amfani da abin rufe fuska ga jama'a.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska wanda ba na likitanci ba ne wanda aka yi da yarn.A China, musamman, an ba da shawarar yin amfani da abin rufe fuska na likitanci ta hanyar jama'a masu lafiya, musamman lokacin da suke cikin kusanci (ƙafa 1 ko ƙasa da haka) tare da sauran mutane.
Hong Kong ta ba da shawarar sanya abin rufe fuska na likitanci yayin amfani da sufuri na jama'a ko kasancewa a cikin cunkoson jama'a.
Jami'an kiwon lafiya na Thai sun ƙarfafa mutane su yi masks na masana'anta a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita ba tare da sanya abin rufe fuska ba ko rufe fuska.
A ranar 16 ga Maris, Vietnam ta bukaci kowa ya sanya abin rufe fuska yayin shiga wuraren jama'a don kare kansa da sauran mutane.
Gwamnatin Austria ta ba da umarnin cewa duk wanda ke shiga shago dole ne ya sanya abin rufe fuska.
Isra'ila ta bukaci dukan mazauna garin su wanke fuskokinsu a duk lokacin da suke zagayawa.
Taiwan, wanda ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar Maris, ya bukaci fasinjojin jirgin kasa da bas su sanya abin rufe fuska a ranar 1 ga Afrilu.
Panama ta tilasta sanya abin rufe fuska yayin fita, yayin da ta ba da shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya saya ba.
Ana kuma amfani da masks a cikin Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa da jama'a (wanda aka fi sani da nisantar da jama'a) ya ƙunshi ayyukan sarrafa cuta da nufin rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyi sun haɗa da keɓewa, ƙuntata tafiya; da kuma rufe makarantu, wuraren wasanni, filayen wasa, gidajen wasan kwaikwayo ko wuraren kasuwanci.
Mutane na iya yin amfani da hanyoyin nisantar zamantakewa ta hanyar zama a gida, iyakance balaguro, guje wa wuraren da jama'a ke taruwa, yin amfani da gaisuwa ta haɗuwa, da nisantar juna ta jiki.
Yawancin gwamnatoci yanzu suna yin watsi da ko aiwatar da nisantar da jama'a a yankunan da cutar ta bulla.
An rage girman taron daga mutane 250 (idan babu wani sanannen COVID-19 a yankin) zuwa mutane 50, kuma daga baya zuwa mutane 10 ta hannun hukumomin gwamnatin Amurka da ƙungiyoyin kiwon lafiya.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane sama da biyu. Manya tsofaffi da waɗanda ke da yanayin likita kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hypertension da cututtukan rigakafi suna cikin haɗarin kamuwa da cuta mai tsanani kuma an shawarci CDC su zauna a gida kamar yadda zai yiwu a wuraren da aka samu barkewar cutar.A ƙarshen watan Maris na 2020, WHO da sauran hukumomin kiwon lafiya sun fara sauya ma'anar "nesa da jama'a" zuwa "nesa da jiki", don bayyana cewa makasudin shine rage haɗarin jiki a yayin hulɗa da jama'a, maimakon yin tafiya ko tafiya.
Amfani da ma'anar "jituwa ta zamantakewa" ya samo asali ne saboda mutane suna buƙatar shiga cikin cikakken nisantar da jama'a, maimakon ƙarfafa su don ci gaba da hulɗa da wasu ta hanyar dalilai na madadin. Wasu hukumomi sun ba da umarnin kiwon lafiya na jima'i don amfani da su yayin annobar.
Waɗannan sun haɗa da shawarar yin jima'i kawai tare da wanda kuka yi tarayya da shi, wanda ba shi da cutar ko alamun cutar.
An ba da shawarar keɓewa a gida ga waɗanda ke da COVID-19 da kuma waɗanda ake tsammanin suna da shi.
Hukumomin kiwon lafiya sun ba da cikakkun jagororin don ingantaccen keɓe kai.Gwamnatoci da yawa sun ba da umarni ko ba da shawarar keɓe kai ga dukkan mazauna da ke zaune a yankunan da abin ya shafa.
An ba da umarnin keɓe kai mafi ƙarfi ga waɗanda ke cikin rukunin haɗari.
Wadanda suka yi hulda da wani da ke dauke da COVID-19 da kuma wadanda kwanan nan suka yi tafiya zuwa wata ƙasa ko yanki da ake da yaduwar cutar an shawarce su da su killace kansu na tsawon kwanaki 14 bayan an yi hulda da su.
Dabaru don shawo kan cutar sun hada da hana ko rage yawan kamuwa da cutar.
Ana gudanar da kariya a farkon lokacin barkewar cutar, da nufin ganowa da ware wadanda suka kamu da cutar tare da sanya wasu matakan sarrafa cutar da alluran rigakafi don dakatar da yaduwar cutar zuwa sauran al'ummomin da ke fama da cutar.
Idan ba a iya sarrafa yaduwar cutar ba, to ana iya shiga cikin matakan ragewa: Ana ɗaukar matakan rage yaduwar cutar da rage tasirinsa ga tsarin kiwon lafiya da kuma al'umma.
Ana iya ɗaukar matakan haɓaka da ragewa a lokaci guda.
Rigakafin na buƙatar ƙarin matakan, don haka juyar da yaduwar cutar daga mutum zuwa mutum ya zama wani ɓangare na gudanarwa da magance cutar ta kamuwa da cuta yana nufin ƙoƙarin rage yanayin cutar ta hanyar daidaita yanayin yaduwar cuta.
Wannan yana rage haɗarin yawan amfani da sabis kuma yana ba da ƙarin lokaci don haɓaka allurar rigakafi da magani.
Ayyukan da ba na asibiti ba da za su iya shawo kan yaduwar cutar sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da keɓewa; matakan al'umma don nisantar da jiki kamar rufe makarantu da hana manyan taron jama'a; shigar da al'umma don ƙarfafa yarda da shiga cikin irin waɗannan ayyukan; da kuma hanyoyin muhalli kamar tsabtace tufafi. Ƙarin ayyukan da aka yi niyya don shawo kan yaduwar cutar sun kasance a cikin wuri lokacin da cutar ta bayyana, kamar keɓe birane gaba ɗaya da kuma sanya takunkumin tafiya.
Sauran ƙasashe kuma sun ɗauki matakai daban-daban don iyakance yaduwar cutar.
Koriya ta Kudu ta aiwatar da gwajin gwaji da keɓaɓɓen keɓewa, kuma ta ba da sanarwar gargadi ga motsi na masu cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda suka kamu da cutar waɗanda suka yi keɓe kansu kuma suka sanya manyan hukunce-hukuncen ga waɗanda ba su yi biyayya ba.
Taiwan ta haɓaka samar da abin rufe fuska kuma ta sanya takunkumi kan yawan sayan kayan aikin likita.Haka ma ya faru ga Burtaniya da Amurka, yana nuna cewa ragewa (sanyi don hana yaduwar cutar) da kuma kawo ƙarshen cutar (mai hana yaduwar cutar) suna da babban kalubale.
Da kyau rage manufofin iya rage bukatar kiwon lafiya ta 2/3 da kuma rage mutuwar da rabi, amma har yanzu yana haifar da daruruwan dubban mutuwar da kuma fatattakar tsarin kiwon lafiya.
Ana iya amincewa da yin rigakafin cutar amma ya kamata a yi watsi da shi har sai an kawar da cutar a cikin al'umma (ko kuma har sai an samu rigakafin, idan ya zo da farko), saboda yiwuwar yaduwa yana ƙaruwa yayin da aka sassauta matakan.
Aiki na dogon lokaci don shawo kan cutar yana haifar da tsada na zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19, amma ana ci gaba da kokarin samar da shi, gami da gwajin magungunan da ake da su a halin yanzu.
Shan magungunan da ke hana sanyi, shan abubuwan sha, da kuma hutawa na iya taimakawa wajen rage alamun.
Dangane da tsananin cutar, ana iya buƙatar maganin oxygen, maganin intravenous, da taimakon numfashi.
Yin amfani da abubuwan motsa jiki na iya yin mummunan sakamako.
Ana binciken wasu sinadarai da dama da aka amince da su a baya don magance wasu cututtukan da ke da nasaba da kwayar cutar don amfani da su wajen magance COVID-19.
WHO ta kuma ce "alamu da magunguna na gida" na iya taimakawa wajen rage alamun cutar SARS-CoV-19.
WHO ta bayyana haɓaka damar da kuma samun damar kula da lafiya ga marasa lafiya da ke fama da cutar COVID-19 a matsayin matakan da za a bi don magance cutar.
ECDC da Ofishin Yankin Turai na WHO sun ba da umarni ga asibitoci da sabis na kiwon lafiya na farko don sauya albarkatu a matakai da yawa, gami da mayar da hankali kan sabis na dakin gwaje-gwaje zuwa gwajin COVID-19, hana ayyukan zaɓi lokacin da ya dace, keɓe marasa lafiya masu COVID-19 masu kyau, da haɓaka ƙarfin kulawa ta hanyar horar da ma'aikata da haɓaka yawan na'urorin numfashi na hannu da magunguna.
Akwai ra'ayoyi da yawa game da inda yanayin farko ya samo asali (wanda ake kira "number zero disease").
Halin da aka sani na farko na kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cuta ta iya komawa zuwa 1 ga Janairu, 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu da sauri.
Yawancin waɗannan suna da alaƙa da kasuwar sayar da abincin teku ta Wuhan, wanda kuma ana sayar da dabbobi masu rai, kuma an yi imani da cewa cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko kuma, a wata ma'anar, yana da asalin dabba. An lura da wani yanayin da ba a san dalilinsa ba na ciwon huhu a ranar 26 ga Disamba kuma an kula da shi ta hanyar Dr. Zhang Jixun a asibitin lardin Hubei, wanda ya sanar da CDC a Wuhan a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, wani rukunin likitoci a asibitin Wuhan Central Hospital sun yi gargadin abokan aikinsu game da "kwayar cutar corona mai kama da SARS".
Takwas daga cikin waɗannan likitocin, ciki har da Lee Wenliang, an yi wa 'yan sanda gargadi da ƙarfi don yada farfaganda, kuma wani, I Fan, ya yi wa shugabansa garkuwa saboda ya ƙara yawan fargabar haɗari.
Kwamishinan lafiya na Wuhan ya yi gargadin jama'a a ranar 31 ga Disamba, kuma ya sanar da Hukumar Lafiya ta Duniya.
An ba da rahoton manyan cututtukan cututtukan huhu da ba a san dalilin su ba ga hukumomin lafiya a Wuhan don fara bincike a farkon Janairu. A farkon farkon barkewar cutar, adadin masu kamuwa da cutar ya ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar Janairu 2020, cutar ta bazu zuwa sauran yankuna na China, wanda ya sami haɗin gwiwar Sabuwar Shekarar Sin da kuma Wuhan a matsayin cibiyar sufuri da tashar jirgin ƙasa.
A ranar 20 ga Janairu, China ta ba da rahoton kusan sabbin maganganu 140, gami da mutum biyu a Beijing da mutum daya a Shenzhen.
Bayanan hukuma sun nuna cewa a ranar 20 ga Janairu 2020, mutane kusan 6174 sun nuna alamun cutar. A ranar 26 ga Maris, Amurka ta bi China da Italiya a matsayin mafi yawan adadin mutanen da aka tabbatar da cutar a duniya.
A cikin kusan ƙasashe da yankuna 200 akwai aƙalla ɗaya da aka kamu da cutar.
Sakamakon annobar a Turai, yawancin ƙasashen yankin Schengen sun hana zirga-zirgar masu zaman kansu da sanya ƙuntatawa a kan iyakoki.
Amsawa ta ƙasa ta haɗa da matakan hanawa kamar su keɓewa (wanda aka fi sani da umarnin zama a gida, umarnin cikin gida, ko kuma keɓewa) da kuma hana zirga-zirga. a ranar 2 ga Afrilu, kusan mutane miliyan 300, kusan kashi 90% na yawan jama'a, suna ƙarƙashin wani nau'i na keɓewa a Amurka, sama da mutane miliyan 50 a Philippines, kusan miliyan 59 a Afirka ta Kudu, da kuma mutane biliyan 1.3 a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wani nau'in hana fita daga gida, wanda ya karu zuwa biliyan 2.6 a cikin kwanaki biyu masu zuwa - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An tabbatar da farkon cutar COVID-19 a Wuhan a ranar 1 ga Disamba 2019; wani rahoto da ba a tabbatar da shi ba ya ba da shawarar cewa farkon cutar ta kasance a ranar 17 ga Disamba.
Dokta Zhang Jixuan ya yi tsokaci game da wani lamari na cutar huhu da ba a san dalilinsa ba a ranar 26 ga Janairu, wanda ya sa asibitin ya sanar da CDC da Wuhan Jiangnan a ranar 27 ga Janairu.
Gwajin kwayar halitta na farko na samfuran marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna kasancewar kwayar cutar corona-like SARS.
An ba da sanarwar sanarwa ta Kwamishinan Lafiya na Wuhan a ranar 31 ga Janairu.
An sanar da Hukumar Lafiya ta Duniya a wannan ranar.
A lokacin da wannan gargadi ya faru, 'yan sanda sun gargadi likitoci a Wuhan game da "yaɗuwar farfaganda" game da yaduwar cutar.
Da farko, Hukumar Kiwon Lafiya ta kasar Sin ta yi ikirarin cewa babu wata "hujja mai kyau" game da yaduwar cutar daga mutum zuwa mutum.
A ƙarshen Janairu, gwamnatin China ta ƙaddamar da kamfen na gogewa wanda Sakatare Janar na Jam'iyyar Kwaminis ta China ya bayyana a matsayin "Yakin Jama'a" don hana yaduwar cutar.
A cikin abin da aka kwatanta a matsayin "mafi girma a cikin tarihin ɗan adam", a ranar 23 ga Janairu, an ba da sanarwar rufewa don dakatar da tafiya zuwa da dawowa daga Wuhan, wanda aka faɗaɗa zuwa garuruwa 15 a Hubei, wanda ya shafi mutane miliyan 57.
An haramta amfani da motoci masu zaman kansu a cikin birnin.
An dakatar da bikin Sabuwar Shekarar Sinanci (25 ga Janairu) a wurare da dama.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, Asibitin Hussain, wanda aka kammala a cikin kwanaki 10.
An kuma gina wani asibiti, asibitin Lashichetshan, don magance ƙarin cututtuka.
Baya ga sabbin asibitocin da aka gina, China ta kuma mayar da wasu gine-gine 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta ɗauki wasu matakan don magance barkewar COVID-19, gami da bayar da sanarwar lafiya ga masu yawon bude ido da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a duk fadin kasar.
Yankin Hong Kong da Macau sun ɗauki matakai da yawa, musamman game da makarantu da jami'o'i.
Ana samun hanyoyin yin aiki daga nesa a yankuna da yawa na kasar Sin.
An sanya takunkumin tafiye-tafiye a ciki da wajen Hubei.
An yi amfani da sufuri na jama'a, kuma an rufe gidajen tarihi a duk fadin kasar Sin.
An aiwatar da takunkumin zirga-zirgar jama'a a birane da yawa, tare da kimanin mutane miliyan 760 (fiye da rabin yawan jama'a) da aka kiyasta sun shiga wani nau'in takunkumin waje. Bayan barkewar cutar ta zama ta duniya a watan Maris, hukumomin China sun ɗauki matakan da suka dace don hana "shigo da" cutar daga wasu ƙasashe.
Misali, Beijing ta sanya keɓewar tilas na kwanaki 14 ga duk matafiya na ƙasa da ƙasa da ke shigowa birni.A ranar 23 ga Maris, a cikin ƙasar China akwai shari'ar kamuwa da cutar guda ɗaya kawai a cikin kwanaki biyar, a wannan yanayin ta hanyar matafiyi da ke dawowa daga Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da sanarwar cewa an dakatar da yaduwar cutar ta gida kuma an sarrafa yaduwar cutar a cikin kasar Sin.
A wannan ranar an sassauta takunkumin tafiye-tafiye a Hubei, ban da Wuhan, watanni biyu bayan an sanya dokar a gida.Ma'aikatar Harkokin Waje ta kasar Sin ta ba da sanarwar a ranar 26 ga Maris, 2020 cewa za a dakatar da izinin shiga kasar don biza ko masu riƙe da takardar izinin zama har zuwa 28 ga Maris, sannan a ba da cikakken bayani game da lokacin da wannan manufar za ta ƙare.
Duk wanda ke son shiga kasar Sin dole ne ya nemi takardar visa a ofishin jakadancin kasar Sin ko kuma a ofishin jakadancin kasar.
Gwamnatin China ta ƙarfafa kasuwanci da masana'antu su buɗe a ranar 30 ga Maris, kuma ta ba da kuɗi don ƙarfafawa ga kamfanoni. Majalisar Jiha ta ba da sanarwar ranar makoki don farawa da nutsuwa na minti uku a karfe 10:00 na safe a ranar 4 ga Afrilu, daidai da bikin Qingming, kodayake gwamnatin tsakiya ta bukaci iyalai da su bar su don yin la'akari da nisantar jiki don hana sake barkewar cutar COVID-19.[1]
A ranar 20 ga Janairu, 2020, an tabbatar da cewa cutar COVID-19 ta bulla a Koriya ta Kudu, wanda ya samo asali ne daga China.
A ranar 20 ga Fabrairu, Hukumar Kiwon Lafiya ta Kasa ta ba da rahoton karuwar karuwar, wanda ya kasance saboda wani taro na addini a Daegu da ake kira Ikilisiyar Shinseonji na Kristi.
An yi zargin cewa jami'an tsaro na Shenxiong da suka ziyarci Daegu daga Wuhan ne suka haifar da barkewar cutar.
A ranar 22 ga Fabrairu, daga cikin mabiyan coci 9,336, 1,261 ko kusan 13% suna da alamun cutar.Koriya ta Kudu ta ba da sanarwar matakin gargadi mafi girma a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an bayar da rahoton fiye da 2000 da aka tabbatar da cutar a Koriya, wanda ya karu zuwa 3150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojan Koriya bayan an tabbatar da cewa sojoji uku sun kamu da cutar.
Ya shafi jadawalin jiragen sama kuma ya canza. Koriya ta Kudu ta ƙirƙiri abin da ake kira mafi girma da mafi kyawun tsari a duniya don bincika mazauna don cutar, keɓe duk wanda ya kamu da cutar da bin sawu da keɓe waɗanda suka yi hulɗa da su.
Hanyoyin gwajin kai sun haɗa da bayar da rahoto na tilasta mutane da suka isa ƙasashen duniya ta hanyar aikace-aikacen hannu, gwajin cikin mota don cutar tare da sakamakon da aka samu a rana mai zuwa, da haɓaka ƙarfin gwaji don ba da damar yin gwaji ga mutane 20,000 kowace rana.
An yi wa shirin Koriya ta Kudu la'akari da nasara wajen shawo kan barkewar cutar duk da cewa ba a kebe dukkan biranen ba. Jama'ar Koriya ta Kudu sun fara rarrabuwar kawuna kan yadda Shugaba Moon Jae-in ya amsa matsalar.
Yawancin masu shigar da kara sun nemi a bincika Moon saboda sun yi ikirarin cewa gwamnati ba ta magance cutar ba, ko kuma sun yaba da amsar.
A ranar 23 ga Maris, an ba da rahoton cewa Koriya ta Kudu ta sami mafi ƙarancin lokuta a cikin kwanaki huɗu.
A ranar 29 ga Maris, an sanar da cewa daga ranar 1 ga Afrilu, za a keɓe dukkan masu shigowa daga ƙasashen waje na tsawon makonni biyu.
A cewar rahotannin kafofin watsa labarai na ranar 1 ga Afrilu, Koriya ta Kudu ta sami buƙatun taimakon gwaji daga ƙasashe 121.
A ranar 19 ga Fabrairu, Iran ta ba da rahoton farkon cutar SARS-CoV-2 a Qom, inda a cewar Ma'aikatar Kiwon Lafiya da Ilimin Kiwon Lafiya, mutane biyu suka mutu daga baya a ranar.
Matakan farko da gwamnati ta sanar sun haɗa da soke kide kide da wasannin kwaikwayo da sauran al'amuran al'adu, wasannin motsa jiki, sallar Juma'a, da rufe jami'o'i, manyan makarantu da makarantu.
Iran ta ware Riyal biliyan biyar don magance cutar.
Shugaban kasar Hassan Rouhani a ranar 26 ga Fabrairu 2020 ya ce babu wani shirin keɓe wuraren da cutar ta shafa, kawai mutane za a keɓe su.
A watan Maris an sanar da shirin rage zirga-zirga tsakanin biranen, kodayake zirga-zirgar ababen hawa tsakanin biranen ya ci gaba har zuwa Sabuwar Shekarar Farisa ta Nuwruz.
Har zuwa 16 ga Maris, 2020, wuraren bautar Shia a Qom sun kasance a buɗe ga masu yin hajjin. Iran ta zama cibiyar da cutar ta fara a watan Fabrairu bayan China.
A kan zargin da ake yi na ɓoye adadin masu kamuwa da cutar a Iran, fiye da kasashe goma sun mayar da su zuwa Iran a ranar 28 ga Fabrairu, suna mai da hankali ga cewa adadin masu kamuwa da cutar na iya zama mafi tsanani fiye da 388 da gwamnatin Iran ta bayyana a lokacin.
An rufe majalisar dokokin Iran, inda 23 daga cikin mambobinta 290 suka kamu da cutar a ranar 3 ga Maris.
A ranar 12 ga Maris, Human Rights Watch ta bukaci hukumomin da ke kurkuku a Iran su saki masu kare hakkin bil adama da aka kama saboda zanga-zangar lumana, da kuma sakin duk wasu 'yan fursunoni masu daraja.
Ya ce akwai haɗarin kamuwa da cutar a cikin wuraren da aka rufe kamar cibiyoyin kulawa, inda ba a buƙatar kulawar likita.
A ranar 15 ga Maris, gwamnatin Iran ta ba da sanarwar mutuwar mutane 100 a cikin rana ɗaya, wanda ya fi kowace rana a cikin ƙasar tun bayan barkewar cutar.
Akalla 'yan siyasa 12 na yanzu ko na baya da jami'an gwamnati na Iran sun mutu sakamakon cutar a ranar 17 ga Maris.
A ranar 23 ga Maris, ana samun sabbin mutane 50 da ke kamuwa da cutar a kowace awa, kuma ana samun mutum daya da ke mutuwa a kowane minti goma a Iran.
A cewar wani jami'in WHO, adadin wadanda suka kamu da cutar a Iran ya ninka wanda aka ruwaito sau biyar.
An kuma ba da shawarar cewa takunkumin da Amurka ta kakaba wa Iran zai yi tasiri ga karfin kuɗaɗen kasar don magance yaduwar cutar.
Babban Kwamishinan Majalisar Dinkin Duniya na 'Yancin Dan Adam ya yi kira da a rage takunkumin tattalin arziki a kan kasashen da cutar ta shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da matafiya biyu na China a Roma suka kamu da SARS-CoV-2.
Lamarin ya karu da sauri, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da kuma daga China kuma ta ayyana dokar ta baci.
Daga baya an gano tarin masu cutar COVID-19 da ba a haɗa su ba, tare da tabbatar da shari'o'i 16 a Lamborghini, wanda ya fara daga ranar 21 ga Fabrairu.A ranar 22 ga Fabrairu, majalisar ministocin ta ba da sabon umarni don ɗaukar fashewar, kamar keɓe mutane sama da 50,000 a cikin gundumomi 11 daban-daban a arewacin Italiya.
Firaminista Giuseppe Conte ya ce, "Ba za a iya shiga ko fita daga wuraren da suka bazu ba.
An kuma dakatar da ayyukan kasuwanci da kuma wasanni a yankunan. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a kasar saboda yawan mutanen da suka mutu a Italiya ya kai 100.
Duk manyan abubuwan wasanni, gami da wasannin ƙwallon ƙafa na Serie A, za a iya yin su ba tare da wani dalili ba har zuwa Afrilu, amma daga 9 ga Maris, an dakatar da duk wasanni gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Giuseppe Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci ban da manyan kantunan abinci da kantunan magani. A ranar 6 ga Maris, Kwalejin Gwaji, Ragewa, Tashin jiki da Kulawa (SIAARTI) ya ba da shawarwarin likitanci game da kimantawa game da hanyoyin da za a iya amfani da su.
A ranar 19 ga Maris, Italiya ta zarce China a matsayin ƙasar da ta fi yawan masu cutar coronavirus a duniya bayan da ta yi rahoton mutuwar 3405 da suka faru a sakamakon cutar.
A ranar 22 ga watan Maris, an ba da sanarwar cewa Rasha ta tura jiragen saman soja tara da kayan aikin likita zuwa Italiya.
Har zuwa ranar 5 ga Afrilu, an tabbatar da mutane 128,948 da suka kamu, 15,887 suka mutu, kuma 21,815 sun warke a Italiya, yawancinsu a lardin Lombardy.
Wani rahoto na CNN ya nuna cewa yawan mutanen Italiya da suka tsufa da kuma rashin iyawar yin gwajin cutar ga duk waɗanda ke da cutar a halin yanzu na iya zama babban dalilin mutuwar.
Da farko dai, Birtaniya ta kasance cikin kasashen da suka fi fuskantar cutar coronavirus, kuma har zuwa ranar 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya dokar nisantar juna ko kebewa jama'a ba.
A sakamakon haka, an soki gwamnati saboda rashin aiki da kuma tsari a yadda ta mayar da martani ga damuwar da mutane ke fuskanta. A ranar 16 ga Maris, Firaminista Boris Johnson ya ba da sanarwa game da duk balaguro da ba dole ba da kuma hulɗa da jama'a, yana ba da shawarar mutane su yi aiki daga gida kuma su guji wuraren da suka dace kamar kulab, gidajen abinci da kuma gidajen kallo.
A ranar 20 ga Maris, gwamnati ta ba da sanarwar rufe duk wuraren nishaɗi kamar kulake da gidajen motsa jiki da sauri, kuma ta yi alƙawarin ba da kashi 80% na albashin ma'aikata har zuwa £ 2,500 a wata don hana rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar tsaurara matakan nisantar da jama'a, hana tarurrukan mutane sama da biyu, da kuma iyakance tafiye-tafiye da ayyukan waje har sai an buƙata.
Ba kamar matakan da aka dauka a baya ba, an sanya takunkumi a kan taron ta hanyar 'yan sanda.
An umarce su da rufe yawancin kasuwancin, tare da ba da izini ga waɗanda aka ɗauka "muhimmanci", kamar manyan kantunan sayar da kayayyaki, kantin magani, bankuna, shagunan kayan masarufi, gidajen mai da gidajen ajiye motoci.
A ranar 20 ga Janairu, an tabbatar da cutar COVID-19 ta farko a Pacific Northwest a cikin jihar Washington daga wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
A ranar 29 ga Janairu, an kafa rukunin masu binciken cutar coronavirus na fadar White House.
A ranar 31 ga Janairu, Ma'aikatar Trump ta ayyana gaggawar cutar lafiya, tare da sanya takunkumi kan shigowar matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka - babbar hukumar kiwon lafiyar jama'a ta gwamnatin Amurka - ta sanar da cewa ta kirkiro kayan gwajin nata.
Duk da wannan, Amurka ta fara gwajin ne a hankali, wanda ya sa ainihin adadin cutar ba ta bayyana ba a lokacin.
A watan Fabrairu, gwajin ya kasance da matsala saboda ƙarancin kayan gwajin da gwamnatin tarayya ta samar, rashin amincewar gwamnatin tarayya ga kayan gwajin marasa ƙarfi (ta fannin ilimi, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma ƙayyadadden adadin mutane da za su cancanci gwajin har zuwa farkon Maris (bayan an nemi takardar likita).
A ranar 27 ga Fabrairu, The Washington Post ya ba da rahoton cewa an yi ƙasa da gwaji 4,000 a Amurka.
A ranar 13 ga Maris, Atlantic ya ba da rahoton kasa da gwaji 14,000 da aka yi.
A ranar 22 ga Maris, The Associated Press ta ba da rahoto: "Yawancin mutanen da ke da alamun cutar da likitocin da ke ba su umarni sun yi sa'o'i ko kwanaki suna jira don a yi musu gwajin cutar". Bayan an sanar da mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ba da sanarwar gaggawa, matakin da sauran jihohi suka bi ba da daɗewa ba.
Makarantun yankin Seattle sun yi watsi da darussan a ranar 3 ga Maris, kuma a tsakiyar Maris, an rufe makarantu a duk faɗin ƙasar.A ranar 6 ga Maris, 2020, Amurka ta nemi hasashen tasirin cutar ta coronavirus a cikin ƙasar ta hanyar ƙungiyar masana masana cutar a Kwalejin Imperial College London.
A wannan ranar, Shugaba Trump ya sanya hannu kan Dokar Kula da Magungunan Kwayar cutar ta Coronavirus, wanda ya ba da dala biliyan 8.3 daga cikin kudaden gaggawa ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni sun hana ma'aikatansu yin tafiya, sun hana su yin taro, kuma sun ƙarfafa ma'aikatansu su yi aiki daga gida.
An hana abubuwan da suka faru da kuma wasanni. A ranar 11 ga Maris, Trump ya ba da sanarwar hana tafiye-tafiye zuwa yawancin Turai, ban da United Kingdom, na tsawon kwanaki 30, daga ranar 13 ga Maris.
Washegari, ya fadada takunkumin zuwa Burtaniya da Ireland.
A ranar 13 ga Maris, ya ayyana gaggawa ta ƙasa, yana ba da damar ba da taimakon tarayya don magance matsalar.
Tun daga ranar 15 ga Maris, yawancin kasuwancin sun rufe ko kuma an rage lokacin aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da cutar a cikin dukkan jihohi 50 da Gundumar Columbia. A ranar 23 ga watan Maris, an ba da rahoton cewa New York City tana da mutane 10,700 da suka kamu da cutar, fiye da Koriya ta Kudu.
A ranar 25 ga Maris, Hachem ya ce nisantar jama'a ta yi tasiri, kamar yadda aka yi hasashen cewa ya ninka daga kwanaki 2.0 zuwa 4.7.
A ranar 28 ga Maris, akwai mutane 32,308 da aka tabbatar da cutar a New York City, kuma mutane 672 sun mutu daga cutar. A ranar 26 ga Maris, an ba da rahoton cewa Amurka tana da yawan mutanen da suka kamu da cutar coronavirus fiye da kowace kasa a duniya, ciki har da China da Italiya.
A cewar rahotannin kafofin watsa labarai a ranar 30 ga Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita umarnin nesanta jama'a har zuwa 30 ga Afrilu.
A ranar, jirgin ruwan UNSS Comfort, wani jirgin ruwan asibiti mai dauke da gadaje kusan 1,000 ya yi karo da New York.
A ranar 3 ga Afrilu, Amurka ta yi rahoton mutuwar 884 a cikin awanni 24 sakamakon cutar coronavirus.
A ranar 3 ga Afrilu, adadin masu cutar a jihar New York ya wuce 100,000. An soki Fadar White House saboda rashin fahimtar barazanar da kuma kula da watsa labarai ta hanyar tura jami'an kiwon lafiya da masana kimiyya don daidaita bayanai da kuma sanarwar jama'a game da cutar tare da ofishin mataimakin shugaban kasa Mike Pence.
Gwamnatin Trump ta rarrabu a kan yadda za ta magance rikicin.
Wasu jami'an Amurka da masu sa ido sun soki Amurka da ke hana shigo da kayayyaki masu mahimmanci, kamar kayayyakin likitanci daga China.
An yi amfani da nazarin hanyoyin da ake amfani da su don ganowa da kuma hasashen hanyoyin da aka yada kuma an buga shi a cikin mujallar Travel Medicine a tsakiyar watan Janairu 2020.
Bisa ga bayanan 2018 daga Hukumar Kula da Sufuri ta Kasa da Kasa, Bangkok, Hong Kong, Tokyo, da Taipei sune mafi yawan baƙi daga Wuhan.
Dubai, Sydney da Melbourne an fi ambata a matsayin wuraren da za a fi zuwa daga Wuhan.
An bayyana Bali a matsayin mafi ƙarancin aiki a cikin biranen 20 da aka fi sani da kasancewa cikin shiri, yayin da biranen Ostiraliya suka kasance mafi dacewa. Ostiraliya ta sanar da shirin ba da agaji na gaggawa na cutar kwayar cutar coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya nuna cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19, kuma Ostiraliya za ta mai da hankali kan kula da kan iyaka da sadarwa a cikin martanin annobar.
A ranar 21 ga Maris, an ba da rahoton wani mummunan bala'in da ya shafi lafiyar ɗan adam a Ostiraliya.
Saboda dokar hana fita ta hanyar zirga-zirgar jama'a a Wuhan da Hubei, kasashe da dama sun shirya dawo da 'yan kasarsu da jami'an diflomasiyyarsu daga yankin, musamman ta hanyar jirgin sama na kasarsu, don yin bayani tare da jami'an China.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostiraliya, Faransa, Argentina, Jamus, da Thailand sun kasance cikin na farko da suka shirya dawo da 'yan ƙasarsu.
Pakistan ta ce ba za ta mayar da 'yan kasarta daga China ba.
A ranar 7 ga Fabrairu, Brazil ta dawo da 'yan Brazil 34 ko kuma danginsu tare da 'yan Poland huɗu, ɗan China ɗaya, da ɗan Indiya ɗaya.
'Yan asalin Poland, China, da Indiya sun sauka a Poland, yayin da jirgin saman Brazil ya tsaya a Brazil kafin ya ci gaba da tafiya zuwa Brazil.
An kebe 'yan Brazil da suka isa Wuhan a wani sansanin soja da ke kusa da Brazil.
A wannan ranar, an dawo da 'yan Kanada 215 (mutane 176 a jirgin farko, da 39 a jirgin da gwamnatin Amurka ta yi hayar) daga Wuhan zuwa Trenton CFB don a kebe su na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama na 185 na Kanada ya sauka a WAN a kan sansanin sojin Kanada a Trenton.
Gwamnatin Ostiraliya ta kwashe 'yan kasar 277 zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka ba da shi a matsayin wurin keɓewa, inda za su zauna na tsawon kwanaki 14.
Jirgin sama na Jirgin Sama na New Zealand ya isa Auckland a ranar 5 ga watan Mayu; fasinjojinsa (wasu daga Australia da Pacific) waɗanda aka keɓe daga sansanin jiragen ruwa na Hangapara a arewacin Auckland.
A ranar 15 ga Fabrairu, Majalisar Dinkin Duniya ta sanar da cewa za ta dawo da fasinjojin Amurka da ke cikin jirgin Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin da ke dauke da fasinjoji 129 na Kanada da ke jigilar su daga Diamond Princess ya isa Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara jigilar 'yan asalin ƙasar daga Iran. A ranar 14 ga watan Maris, jirgin saman jigilar kaya na Afirka ta Kudu wanda gwamnatin Afirka ta Kudu ta hayar ya dawo da 'yan Afirka ta Kudu 112 zuwa kasar.
An gudanar da gwaje-gwajen likita don zafin jiki, kuma an sanya 'yan Afirka ta Kudu huɗu da ke da alamun cutar COVID-19 a cikin kulawa mai tsanani don rage haɗarin.
'Yan Afirka ta Kudu ne kawai aka dawo da su zuwa ƙasarsu waɗanda ba su da cutar.
Sakamakon gwajin ya tabbatar da cewa duk 'yan Afirka ta Kudu, ciki har da matukan jirgin sama, matukan jirgi, ma'aikatan otel, 'yan sanda da sojoji da ke da hannu a aikin soja sun sami lafiya. A matsayin maganin, an sanya kowa a cikin kulawa da keɓewa na kwanaki 14 a Ranch Resort.
A ranar 20 ga Maris, Majalisar Dinkin Duniya ta fara janye sojoji daga kasar Iraki saboda barkewar cutar.
A ranar 5 ga watan Fabrairu, Ministan Harkokin Wajen Sin ya ba da sanarwar cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun ba da tallafi ga Sin.
Wasu daliban Sin daga jami'o'in Amurka sun haɗu don aikawa da taimako ga yankunan Sin, tare da wani rukuni na Chicago da ke da haɗin kai a yankin Raport wanda ke kula da aikawa da kayan aikin N95 na 50,000 zuwa asibitocin Hubei na 30/1 .Relife, a cikin haɗin gwiwa tare da FedEx, ya aika da kayan aikin rufe baki 200,000 da sauran kayan aikin kariya na mutum, ciki har da safar hannu da wando, ta hanyar jigilar iska ta gaggawa zuwa asibitin Wanwan a ranar 30/1 .
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun ba da sanarwar cewa za su ba da dala miliyan 100 ga duk wanda ya sami allurar rigakafi da magani don kare "mutane da ke cikin haɗarin cutar a Afirka da Kudancin Asiya".
Interaction ta ba da rahoton cewa gwamnatin Sin ta ba da kyautar abin rufe fus 200,000 ga Filipinos a ranar 6 ga Fabrairu, bayan da Cibiyar Richard Gordon ta ba da miliyan 3.16 ga birnin Wan.
A ranar 19 ga watan Fabrairu, Red Cross ta Singapore ta sanar da cewa za ta tura Sin dala miliyan 2.26 a matsayin tallafi.
Japan ta ba da kyautar abin rufe fuska miliyan 1, Turkiyya ta aika da kayan aikin likita. Rasha ta aika da tan 13 na kayan aikin likita zuwa birnin Wan. Malaysia ta ba da sanarwar bayar da tan miliyan 18 ga Sin. Jamus ta aika da kayan aikin likitancin cutar da suka hada da rigunan rigakafin cutar ta 10,000.
A watan Maris, Cuba da Rasha sun aika da taimakon likita da ƙwararrun mutane zuwa Italiya don magance barkewar cutar a cikin ƙasar.
Kamfanin JAMA ya tura kayan gwajin likita miliyan 1.1, abin rufe fuska miliyan 6 da tufafin kariya 60,000 zuwa Addis Ababa, Habasha don rarraba ta hanyar sadarwa a Tarayyar Afirka.
Daga nan sai ya tura kayan bincike na likita 5,000, da kayan aikin 100,000 da kuma kwandishan guda 5.
Hakanan China ta aika kayan aikin likita zuwa Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun ba da ra'ayinsu game da abin rufe fuska da kayan aikin bincike na Sin.
Misali, Spain ta dawo da kayan aikin rigakafin cutar coronavirus 58,000 da aka yi da sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin
Belgium ta dawo da abin rufe fuska 100,000 da ba a yi amfani da su ba, ana zaton an yi su ne a Sin, amma a zahiri an yi su ne a Kolombia.
A gefe guda, taimakon Sin ya sami karbuwa a wasu sassan Latin Amurka da Afirka a 4/2. Bankin Duniya ya fara aikin aikawa da taimakon gaggawa ga ƙasashe masu tasowa.
WHO ta yaba wa kokarin Sin na hana yaduwar cutar.
Hukumar Lafiya ta Duniya ta lura da bambancin da ya faru a yayin da cutar SARS ta bazu tsakanin 2002-2004. An zargi gwamnatin Sin da yin sirrin cutar da ke haifar da matsalolin da ke fuskantar kokarin dakile cutar da kuma rikicin da ake ciki yanzu inda gwamnatin tarayya ta "ba da umarnin da za a guje wa barkewar cutar a cikin hutun New York".
A ranar 23/1 a mayar da martani ga matakin da gwamnatin tsakiya ta dauka na hana zirga-zirga a birnin Wuhan, wakilin WHO Gaudin Galia ya bayyana cewa yayin da "ba a bin umarnin WHO ba" ya zama muhimmin alama na hana yaduwar cutar a yankin da cutar ke da karfi sosai. Kuma ya kira shi "ba a taɓa yin irinsa ba a tarihin lafiyar jama'a". Daga 30/1 ya yi daidai da yadda cutar ta bazu daga mutum zuwa mutum a cikin sauran ƙasashe da kuma karuwar adadin masu cutar a wasu ƙasashe.
Babban daraktan WHO Tedros Adhanom, ya ce sanarwar gaggawa ta kiwon lafiya ta kasa ta haifar da "tsoron yaduwar cutar a duniya, musamman a kasashe masu talauci da matsakaicin arziki wadanda ba su da tsarin kiwon lafiya mai karfi".
Da yake mayar da martani ga dokar hana tafiye-tafiye, Tedros ya ce "babu wani dalili da zai sa a yi kokarin yin kutse a harkokin tafiye-tafiye da cinikayyar duniya" kuma "Shirye-shiryen duniya ba ya yin dokoki na hana kasuwanci da zirga-zirga".
A ranar 5 ga watan Fabrairun, Hukumar Lafiya ta Duniya ta yi kira ga al'ummomin duniya da su ba da tallafin dala miliyan 675 don ba da kuɗin don shirya kasashe masu talauci, suna kira ga kotun ta ba da tallafi ga ƙasashe waɗanda "ba su da tsarin tantance mutanen da ke da cutar, ko da a cikin mawuyacin hali".
Tedros ya kara da cewa "nasara ta hanyar kokarinmu ta kai ga kowa" kuma ya bukaci kasashen duniya su "ba da gudummawa a yau ko gobe", a ranar 11 ga watan Fabarairu, yayin da Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin sunan cutar a wani taron manema labarai.
A wannan ranar, Tedros ya ba da sanarwar cewa Babban Jami'in leken asirin Majalisar Dinkin Duniya Antonio Guterres ya amince da samar da "dukkanin sojojin tsarin Majalisar Dinkin Duniya a cikin aikin".
An kunna wani darektan rikicin rikicin na Majalisar Dinkin Duniya a sakamakon haka, wanda ya ba da damar haɗin gwiwar duk Majalisar Dinkin Duniya wanda WHO ta ba da damar "mai da hankali kan maganin lafiya yayin da sauran masu tasiri za su iya kawo gogewarsu don haɗa kan al'umma, tattalin arziki da kuma hana yaduwar cutar".
A ranar 14 ga watan Fabrairu, an tura manajan tawagar WHO da Sin don ba da ƙwarewar duniya da WHO ga yankin Sin don taimakawa wajen kimantawa da gudanar da gida "ƙarfin cutar da yaduwar cutar" shirya bita da ganawa da manyan hukumomi a matakin ƙasa da kuma gudanar da tafiye-tafiye na yanki don yanke shawara kan "tasirin amsar ayyukan ga mutanen da ke zaune a ƙasashe masu nisa da sauran ƙasashe, wanda ya haɗa da ƙungiyoyin birane da ƙauyuka". A ranar 25 ga watan Fabrairu, WHO ta ba da sanarwar cewa "dole ne duniya ta ƙara shirya don yiwuwar barkewar cutar ta coronavirus", tana mai cewa yayin da har yanzu ba a fara kiran ta ba, ya kamata ƙasashe su kasance "a cikin yanayin rashin shiri".
Dangane da ci gaban annobar a Iran, Hukumar Lafiya ta Duniya ta tura wata kungiya mai hadin gwiwa zuwa Iran don tantance yanayin. A ranar 28 ga watan Fabrairu, Hukumar Lafiya ta Duniya ta sanar a hukumance cewa fargabar yaduwar cutar ta duniya ta tashi daga "babba" zuwa "babba", wanda aka kimanta a matsayin "mafi girman matakin fargabar barazana da damuwa".
Mike Ryan, mai kula da shirin gaggawa na Hukumar Lafiya ta Duniya, ya yi gargadin a cikin wata sanarwa ga duniya cewa "akwai ainihin gwajin ga kowace gwamnati a duniya: farkawa daga barci.
"Cin zarafin na iya zuwa kuma ya kamata mu kasance a shirye, "kuma sanin hanyoyin da suka dace na mayar da martani zai iya taimaka wa duniya ta kauce wa mafi munin cutar".
Ri ya ce bayanan da aka samu a yanzu sun hana hukumar kiwon lafiyar kasa daga sanar da annobar cutar a duniya, yana mai cewa sanarwar na nufin "mun yarda cewa kowa a duniya na iya kamuwa da cutar".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta ayyana annobar cutar coronavirus.
Babban Darakta-Janar ya ce WHO "ta yi watsi da yaduwar cutar da ke da karfi, da kuma mummunan yanayin da ke faruwa a hankali". WHO ta fuskanci zargi mai tsanani game da ɓangarorin da ba a gano ba na cutar, ciki har da sanar da gaggawa na gaggawa na gaggawa da kuma rarraba cutar a matsayin annoba.
Damuwar jama'a ta ƙunshi takardar neman shugaban hukumar WHO Tedros Adhanom Ghebreyesus ya yi murabus, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, kwararru na Majalisar Dinkin Duniya na kare hakkin bil adama sun sake jaddada cewa za a girmama hakkin dukkan mutane a yayin annobar COVID-19.
Kungiyar ta ce kowa ya ba da kariya, kuma gwamnati ta dauki alhakin hakan.
Ƙungiyar ta sake jaddada cewa rashin wadataccen kayan aiki ko inshorar lafiya bai kamata a ba da hujja don nuna bambanci ga wasu kungiyoyi ba.
Masana sun jaddada cewa kowane mutum yana da 'yancin samun lafiya, gami da marasa galihu, kungiyoyin marasa rinjaye, tsofaffi,' yan gudun hijira na cikin gida, marasa gida, marasa galihu, mutanen da ke zaune a cikin wahala, mutanen da ke kurkuku, 'yan gudun hijira, da kuma sauran kungiyoyin da ba a san su ba da ke buƙatar tallafin gwamnati.
Hukumomin gwamnati na ƙasa suna fuskantar tasirin tattalin arziki da zamantakewa a cikin rikicin COVID-19
Kungiyar Tattalin Arziki da Ci Gaban Ƙasashen Duniya ta kafa wani dandamali don samar da cikakkun bayanai da kuma bayanai game da abubuwan da suka faru a ƙasashen duniya, da kuma shawarwari da shawarwari.
Daga 'yan sanda zuwa tsarin kiwon lafiya mai ƙarfi da tattalin arziƙin duniya don nuna tasirin takunkumin hana zirga-zirga da dakatar da tafiye-tafiye, ya haɗa da jigon dijital na ofishin' yan sanda na ƙasa, da kuma burin taimaka wa ƙasashe su koya daga juna da kuma sauƙaƙa haɗin gwiwar duniya don magance cutar.
Gwamnatin Sin ta soki Majalisar Dinkin Duniya da Ministan Burtaniya don majalisar ministocin Michael Gove da dan shugaban Brazil Eduardo Bolsonaro don rashin kula da annobar, wanda ya fara ne a Sin a lardin Hubei.
An kori wasu shugabannin jam'iyyar Shuwabi a yankin Sin daga kokarin da ake yi na rufe tsakiyar Sin, wata alama ce ta rashin amincewa da yadda hukumomin siyasa suka mayar da martani ga yaduwar cutar a yankin.
Wasu masu faɗar ra'ayi sun yi imanin cewa an yi wannan ne don kare babban sakataren Sin Kyaw Jinping daga yunwa a lokacin cutar ta COVID-19.
Wasu daga cikin jami'an Sin, kamar su Juan Lilian, sun ƙi amincewa da farkon barkewar cutar coronavirus a Wuhan, suna ba da shawarar tsarin COVID-19 na Amurka ko Italiya.
Gwamnatin Donald Trump ta yi magana game da cutar a matsayin "Chenna Virus" ko "Chenna Virus". Ya ce masu lura da cutar sun inganta cutar da ta zama annoba a duniya. Wannan ya haifar da zargi da yawa daga masu sukar gwamnati da nuna wariyar launin fata da kuma yin watsi da gazawar gwamnatin don hana cutar.
Daily Beast News ta sami labarin cewa daya daga cikin bangarorin da ke shirin Majalisar Dinkin Duniya ya yi yarjejeniyar canja wuri tare da wani babban jami'in tsaron kasa, kuma an ba da labarin "Dukkanin Game da Sin".
An gaya mana mu yi kokarin yada wannan sakon ta kowace hanya, a taron manema labarai da kuma bayyanar da talabijin, kafofin kamar 'yan siyasa, 'yan sanda na kasashen waje da kuma Bloomberg sun yi iƙirarin cewa kokarin Sin na taimakawa ƙasashen da ke fama da cutar na da alaƙa da farfaganda na cutar ta duniya.
Babban jami'in 'yan sandan waje na tarayya Joseph Borel ya yi gargadin cewa tushen siyasa na rikici da cutar ya ƙunshi maganin siyasa da kuma karimci.
Borrell ya kuma ce "Sin ta yi amfani da karfi wajen yada sakon cewa, ba kamar Majalisar Dinkin Duniya ba, tana da abokin tarayya mai gaskiya da aminci.
Xi ya kuma nemi Majalisar Dinkin Duniya ta sanya takunkumi kan Syria, Venezuela da Iran, wadanda suka ce sun aika da agaji ga kasashen biyu a baya.
Kyautar Jack Ma ta 100,000 masks ta kasance ta Cuba ta hannun Hukumar Kare Hakkin Dan Adam ta Majalisar Dinkin Duniya a ranar 3 ga Afrilu.
An kuma zargi Majalisar Dinkin Duniya da yin amfani da taimakon da wasu ƙasashe ke bayarwa don amfani da ita.
Hakanan an kulla yarjejeniya don jigilar masks tsakanin ƙasashe, kamar Jamus, Austria da Switzerland da Jamhuriyar Czech da Italiya.
Bugu da ƙari, Turkiyya ta kwace ɗaruruwan kayan aikin iska da aka ba Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin goyon bayan Tarayyar Turai ga mutanen da ke fama da cutar coronavirus a Italiya.
Maurizio Massari, jakadan Italiya a Tarayyar Turai, ya ce "kawai martani ne daga abokan hulɗa".
Tabbas, wannan ba alama ce mai kyau ba game da goyon bayan Turai.
A ranar 22 ga Maris, bayan tattaunawa ta wayar tarho da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya umurci sojojin Rasha da su tura dakaru na likitoci, motocin kashe kwayoyin cuta, da sauran kayan aikin likita zuwa Italiya.
Wani ɗan jarida a Italiya mai suna La Stampa ya ba da tabbaci daga wani babban jami'in siyasa da ba a san ko wane ba cewa kashi 80 cikin ɗari na taimakon da Rasha ta ba wa Italiya ba ta da amfani ko kuma ta yi amfani kaɗan.
Wannan majiya ta zargi Rasha da yin amfani da matsalolin (dangane da siyasa da diflomasiyya) da kuma kai hari ga bangarorin.
Shugaban Lombard Attilio Fontana da Ministan Harkokin Waje na Italiya Luigi Di Maio sun yi watsi da rahotannin kafofin watsa labarai kuma sun bayyana godiyarsu.
Rasha ta kuma aika da jirgin sama na kayan aikin likita zuwa Amurka.
"A lokacin da ake tura kayan agaji zuwa Majalisar Dinkin Duniya, Putin ya ce a lokacin da kayan agaji da kayan aikin likita na Majalisar Dinkin Duniya suka zo, za su kasance a shirye su musanya idan ya cancanta", in ji mai magana da yawun Kremlin Dmitry Peskov.
An gudanar da atisayen Sojan Sama na NATO na 2020 a Jamus, Poland da kuma kasashen Baltic, wanda shi ne babban atisayen yaki da aka gudanar tun bayan yakin sanyi.
Kamfen din Janar Kate Hudson ya soki aikin soja na 2020 na Janar, "A cikin wannan rikicin kiwon lafiyar da ake ciki, wannan yana sanya rayukan mutane cikin hadari ba kawai sojojin Majalisar Dinkin Duniya da yawancin ƙasashen Turai ba, amma kuma al'ummomin ƙasashen da ke yin hakan". Gwamnatin Iran ta kamu da cutar, har da 'yan majalisar dokoki biyu da kuma 15 da suka kamu da cutar.
Shugaban Iran Hassan Rouhani ya rubuta wasikar jama'a ga shugabannin duniya inda ya nemi taimako a ranar 14/3/2020, yana mai cewa kasarsa tana fama da cutar saboda rashin samun damar shiga kasuwannin duniya kamar yadda takunkumi na Majalisar Dinkin Duniya ya shafi Iran, yaduwar cutar ta sa Majalisar Dinkin Duniya ta yi kira kai tsaye ga Majalisar Dinkin Duniya don hana rufe hanyoyin zamantakewa a cikin kasashe masu tasowa, wanda ya hada da kula da lafiyar duniya, kula da yara na duniya, kula da gida, da kuma bayar da kudi mai yawa ga lafiyar jama'a.
Masu sharhi kan harkokin siyasa sun yi hasashen cewa hakan zai iya yin tasiri a kan damar da Trump ke da shi na sake tsayawa takara a zaben shugaban kasa na 2020.[1] Hadin gwiwar da ke tsakanin Japan da Koriya ta Kudu ya sa cutar ta fi kamari.
Koriya ta Kudu ta soki "rashin gaskiya da kuma kokarin da aka yi" na Japan. Bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu dole ne a kebe shi a wasu wuraren gwamnati na makonni biyu.
Koriya ta Kudu ta rabu biyu kan yadda shugaban kasar Moon Jae-in ya mayar da martani ga rikicin.
Yawancin 'yan Koriya sun yi zargin cewa dole ne a tuhumi Moon a kotu saboda rashin kula da cutar. Ko kuma a bayyana ƙoƙarinsa. Cutar ta ba da damar ƙasashe su zartar da dokoki a cikin gaggawa.
Wasu masu magana da yawun sun nuna cewa hakan zai baiwa gwamnatoci damar kara karfin iko.
A Hungary, majalisar dokoki ta kada kuri'a don ba wa Firaminista Viktor Orban damar fitar da doka, tare da dakatar da majalisar da zaɓe da kuma hukunta waɗanda suka ba da labarin da ba daidai ba game da cutar da kuma yadda gwamnati ke kula da rikicin.
An danganta barkewar annobar korona da wasu misalai kamar rage tallafi; dakatar da amfani da kayan yaƙi yayin da cutar ke yaduwa a duniya; tsada; da kuma mawuyacin yanayi ga masana'antu da ayyukan sufuri na soja.
Hukumar Abinci da Magunguna ta Majalisar Dinkin Duniya ta ba da rahoton karancin magunguna da kayan aikin likitanci saboda karuwar buƙatun masu amfani da tarin kayan aiki a cikin mawuyacin hali.
Yawancin yankuna sun ga manyan abubuwan da suka faru a cikin ɗakunan ajiya, kamar abinci, ɗakunan wanka, da kuma ɗakunan ruwa, wanda ke nuna rashin kayan aiki.
Masana'antar fasaha musamman tana faɗakar da mu game da jinkirin jigilar kayan lantarki.
Babban Daraktan WHO Tedros Adhanom ya ce, bukatar kayan kariya ta mutum ya karu da kashi 100.
Wannan ya sa farashin ya kai 20 fiye da yadda aka saba. Har ila yau, an yarda da jinkirta jinkirta kayan aikin likita na tsawon watanni hudu zuwa shida.
Hakanan ya haifar da raguwar kayan kariya na mutum a duk duniya, tare da gargadin Hukumar Lafiya ta Duniya cewa hakan na iya haɗarin lafiyar ma'aikata.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu siyar da kayayyaki na Australiya a Sin.
Wannan ya haifar da matsalar karancin madarar jarirai a manyan kantunan sayar da abinci, kuma daga baya gwamnatin Ostiraliya ta dakatar da shi.Duk da haka, ƙaruwar adadin masu cutar COVID-19 a arewacin Italiya da Yankin, da kuma ƙarancin abinci mai gina jiki, duka yankuna sun fuskanci ƙarancin abinci.
Sin da Italiya sun yi kira ga cin abinci da kuɗi da kuma cinikin haramtacciyar kayayyaki, sun yi nasara, sun kauce wa matsalar karancin abinci da aka yi hasashen za ta faru a Turai da Arewacin Amurka.
Ba a sami raguwar kayayyakin gona ba a arewacin Italiya, amma farashin zai iya ƙaruwa, in ji wakilan masana'antu.
Rashin abinci a cikin ɗakunan abinci na ɗan lokaci ne, har ma a cikin birni, yayin da jami'an gwamnatin Sin suka rarraba kayan alade don tabbatar da jama'a game da rarraba abinci.
Akwai dokoki masu kama da juna a Italiya don buƙatar masu samar da abinci don adana abinci don jigilar gaggawa.
Ana jin rauni ga tattalin arzikin duniya a Sin; a cewar rahoton kafofin watsa labarai na 16/3 , tattalin arzikin Sin ya yi rauni sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka don rage yaduwar cutar, kuma tallace-tallace na mutum ya ragu da kashi 20.5%.
A matsayin babban yanki na nahiyar Sin, shine babban tattalin arziki da kuma cibiyar kasuwanci. Ana ganin cewa cutar ta zama babbar barazana ga tattalin arzikin duniya.
Agassi Desmarias na sashen labarai na tattalin arziki ya yi hasashen cewa kasuwanni za su kasance cikin haɗari har sai an sami cikakken hoto game da sakamakon da ke faruwa.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa matsalar tattalin arzikin duniya da ke tattare da cutar za ta iya shafar ci gaban duniya fiye da yadda cutar SARS ta yi nasara a shekarun 2002-2004.
Wani masanin da ke nazarin Washington University a St. Louis ya ba da kimar dala biliyan 300 ga jerin ajiyar duniya wanda zai iya wuce shekaru biyu.
Kungiyar Kasashen da ke fitar da man fetur ta OPEC ta ce ta yi "rashin amincewa" da wannan kudurin, bayan da farashin mai ya ragu sosai sakamakon karuwar bukatarsa a Sin.
An fara rufe kasuwannin duniya a ranar 24 ga watan Janairu saboda alamun karuwar cutar COVID-19 a wajen Sin.
A ranar 27 ga watan Fabrairu, sakamakon karuwar damuwa game da cutar ta COVID-19, akwai cutar a cikin Amurka wanda NASDAQ-100 ke rufe, S&P ya rufe wurare 50, inda Dow Jones ya ba da rahoton mafi munin masana'antar masana'antu a cikin 2008 wanda ya kai maki 1,191, mafi girman faɗuwa a cikin rana ɗaya tun lokacin rikicin kuɗi na 2007-2008.
Dukkanin waɗannan shari'o'in sun ƙare makon da sama da kashi 10.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ya tabbatar da matsakaicin kudin shiga na Sennheiser, amma ya ba da rahoto mara kyau.
An sake samun koma bayan tattalin arziki sakamakon fargabar annobar coronavirus, inda aka samu asarar da ta fi yawa a 16/3.
Mutane da yawa suna ganin cewa tattalin arziki zai sake komawa baya.
Masanin tattalin arziki Mohammed E-Erian ya gode wa bankin da jihohin tsakiya don kokarin da suka yi a wannan gaggawa.
Babban Bankin ya yi hanzarin mayar da martani ga matsalar tattalin arziki a 2008.
Tafiya da cin abinci na daga cikin wuraren da aka fi fama da cutar, saboda dakatar da tafiye-tafiye, rufe wuraren da jama'a ke da shi wanda ke hana tafiye-tafiye, da kuma shawarar gwamnati game da duk wani irin tafiya a duniya.
A sakamakon haka, an soke yawancin jirage saboda ƙarancin buƙata, gami da British Airways, Eastern Sinai Airways, da Qantas Airways, yayin da aka rufe yankin Flybe Airways.
Ya shafi layin masana'antu a matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da yawa.
Annobar ta kuma shafi bikin Yunnan, da kuma yawan yawon shakatawa na yanayi da ke da alaƙa da hutun shekara ta Sin.
An dakatar da wasu abubuwan da suka shafi taron jama'a da yawa daga gwamnatocin ƙasa da na yanki, ciki har da bikin Sabuwar Shekara ta shekara, kuma kamfanoni masu zaman kansu sun dakatar da yawon shakatawa da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
Yawancin bukukuwan Kirsimeti da balaguro sun hana hana taron jama'a, misali, birnin Forbidden na Beijing da kuma manyan bukukuwan gargajiya.
A cikin gundumomi 24, birane da yankuna 31 na yankin Sin, gwamnati ta tsawaita hutun hutun shekara zuwa 10/2, tare da gargadi ga wuraren kasuwanci da kada su sake buɗewa har sai lokacin.
Wannan yanki ya ƙunshi kashi 80 cikin 100 na ma'aikatan ƙasar da kashi 90 cikin 100 na ƙwararrun masana.
Hong Kong ta ɗaga matakin rigakafin cutar zuwa matakin farko, ta sanar da dokar ta baci, ta rufe makarantu har zuwa Maris, kuma ta soke bukukuwan Sabuwar Shekara.Harkokin kasuwancinsa sun shafi duniya baki ɗaya, tare da rage lokacin kasuwanci ko rufewa.
Kasuwancin kasuwanci a Turai da Latin Amurka sun ragu da kashi 40 cikin ɗari.
Kasuwanci a Latin Amurka da Gabas ta Tsakiya sun yi asarar kashi 50-60 cikin ɗari.
Wannan kuma ya haifar da asarar kashi 33-43% na yawan masu tafiya a cikin manyan kantunan a watan Maris idan aka kwatanta da na Fabrairu.
Manajojin manyan kantunan duniya sun ba da wasu shawarwari, kamar ƙara yawan na'urorin tsabtace jiki, samar da na'urar duba zafin jiki ga abokan ciniki, da kuma tara mutane a wuraren taron. In ji Kwamitin Tattalin Arziki na Amurka don Latin Amurka, annobar cutar ta iya haifar da talauci ga mutane miliyan 14 zuwa 22 a Latin Amurka waɗanda ke cikin wannan halin ba tare da wata annoba ba.
A cikin Janairu da Fabrairu 2020, yayin da cutar ta yi yawa a cikin Wuhan, kusan mutane miliyan 5 sun rasa ayyukansu a Sin.
Yawancin ma'aikatan karkara a Sin, kusan miliyan 300, an tura su gida zuwa yankunan ruwa ko kuma an tsare su a lardin Hubei. A watan Maris na 2020, sama da Amurkawa miliyan 10 sun bar aikinsu kuma sun nemi taimakon gwamnati.
An yi hasashen cewa, takunkumin ya sa ma'aikatan gida miliyan goma a Indiya sun rasa aikinsu (wanda ake ba su albashi na yau da kullum). Wani bincike da Cibiyar ta yi ya gano cewa, kashi 44 cikin 100 na gidajen da aka yi wa allurar rigakafi sun rasa aikin yi. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka fara takunkumin a tsakiyar watan Maris na shekarar 2020
A cikin rabin watan Maris, ma'aikata miliyan 4 a Faransa sun nemi a ba su kuɗin rashin aikin yi, kuma ma'aikata miliyan 1 a Burtaniya sun nemi a ba su kuɗin aiki na duniya. Kusan kamfanoni miliyan ɗaya da rabi a Jamus sun ba da kuɗin gwamnati ga ma'aikatansu a ƙarƙashin shirin gajeren lokaci na aiki da aka sani da Kurzarbyte.
An aiwatar da tsarin rarraba albashi na Jamus a Faransa da Burtaniya.
Aikin fasaha da al'adun gargajiya sun sha wahala sosai daga annobar, kuma ayyukan ƙungiyoyi sun yi tasiri, tare da masu amfani da duniya da masu amfani da su.
Ƙungiyoyin al'adu da na al'adu sun yi ƙoƙari don haɓaka (da kuma kuɗin da aka tara) don samar da damar yin amfani da kayan aikin birni ga al'umma, ci gaba da kiyaye kayan aikin su, da kuma tallafawa masu zane-zane a duk lokacin da ya dace.
Tun daga watan Maris na 2020, a duk duniya, an rufe jami'o'i, gidajen tarihi, dakunan karatu, wuraren ba da tallace-tallace, da sauran cibiyoyin jama'a ba tare da sanarwa ba, kuma an soke ko jinkirta baje kolin, abubuwan da suka faru, da gabatarwa.
A cikin amsar, akwai ƙoƙarin da aka yi na yin hidima ta hanyar dandamali na dijital, sabon cutar da ke yaduwa da kuma haɗarin haɗari ya hana ayyukan ibada da kuma abubuwan wasanni da abubuwan zamantakewa, kamar bikin kiɗa da kide kide da wake-wake da taron fasaha da kuma nuna kayan ado.
Har ila yau, an yi wa fim din fim din wahala, kuma Vatican ta yi watsi da lokacin da aka yi wa Ikilisiyar Ikilisiyar Ikilisiya a Roma, wanda ya dace da makon karshe na tuba na Kirista a lokacin Lent.
Yawancin firistoci sun gaya wa tsofaffi Kiristoci su zauna a gida kuma kada su halarci taron addini na Lahadi; wasu majami'u suna ba da sabis na addini ta hanyar rediyo ko kuma kai tsaye ta kan layi ko ta talabijin, yayin da wasu ke ba da sabis a kan titi.
Tare da rufe cocin Roman Katolika a Rome, an rufe coci da rassa da wuraren bautar Krista, sauran addinai sun dakatar da ayyukansu kuma sun rufe taro a majami'u, majami'u, wuraren bautar Yahudawa, majami'u da majami'u.
Ministan Kiwon Lafiya na Iran ya sanar da rufe sallar Juma'a da masallatai a yankunan da cutar ta shafa, yayin da Saudi ta dakatar da baƙi daga kasashen waje zuwa wuraren bautar Makka da Madina.
Wannan annoba ce da ta fi yin illa ga harkokin wasanni a duniya tun bayan Yaƙin Duniya na II.
Yawancin abubuwan wasanni sun kasance ko dai an dakatar da su ko kuma an jinkirta su, ciki har da gasar zakarun Turai ta 2019-2020, gasar Premier ta 2019-2020, NBA ta 2019-2020, da kuma NHL ta 2019-2020.
Wannan annoba ta haifar da matsala ga shirye-shiryen wasannin Olympics na bazara na 2020, wanda aka shirya za a gudanar da shi a watan Yuli. Hukumar Olympic ta Duniya ta sanar a ranar 24 ga Maris cewa an jinkirta gasar zuwa bayan 2020 amma ba za a iya jinkirta ta zuwa bayan bazara na 2021 ba. An rufe wuraren wasannin motsa jiki a duk duniya kuma an dakatar da wasannin caca ko kuma an jinkirta.
Wannan ya sa 'yan caca suka koma kan layi, shafukan yanar gizo masu caca sun yi yawa tare da sabon kudaden shiga, wuraren nishaɗin jama'a sun lalace, kuma ƙungiyoyin kiɗa sun soke ko soke wasannin su.
Ya dakatar da yawancin wasan kwaikwayon na Broadway.
Wasu masu fasaha sun gwada sabbin hanyoyin da za su iya tallata kayan su da kuma sanya su a yanar gizo a matsayin wani zaɓi na nuna al'adunsu, kamar ƙirƙirar kide kide da wake-wake na kan layi ko ƙirƙirar rukunin yanar gizon bikin don masu fasaha su fito.
A yanar gizo, an yi amfani da labaran ban dariya da yawa game da cutar coronavirus wanda ya haifar da rikice-rikice da rikice-rikice.
Tun bayan barkewar COVID-19, an sami ƙiyayya, tsoron ƙasashe da ke kewaye, da nuna bambancin launin fata tsakanin Sinawa da mutanen kudu maso gabashin Asiya, da kuma mutanen da ke adawa da siyasa a Turai, Majalisar Dinkin Duniya da sauran ƙasashe.
An lura da tashin hankali da rashin yarda da juna da kuma nuna bambanci a kasashe da dama, musamman a Turai, Gabashin Asiya, Arewacin Amurka, da yankin Asiya Pacific.
Rahotannin na Fabrairu (lokacin da yawancin shari'o'in har yanzu suna cikin Sin) sun nuna nuna bambancin launin fata ta ƙungiyoyin ƙwayoyin cuta a duk duniya waɗanda ke cewa mutanen Sin sun cancanci kamuwa da cutar ko kuma sun hana abin da aka nema a matsayin abin da aka nema.
Wasu ƙasashen Afirka ma sun nuna tsananin ƙiyayya ga Sinawa.
Mazauna da yawa a biranen Wan da Hubei sun yi watsi da ra'ayinsu na zama 'yan asalin yankin.
Akwai tallafi ga al'ummar Sin, kai tsaye ko kuma a kaikaice, suna kai kayan agaji zuwa yankunan da cutar ta shafa.
A cikin kasashen da suka ci gaba, an sami karuwar mutane a Italiya, wanda shi ne farkon Turai da aka samu a cikin COVID-19. Wannan ya haifar da shakku da tsoro. Mutanen Malaysia, New Zealand, Singapore da Koriya ta Kudu sun yi korafi game da hana 'yan kasar Sin shiga ƙasarsu, a matsayin ƙoƙarin hana cutar.
A Japan, hashtag #Siniyas_Mine_Japan ya mamaye shafin Twitter.
Sinawa, kamar sauran 'yan Asiya a Burtaniya da Majalisar Dinkin Duniya, sun ba da rahoton karuwar yawan cin zarafin' yan asalin ƙasar, da kuma hare-haren ta'addanci.
An soki shugaban Amurka Donald Trump saboda kiran coronavirus a matsayin "kwayar cutar Sin", wanda masu sukar suka kira wariyar launin fata da kuma "anti-Sin".
Masu zanga-zangar Ukraine sun kai hari kan motocin bas da ke dauke da 'yan Ukraine da baƙi daga birnin Van zuwa Novi Sad.
Masu binciken da ke arewacin Indiya, makwabtan Sin, sun gudanar da gwaje-gwajen kimiyya da yawa kan yaduwar cutar coronavirus a jami'o'i da yawa a Indiya.
Shugaban Jam'iyyar BJP na Yammacin Bengal, Deollip Bhat, ya yi iƙirarin cewa Sinawa sun lalata yanayin, "don haka wannan azabar Allah ne a kansu".
Daga baya, an yi wa 'yan Leydu da aka yi wa ba'a da sunan "rashin fahimta" daga ofishin jakadancin Sin a Kolkata. A Sin, ana nuna ƙiyayya da wariyar launin fata ga baƙi daga Sin saboda annobar, an bayyana baƙi a matsayin "sauran baƙi" kuma an yi niyyar fitar da su.
Da yawa daga cikin 'yan jarida da ke da asusun kansu sun yi watsi da labaran da suka wallafa game da cutar korona.
Yawancin masu wallafa bayanai sun shirya takardun da suka shafi cutar tare da shiga cikin labarai.
Wasu masana kimiyya sun zaɓi su rarraba sakamakon su ta hanyar yanar gizo kamar shafin yanar gizon bioRxiv.
Bayyanawar cututtukan cututtuka - bayyanar cututtukan cututtuka, bambancin da ke cikin hanyar da suka yada da kuma watsa su.
Duniya da cututtuka - wani bincike na duniya da cututtuka da aka dauka.
Jerin cututtukan cututtuka da annoba - Jerin waɗanda suka mutu saboda wasu cututtuka.
Shigo da kuma ware dabbobin daji - Akwai haɗarin lafiya da ke tattare da cinikin dabbobin daji.
Gwajin gwaji na cutar numfashi na cutar coronavirus ta 2019 (COVID-19) da ke da alaƙa da SARS-CoV-2 ya haɗa da wasu batutuwa da ake bincika don kasancewar kwayar cutar da waɗanda ake bincika don samar da maganin rigakafi ga cutar.
An tabbatar da kwayar cutar a cikin samfuran ta hanyar RT-PCR, wanda ke nazarin RNA na kwayar cutar corona.
Wannan gwajin na musamman ne kuma an tsara shi ne kawai don nazarin RNA na SARS-CoV-2.
Ana amfani da wannan don ɗaukar sabon kamuwa da cuta mai aiki sosai.
Ana iya amfani da binciken antibody don gano cututtuka da kuma kula da yawan jama'a.
Gwajin antibody ya nuna yawan mutanen da suka kamu da cutar, wanda ya haɗa da waɗanda ba su da alamun bayyanar da za a iya bayyanawa da kuma waɗanda ba su da alamun cutar.
Za a iya tantance ainihin adadin mutuwar da cutar ta haifar da kuma yawan mutuwar da ake samu a cikin yawan jama'a daga gwajin.
Bisa ga gwajin da aka yi, a watan Maris na 2020, babu wata ƙasa da ta sami ingantaccen bayani game da yadda cutar ta yadu a cikin yawan jama'arta.
A cikin 23/3, babu wata ƙasa da ta yi gwajin fiye da kashi 3 cikin ɗari na yawan jama'arta.
Wannan bambancin yana da mahimmanci a cikin tasirin cutar mai saurin kamuwa da cutar, wanda aka fara la'akari da mahimmanci a wasu ƙasashe.
Amfani da amsar jerin kwayoyin polymerase (rRT-PCR) Ana iya yin gwajin a kan samfuran numfashi na numfashi da nau'in kwayar cutar ta ɗauka. Wannan ya haɗa da duban hanci da hanci da kuma samfurin leak.
Ana samun sakamakon a cikin sa'o'i ɗaya zuwa kwana biyu.
Gwajin RT-PCR da aka yi tare da gwajin makogwaro shine kawai gwajin da aka amince da shi a cikin makon farko na kamuwa da cutar.
Bayan haka, kwayar cutar za ta iya ɓacewa daga hanci yayin da take ci gaba da yawaita a cikin huhu.
Ga waɗanda aka gwada su a mako na biyu, ana iya ɗaukar samfurin daga cikin rami ta hanyar na'urar inhaler ko kuma ta hanyar leak.
Ofaya daga cikin gwajin PCR na farko da aka haɓaka a Charité University a Berlin a cikin Janairu 2020 wanda ke amfani da polymerase chain reaction immunization (rRT-PCR). An kuma samar da kayan aikin likita 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Burtaniya ta ƙaddamar da gwajin a ranar 23/1/2020. Kudancin Koriya ta CojeniBioch ya ƙaddamar da sabon ƙofar magani, PCR baya-bayan SARS-CoV-2 (SARS-CoV-2 potency test) a ranar 28/1/2020.
Wannan gwajin yana neman kwayar "E" da ke yawo a cikin dukkanin masu karɓar kwayar cutar corona, da kwayar RdRp na musamman ga SARS-CoV-2. A Sinanci, rukunin BGI ya kasance ɗaya daga cikin kamfanoni na farko da suka sami kayan aikin gaggawa daga Ma'aikatar Kiwan lafiya ta Sin, PCR da aka gina akan kayan aikin bincike na SARS-CoV-2, a cikin Amurka da Cibiyar Kula da Cututtuka da Cututtuka (CDC) sabon gwajin cutar coronavirus 2019 RT-PCR ya ba da samfurin gwajin ga dakunan bincike na kiwon lafiya ta hanyar hanyoyin bincike na duniya.
Ofaya daga cikin gwajin gwajin kwayar halitta don sigar kayan gwaji ya haifar da sakamakon rashin lafiya saboda amfani da kayan gwaji da allon gwaji a CDC a Atlanta; wannan ya haifar da matsakaicin matsakaicin samfuran 100 a kowace rana a cikin Fabrairu 2020.
Ba a tantance gwajin amfani da abubuwa daban-daban a matsayin abin dogaro ba a ranar 28/2/2020. Ba a sanar da cewa an ba da izinin ci gaba da gwaji ba a cikin dakunan gwaje-gwaje na gida da na jihohi ba.
Gwajin da Hukumar Abinci da Magunguna ta amince da shi ya kasance a ƙarƙashin kulawar gwamnati a matsayin gaggawa. Laboratories na Majalisar Dinkin Duniya sun fara gwajin a farkon Maris 2020.
A ranar 5/3/2020, LabCorp ya ba da sanarwar samun gwajin COVID-19 na ƙasa bisa ga RT-PCR
Hukumar Kula da Gano Cututtuka ta fitar da wani sabon bincike na kasa na COVID-19 a ranar 9 ga watan Maris, 2020.
Ba a bayar da wani takamaiman adadin ba, amma za a yi tattara samfuran da kuma bibiya bisa ga bukatun CDC.
A Rasha, an kirkiro gwajin COVID-19 kuma an samar da shi ta VECTOR Research Center for Virology and Bacteriology.
A ranar 11/2/2020 an yi rajistar gwajin ta Hukumar Kula da Kula da Lafiya ta Tarayya. a ranar 12/3/2020, Mayo Clinic ta sanar da cewa ta haɓaka gwajin don nazarin cutar COVID-19. a ranar 13/3/2020 , Hukumar Kula da Cututtuka ta Roche ta sami amincewar FDA don gwajin da za a iya yi a cikin sa'o'i 3.5 a cikin kamuwa da cuta mai tsanani, don haka ba da damar na'urar ta iya yin gwaje-gwaje 4,128 a cikin sa'o'i 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin EUA ga Abbott Laboratories don gwaji a kan tsarin Abbot 2000m. FDA ta ba da izinin izini na farko ga Hollotec da LabCorp da Cermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cifid ya sami izinin EUA daga FDA don gudanar da gwajin da zai ɗauki minti 45.
FDA ta amince da gwajin da ke amfani da fasahar nucleic acid mai amfani maimakon PCR.
Saboda wannan ba ya buƙatar jerin canje-canje na zafin jiki, wannan hanyar na iya ba da sakamako mai kyau a cikin minti 5 da sakamako mara kyau a cikin minti 13.
Akwai kimanin 18,000 na na'urori a cikin Amurka a yanzu, kuma Abbott yana sa ran ƙara yawan zuwa gwajin 50,000 a kowace rana.Ana shirin gwajin da ke amfani da bayanan antibody da ke ɗaure da furotin N na kwayar cutar coronavirus a Taiwan, tare da fatan cewa zai iya ba da sakamako a cikin minti 15 zuwa 20 kamar yadda gwajin cutar mura mai sauri yake.
Wani bita na wallafe-wallafen Maris 2020 ya nuna cewa "hoto na CT yana taka rawa wajen gano cutar a farkon matakan. Yayin da CT (ƙididdigar ƙididdigar ƙididdiga) ya gano cewa yana iya faruwa tun kafin alamun farko. "
Hanyoyin da aka saba amfani da su akan CT sun haɗa da na'urar gilashi mai yawa, na'urar hoto ta geometric, na'urar rashin daidaituwa, da kuma rarraba baya.
Rashin rinjaye na subpleural, rashin hankali da kuma rashin ƙarfi ana bi da su a matsayin cututtukan haɓaka.
Wani binciken kimiyya da aka yi a Wuhan wanda ya kwatanta PCR da CT a asalin cutar ya nuna cewa CT ya fi PCR hankali, kodayake ya fi ƙarancin ƙwarewa, tare da nuna halayen da ke bambanta da cutar huhu da kuma hanyoyin cutar.
A cikin Maris 2020, Kwalejin Magungunan Radiology a Amurka ya ba da sanarwar cewa "Ba za a yi amfani da CP ba don ganowa da gano cutar COVID-19".A cikin Maris 2020, CDC ta ba da sanarwar amincewa da PCR don cutar farko.
Wani ɓangare na amsar rigakafin jiki ga kamuwa da cuta shine samar da antibodies, gami da IgM da IgG.
Ana iya amfani da su don yin bincike kan mutane a cikin kwanaki 7 na fara kamuwa da cuta ko bayan bayyanar da alamun farko don tantance rigakafi da kuma gano cutar a cikin mutane.
Ana samun tsarin sarrafa kansa mai yawa a cikin dakunan gwaje-gwajen likita don gudanar da waɗannan gwaje-gwajen, amma wadatarsu ta dogara da matsakaicin samarwa ga kowane tsarin.
Don CLT, ana amfani da samfurin gwajin jini na waje, duk da haka, ana iya amfani da jerin samfuran don jinkirta aikin.
Don PoCT, ana yawan ɗaukar samfurin jini ta hanyar yin allura a cikin fata.
Ba kamar matakan PCR ba, ba a buƙatar matakin cirewa kafin gwajin. A ranar 26 ga Maris, 2020, FDA ta ba da sunayen masu izini 29 waɗanda suka ba da sanarwar ga mai binciken kamar yadda aka buƙata kuma yanzu suna shirye don rarraba kwayoyin gwajin su.
A ranar 7/4/2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris 2020, Laboratory for Diagnostic and Epidemiological Manual Disease ya sami izinin Turai don kayan aikin lab, wanda zai iya bincika ƙwayoyin rigakafin IgG da IgA don ƙwayoyin cuta daga samfuran jini.
Gwajin yana iya ɗaukar samfurori 100 a cikin awa ɗaya kuma saboda haka ya fi sauri fiye da gwajin PCR na yau da kullun don RNA na kwayar cutar.
Antibodies suna da yawa a cikin kwanaki 14 na kamuwa da cuta na farko. A farkon Afrilu, Burtaniya ba ta sami maganin rigakafin gwaji ba, don haka ya sayi maganin rigakafin da ya dace don amfani.
Hong Kong ta ba da shirin cewa waɗanda ake zargi da cutar na iya zama a gida, sashen gaggawa yana ba da allurai don ɗaukar samfurori, saka su, dawo da su, sannan kuma karɓar sakamakon gwajin. NHS na Burtaniya ya ba da sanarwar cewa suna gwada wani shiri don bincika waɗanda ake zargi da cutar a gida, inda za a iya ɗaukar haɗarin kamuwa da wasu daga mai cutar idan sun zo asibiti ko kuma idan an buƙaci amfani da motar asibiti.
Cibiyoyin isar da sako sun taimaka wa Koriya ta Kudu, suna gudanar da wasu daga cikin mafi sauri da kuma mafi yawan bincike a cikin kasar.A Jamus, Ƙungiyar Ƙasa ta Kasa ta Kasa ta Kasa ta Kasa ta Kasa ta Duniya ta ce a ranar 2/4 cewa tana da damar yin gwajin 12,000 a kowace rana a cikin aikin motsa jiki, kuma an yi gwaje-gwaje 10,700 a makon da ya gabata.
Asusun inshora na lafiya yana biyan kuɗin idan likita ya buƙaci gwajin.
A cewar shugaban cibiyar Robert Koch, Jamus na iya yin fiye da 160,000 a kowane mako.
A ranar 19 ga Maris, an ba da gwajin gwaji a manyan birane da yawa.
A ranar 26 ga Maris, 2020, ba a san yawan adadin gwajin da aka yi a Jamus ba, saboda sakamakon da aka bayar kawai ya nuna cewa an yi gwajin a cikin gida.
A cikin makon 12/2020, aƙalla 483,295 samfurori sun yi gwaji, kuma a tsakanin makon 12/2020 da 33,491 (%6.9) na gwajin sun tabbatar da SARS-CoV-2, masu bincike a asibitin Teknion da Rambam a Isra'ila sun haɓaka da gwada sabuwar hanyar gwajin samfuran ga marasa lafiya 64 a lokaci guda, ta hanyar tattara samfuran da kuma yin cikakken bincike kan yiwuwar samun tabbataccen samfurin.
Ta hanyar sa ido daga wanda ya kafa BGI, Wang Jian, da kuma kwanaki 5, ayyukan sun nuna cewa cutar a Hubei ya kamata ya kasance 47% mafi girma kuma farashin rage yawan kokarin keɓewa ya kamata ya ninka idan ba a sami damar yin gwajin ba.
An tuntubi dakin gwaje-gwaje na Wan kai tsaye daga dakunan gwaje-gwaje na Hu-yan a Shenzhen, Tianjin, Beijing da Shanghai daga biranen Sin 21 gaba ɗaya.
A ranar 4/3/2020, matsakaicin matsakaicin gwajin yau da kullun ya kai 50,000 a kowace rana, an buɗe tushen taswirar kemikal, wanda aka buga ta Origami Tests wanda aka ba da rahoton cewa za su iya gwada samfuran marasa lafiya 1122 don COVID-19 ta amfani da gwajin 93 kawai, ana iya amfani da waɗannan taswirar masu ɗorewa a ƙananan dakunan gwaje-gwaje ba tare da buƙatar na'urar gwajin ruwa ba.
A watan Maris, saboda karancin gilashin gilashi, an yi amfani da gilashin mai mai amfani da gilashi don gwajin ƙarfin ƙarfin gilashi a Turai da Burtaniya.
Wannan ya sa marubuta suka yi bincike don shirya tsarin gwajin samfurin wanda ya ɗauki ƙarancin 98 ° C (208 ° F) na tsawon minti 5 don nuna kwayar halittar RNA don cikakken bincike. An sanar a ranar 31/3 cewa Hadaddiyar Daular Larabawa ta yi gwajin cutar coronavirus a kan kowane mutum a cikin yawan jama'arta fiye da sauran ƙasashe, kuma suna ƙoƙari su ƙara yawan gwajin zuwa mafi yawan jama'a.
Wannan ya danganta ne da haɗin gwajin na'urar hannu da kuma sayen kayan aiki na dakin gwaje-gwaje daga 42 Groups da BGI (da aka haɗa da Laboratories na Hu-wan Emergency Research Laboratories a Shenzhen).
Tare da adanawa na kwanaki 14, dakin gwaje-gwaje yana da ikon yin gwajin ST-PCR na 10,000 a kowace rana kuma ana yin rikodin kashi na farko a cikin ciki.
An haɓaka gwaje-gwaje daban-daban na masu karɓa don gano nau'ikan kwayar kwayar cutar corona a China, Faransa, Jamus, Hong Kong da Majalisar Dinkin Duniya.
Hukumar Lafiya ta Duniya ta ɗauki ra'ayin Jamus don ƙirƙirar kayan aikin gwaji da aikawa zuwa ƙasashe marasa talauci waɗanda ba su da kuɗin haɓaka kayan aikin su.
An sanar da manufar Jamus a ranar 17/2/2020, ba a sami yarjejeniya da Cibiyoyin Kula da Cututtuka na Majalisar Dinkin Duniya suka tsara ba har zuwa 28/2, jinkirta samun gwajin a China da Amurka yana da matsala game da amincin kayan gwaji tun farkon ɓarkewar cutar, waɗannan ƙasashe da Ostiraliya ba su iya samar da kayan gwajin da suka dace don biyan buƙatun da umarnin gwajin da kwararrun kiwon lafiya suka bayar ba.
Akasin haka, masana sun ce wadataccen gwajin da Koriya ta Kudu ke yi ya taimaka wajen rage yaduwar sabon coronavirus.
An yi amfani da gwaji mai yawa, da kuma ɗakunan gwaje-gwaje masu zaman kansu da yawa a cikin shekaru da yawa ta hanyar gwamnatin Koriya ta Kudu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira ga a kara yawan shirye-shiryen gwaji don nuna cewa wannan ita ce hanya mafi kyau don nuna ci gaban annobar COVID-19. Babban bukatar yin gwaji saboda yaduwar cutar ya sa an yi gwajin da ba a yi ba a cikin dakunan gwaje-gwaje na Majalisar Dinkin Duniya, da kuma samar da kayan gwaji da kuma ruwan tabarau na sinadarai.
A watan Maris na 2020, Sin ya ba da sanarwar cewa yana da matsala game da daidaito da daidaito na kayan aikinsa.
A cikin Majalisar Dinkin Duniya an samar da kayan gwaji daga CDC wanda ke da kuskure sannan gwamnati ta cire shingen doka, wanda ya hana takamaiman gwaji. Spain ta sayi kayan gwaji daga Shenzhen Biobys Biotechnology Co Ltd, amma ta gano cewa sakamakon ba daidai ba ne.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya haifar da kuskuren tattara samfurin ko amfani da allurai ba daidai ba.
Ma'aikatar Spain ta ba da sanarwar cewa za ta dawo da kayan aikin da ke ba da sakamako mara kyau, kuma ta maye gurbin su da kayan aikin gwaji daban-daban waɗanda aka samar da su da shingen shingen na biosis. 80% na kayan aikin gwaji da Jamhuriyar Czech ta saya daga Sin sun ba da sakamako mara kyau. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga Sin wanda ya bayyana ba daidai ba.
Firayim Ministan Slovakia Matović ya ba da shawarar a mayar da su zuwa Danube. A ranar Lahadi, Ma'aikatar Lafiya ta Turkiyya ta ce kayan aikin binciken da Turkiyya ta saya daga Sin suna da "kuskuren da yawa", kuma "ba a cire su ba".
Bincike, keɓe waɗanda suka kamu da cutar, da kuma gano waɗanda suka yi mu'amala da waɗanda suka kamu da SARS-CoV-2 kuma suka kamu da cutar tun lokacin da suka kamu.
Masu binciken suna aiki a garin Voi, Italiya, wanda shine farkon wanda aka ba da rahoton mutuwarsa daga COVID-19. sun gudanar da bincike guda biyu na kusan mutane 3,400 a cikin kwanaki goma.
Kusan rabin mutanen da suka kamu da cutar ba su da alamun cutar, kuma an killace duk waɗanda suka kamu da cutar.
Ta hanyar tafiya zuwa yankuna masu zaman kansu, ba a sami sabon shari'ar ba.
Tare da tsauraran matakai na sa ido, ƙuntata ƙa'idodin tafiye-tafiye, da gwaji da keɓewa, annobar coronavirus ta 2020 ta bazu a cikin Singapore a hankali fiye da sauran ƙasashe masu ci gaba. ba tare da ƙa'idodi masu ƙarfi kamar tilasta rufe gidajen abinci da kasuwanni ba.
An soke wasu bukukuwa, kuma Singapore ta fara ba da shawara ga mazauna su zauna a gida daga 28/3 amma makarantu sun sake buɗewa a kan lokaci bayan hutun ranar 23/3.
Yawancin ƙasashe sun magance cutar ta hanyar keɓewa, dakatar da tafiye-tafiye, gwaji, da keɓewa, amma ba tare da tsauraran matakan hana zirga-zirga ba kamar Iceland da Koriya ta Kudu.
Binciken ƙididdiga ya nuna cewa ƙasashen da ke da yawan gwaji da yawan mace-mace, suna da ƙananan mutuwar, wanda zai iya zama dalilin da ya sa waɗannan ƙasashe za su iya yin bincike a kan mutanen da ke da rauni ko marasa lafiya.
WHO ta ba da sanarwar cewa ƙasashen da ba su da ƙarfin gwajin da kuma cibiyoyin bincike na ƙasa da ke da ƙwarewa a kan COVID-19 za su aika da samfuran farko na COVID-19 na mutane biyar da na goma zuwa ɗaya daga cikin cibiyoyin bincike na WHO guda 16 don tabbatar da gwajin.
Daga cikin 16 da aka gano, bakwai daga Asiya ne, biyar daga Turai, biyu daga Afirka, daya daga Arewacin Amurka, da daya daga Australia.
A cikin jerin, an tsara "rabon gwajin gwaji mai kyau" wanda ya samo asali ne daga 'yan sanda na gwaji na kasar.
Ƙasar da ke gwada waɗanda suka je asibiti ne kawai za ta fi samun ƙarancin waɗanda suka yi gwajin fiye da ƙasar da ke gwada dukan mutanen, ko suna da alamun cutar ko babu, sauran abubuwa za su kasance iri ɗaya.
Wanke hannu, wanda aka fi sani da tsabtace hannu, shine aikin tsabtace hannu don cire ƙura, ƙura, ƙwayoyin cuta, da sauran ƙazanta.
Wanke hannu da sabulu don tabbatar da "lokacin haɗari" a rana yana hana yaduwar cututtuka da yawa, misali, zawo, da kwalara da ake samu ta hanyar najasa.
Hakanan mutane na iya kamuwa da cututtukan numfashi kamar mura ko cutar huhu, misali, idan ba su wanke hannuwansu ba kafin su taɓa idanunsu ko bakinsu.
Akwai lokuta guda biyar a rana da suke da muhimmanci a wanke hannaye da sabulu: kafin da kuma bayan wanka, bayan wanke jariri ko canza masa kayan wanki, kafin ciyar da jariri, kafin cin abinci, da kuma bayan shirya abinci ko shirya nama, kifi, da tsuntsaye.
Idan ba a da ruwa da sabulu, za ka iya wanke hannuwanka da sabulu. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu a cikin:
Kafin da bayan shirya abinci
Kafin da kuma bayan kula da marar lafiya
Bayan an canja kayan yara ko an tsabtace wanka na yaro
Sa'an nan da an yanka daga bãkunansu, da kuma kãwunansu, da kuma hufõjinsu.
Bayan mun taɓa dabbobi, abinci, dabbobin gida, da kuma kwandon dabbobi.
Sanin kiwon lafiya yana nufin yin aikin tsabtace jiki wanda ya shafi kayan kiwon lafiya.
Wanke hannu kafin a yi aiki ko kuma duba likita zai iya hana ko rage yaduwar cututtuka.
Babban manufar kiwon lafiya na wanke hannu shine tsaftace hannaye daga microbes (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cuta), da kuma sunadarai waɗanda zasu iya haifar da lahani ko cuta.
Wannan yana da mahimmanci ga mutanen da ke dafa abinci ko aiki a yankin likita, amma kuma yana da mahimmanci ga wuraren jama'a.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da rage kamuwa da mura, coronavirus da sauran cututtukan da ke yaduwa; hana cututtukan da ke haifar da cututtukan cututtukan cututtuka; rage cututtukan da ke haifar da cututtukan cututtuka; da rage yawan cutarwa na numfashi.
Saukewa ya haɗa da rage yawan mutuwar jarirai da aka haifa a gida.
Wani bincike na 2013 ya nuna cewa inganta aikin wanke hannu zai iya taimakawa wajen rage tsawon lokacin da yara ke da shekaru 5 da haihuwa.
A cikin ƙasashe masu tasowa, yawan mutuwar yara ya danganta da cututtukan numfashi da na hanji, wanda za a iya ragewa ta hanyar gabatar da halaye daban-daban kamar wanke hannu da sabulu.
Wannan aikin mai sauki zai iya rage yawan mace-mace a cikin wadannan kasashe da kusan kashi 50%.
Shawarwarin likitoci sun ce wanke hannu zai iya rage kusan kashi uku na yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka, wanda aka kwatanta da samar da ruwa mai tsabta ga matalauta.
Za a iya danganta rage yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na 48% ta hanyar wanke hannu. Wanke hannu da sabulu yana daya daga cikin mafi kyawun kuma mafi arha hanyoyin hana cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na cututtukan cututtukan cututtuka, ana aiwatar da su ta atomatik a gida, makarantu, da kuma a cikin al'ummomin duniya.
Cutar, wanda ya hada da ARI, ita ce babbar hanyar mutuwar yara a ƙarƙashin shekara biyar, wanda ke haifar da mutuwar kimanin miliyan 1.8 a kowace shekara.
Cutar cututtukan huhu da cututtukan huhu suna kashe kusan yara miliyan 3.5 kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma bayan an yi amfani da kayan wanki mai ɗorewa na iya ceton rayuka fiye da duk wani allurar rigakafi da magani, yana hana mutuwar mutane daga kamuwa da cutar ta hanyar shan kashi 50%, kuma yana hana mutuwar mutane daga cututtukan numfashi da kashi ɗaya bisa huɗu.
Wanke hannu yana da alaƙa da sauran tsaftacewar likita kamar wanke ruwa da wanke ruwa da wanke ruwa.
Wanke hannu yana kuma kare ka daga cututtukan fata da ke yaduwa ta hanyar saduwa ta jiki.
A takaice, wanke hannu da yawa yana iya haifar da lalacewar fata saboda bushewar fata.
Wani binciken kimiyya na Danish a 2012 ya gano cewa yawan wanke hannu zai iya haifar da saurin bushewa da kuma yanayin fata mai laushi wanda aka sani da intyahabatis ko kuma hand rash, wanda ya fi dacewa a cikin ma'aikatan kiwon lafiya.
Ana ganin yawan wanke hannu a matsayin alamun OCD.
Akwai lokatai guda biyar da wanke hannu da sabulu ke da mahimmanci don rage haɗarin kamuwa da cuta ta hanyar datti; bayan yin wanka (wanka da yin wanka), bayan wanke tufafin yara (canji), kafin cin abinci da kuma kafin da kuma bayan shirya abinci ko shirya nama, kifi da kaji.
Sauran lokutan da ya kamata a yi amfani da dabarun wanke hannu don hana yaduwar cuta sun haɗa da kafin da bayan kula da rauni, bayan wanka ko wanke gashi, bayan taɓawa da najji ko taɓawa da dabbobi, da kuma bayan taɓawa da najji.
A cikin ƙasashe da yawa, akwai ƙananan adadin wanke hannu da sabulu.
Wani bincike na wanke hannu a kasashe 54 a shekarar 2015 ya nuna cewa kimanin kashi 38.7 cikin dari na mutane a gida suna wanke hannu da sabulu. Wani bincike na 2014 ya nuna cewa Saudi Arabia tana da mafi yawan adadin wanke hannu da kashi 97, Amurka tana da matsakaicin kashi 77, kuma Sin tana da mafi ƙarancin wanke hannu da sabulu da kashi 23 kawai.
Shirin Kula da Lafiya na Manyan Manyan da aka aiwatar a bangaren Turai a Philippines misali ne na inganta lafiyar yara da ilimi.
Cutar da tsutsotsi sau biyu a shekara. Ƙara tare da wanke hannu da sabulu yau da kullum, wanke haƙora da aljihun haƙora, da kuma wanke haƙora, shine babban ɓangare na wannan shirin na duniya.
An yi nasarar aiwatar da wannan a Indonesia.
An yi amfani da labaru na Microbial a kan fata ta hanyar ƙara sabulu ko ruwa.
Babban aikin sabulu da taƙaitawa shine rage ƙuntataccen abu da kuma ƙara ƙarfin abu.
Ruwa ne kawai ba dole ba ne mai tsabtace fata saboda fats da sunadarai, wanda ba su da asali kuma ba a kai su kai tsaye ba.
A kowane hali, ana iya yin tsaftacewa ta hanyar ruwan da ke gudana.
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, yana riƙe da ƙwayoyin cuta da masu amfani da shi suka yi.
Ƙananan bincike da aka yi a kan ƙwayoyin cuta a cikin sabulu don cire ruwan sha ya gano cewa ƙwayoyin cuta suna ƙara yawan ƙwayoyin cuta a cikin tururi.
CDC ta ce "sabulu da ruwa tare da sarrafa hannu don tsaftacewa sun dace".
An ba da sabulun antibacterial mai tsada ga lafiyar jama'a.
A halin yanzu, babu wata shaida da ke nuna cewa amfani da maganin rigakafi ko kashe kwayoyin cuta na iya haifar da rigakafin kwayoyin halitta a cikin yanayi.
Duk da haka, sabulu na antibacterial ya ƙunshi maganin rigakafi na yau da kullun a matsayin mai samar da maganin rigakafi, wanda ke da jerin nau'ikan rigakafi na kwayoyin cuta.
Saboda haka, ko da an ba da rigakafin antibacterial ga sabulu, ba zai yi tasiri kamar yadda aka tallata ba.
Tare da sabulu da kayan aikin kare fata, ƙwayoyin cuta na iya haɗawa da acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, acid mai aiki antibacterial, benzoic acid da masu taimakawa na fata (alone vera, bitamin, menthol, abubuwan da ke cikin shuka). Wani bincike na duniya na Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun yana da tasirin antibacterial kamar sabulu na gida wanda ke da antibacterial da antibacterial a hannaye.
Ruwa mai ɗumi da ke da sauƙin wanke hannu ba shi da girma da zai kashe ƙwayoyin cuta.
Kwayoyin suna girma cikin sauri a zafin jiki na 37 ° C.
Duk da haka, ruwan zafi da sabulu sun fi ruwan sanyi da sabulu tasiri wajen kawar da kitse na halitta wanda ke ɗauke da datti da ƙwayoyin cuta.
Sabanin ka'idar ƙasa, duk da haka, gwaje-gwajen kimiyya sun nuna cewa amfani da ruwan zafi ba shi da tasiri a kan ƙwayoyin cuta masu ƙwayoyin cuta.
Ana amfani da ruwan wanke hannu don wanke hannu ba tare da amfani da ruwa ba.
A ƙarshen shekarun 1990s da farkon karni na 21, ana amfani da na'urar tsabtace hannu ba tare da ruwa ba (wanda aka fi sani da na'urar tsabtace hannu, na'urar tsabtace hannu, na'urar tsabtace hannu) ta zama ta kowa.
Yawancin su sun dogara ne da isopropyl ko ethanol da aka haɗa tare da mai tsabtace microbial kamar carbonomer (polymer na acrylic acid) a cikin wani abu mai haɗuwa, ko ammonium kamar glycerin a cikin wani abu mai ruwa, ko kuma mai sauƙi don amfani ko don rage tasirin bushewar giya.
Oxygenarin oxygen yana ƙara aikin antimicrobial. Sanitizer na hannu yana ƙunshe da ƙarancin 60% zuwa 95% na barasa wanda ke kashe ƙwayoyin cuta masu aiki.
Masu tsarkakewa na barasa suna kashe kwayoyin cuta, kwayoyin cuta masu dauke da kwayoyin cuta masu yawa (MRSA da VRE), cutar tarin fuka, da wasu ƙwayoyin cuta (wanda ya haɗa da HIV da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka, RSV da Rhino, ƙwayoyin cuta na cutar da mura da cutar mura da kuma cutar hepatitis C).
Maganin wanke hannu yana kashe 70% na barasa, 99.97% (3.5 logarithm ragewa, daidai yake da 35 logarithm ragewa) na kwayoyin cuta a hannu 30 seconds bayan aikace-aikace da 99.99% zuwa 99.9995% (4-5 logarithm ragewa) na kwayoyin cuta a hannu minti daya bayan aikace-aikace, sa hannu mai tsabtace hannu ya fi tasiri akan kwayoyin cuta kuma ya fi rashin ƙarfi akan ƙwayoyin cuta.
Ba a amfani da maganin wanke hannu ba tare da maganin da ke da illa ga ƙwayoyin cuta (ko ƙwayoyin cuta na Norovirus) waɗanda ke haifar da cutar sankara, ana buƙatar amfani da kayan tsabtace hannu ko na gida don tsabtace hannu ko rufe hannu.
Ana wanke gaba da baya na hannu biyu da tsakiya da kuma dukkan yatsunsu na tsawon dakika 30 har sai ruwan ya narke.
Ya kamata a rufe yatsunsu da kyau kuma a sanya su a cikin hannayen hannu. Cibiyar Kula da Cututtuka ta Majalisar Dinkin Duniya ta ba da shawarar wanke hannu kafin a wanke hannu da ruwa, musamman idan hannayen hannu sun lalace.
Yawan waɗannan kayan ya dogara ne da sauƙin amfani da kuma saurin kashe ƙwayoyin cuta, duk da haka, bai kamata su zama madadin wanke hannu ba sai dai idan akwai sabulu da ruwa.
Yawan amfani da ruwan tsabtace hannu na barasa na iya haifar da bushewar fata sai dai idan an ƙara cream na fata ko mai saurin fata.
Za'a iya rage ko kawar da tasirin bushewar giya ta hanyar ƙara glycerin cream ko wasu kayan shafawa na fata don aikin.
A cikin maganin likita, masu tsabtace hannu na giya sun ƙunshi ƙwayoyin fata waɗanda ba su da saɓo da magungunan antimicrobial da ke haifar da rauni ko bushewar fata.
Hanyoyin hanci na hanci, masu fama da ciwon hauka ko masu fama da ƙwayoyin cuta suna da ƙarancin haɗari ga barasa ko abubuwan da aka haɗa da tsabtace jiki.
Ƙananan shirye-shiryen don ƙara kayan zaki mai laushi ya zama mafi tasiri fiye da wanke hannu da sabulu da ruwa.
Duk da tasirin su, masu tsabtace ruwa ba sa tsabtace dukkan sassan hannu amma suna tsabtace su.
Wannan ya faru ne a lokacin da na'urorin tsabtace hannu kamar ruwa da sabulu ba su da tasiri wajen hana yaduwar cututtuka da yawa, saboda haka cututtuka suna ci gaba da kasancewa a hannu.
Alcoholism yana da ƙarfi sosai a cikin tsari da tsari, kuma ya kasance tarihi na rashin nasara.
Kwanan nan, an nuna cewa magunguna masu amfani da benzalkonium chloride suna da aiki mai ɗorewa da kuma ƙaruwa bayan amfani, ba kamar barasa ba, wanda aka nuna yana da tasiri kaɗan bayan sake amfani da shi, wanda zai iya haifar da mummunan sakamako na rashin lafiyar fata.
Mutane da yawa a ƙasashe matalauta ba su da isasshen sabulu, suna amfani da ƙura ko shara a maimakon.
Ƙasa ko turɓaya na iya zama mafi tasiri fiye da ruwa kawai, amma ba ta da tasiri kamar sabulu.
Daya daga cikin damuwa shi ne cewa idan turɓaya ko turɓaya ta kasance mai ƙazantar da kwayoyin cuta, zai iya ƙara yawan yaduwar cutar maimakon rage shi.
Abubuwan da ke kashe ƙwayoyin cuta kamar sabulu, toka, da kuma ƙura suna da haɗuwa da ruwa, wanda ke haifar da ƙura mai laushi.
Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da ƙura a matsayin madadin sabulu lokacin da sabulu bai samu ba.
Hanyar wanke hannu mai kyau da Cibiyar Kula da Cututtuka ta Majalisar Dinkin Duniya ta ba da shawarar don hana yaduwar cututtuka ta ƙunshi:
Wanke hannuwanku da ruwan sanyi da ruwan zafi.
Ana ba da shawarar ruwan da aka sha saboda yana iya ƙazantar da shi, yayin da zafin jiki na ruwa ba zai zama mai banbanci ba.
Wanke hannu da sabulu ya haɗa da bayan hannu, tsakanin yatsun hannu da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane sun fi son wanke hannayensu a gaban sabulu fiye da wanke hannayensu da ruwa.
A shaƙa hannu da sabulu aƙalla na tsawon dakika 20.
Yin wanka da sabulu yana haifar da wanka, wanda ke taimakawa cire ƙwayoyin cuta daga fata, kuma da zarar ka wanke hannayenka, da sauri za a iya kashe ƙwayoyin cuta.
Wanke hannuwanka sosai da ruwa mai daɗi.
Wanke hannu a cikin ruwa na iya ƙazantar da hannaye.
Ka bushe shi da ruwa mai tsabta ko ka bar shi ya bushe a cikin iska.
Hannun da ke da ruwa da bushewa suna da sauƙin gurɓata, wurare da suka fi dacewa da gurɓataccen abu sune farce, ƙwallon ƙafa, da kuma yankin tsakanin yatsunsu da kuma ƙarƙashin yatsunsu.
Nails da kuma ƙusa na iya zama wuraren da kwayoyin cuta ke taruwa.
An ba da shawarar yin amfani da kayan aikin fata don hana hannaye bushewa. Dry skin zai iya haifar da lalacewar fata wanda zai iya ƙara yawan kamuwa da cutar.
Za'a iya yin zaɓuɓɓukan rigakafin ƙwayoyin cuta don sauƙaƙe wanka lokacin da babu ruwan sha da sabulu, misali adana ruwa a cikin jaket ko kwalban kwalba a cikin kwalliyar da aka yi ko amfani da ashtrays idan ya cancanta a ƙasashe masu tasowa. A wasu yanayi na iyakance samar da ruwa (kamar makarantu ko yankuna na ƙauyuka na ƙasashe masu tasowa), akwai hanyoyin adana ruwa kamar "yin ruwa" da sauran zaɓuɓɓuka.
Ruwan da aka yi amfani da shi ya ƙunshi wani nau'i na mai wanki da aka rataye da wani abu mai laushi, da kuma wani kayan aiki na wankewa don zuba ruwa a hannunka, da kuma sabulu.
Tasirin bushewar hannu wani muhimmin bangare ne na aikin tsabtace hannu, amma akwai wasu ra'ayoyi game da tasirin bushewar hannu a cikin wanke hannu na jama'a.
Littafin bincike mai tasowa ya ba da shawarar cewa kayan aikin wanka sun fi tsabtace hannu mai bushewa na lantarki wanda aka samo a wasu hannayen hannu.
A shekara ta 2008, wani bincike da Jami'ar Westminster a Landan ta gudanar, kuma kamfanin samar da wanki na Turai ya tallafa, ya gwada matakan wanka na wanki, da kuma yanayin wanki mai wanki da wanki mai wanki.
Bayan wankewa da bushewa da aka yi da na'urar busar hannu mai zafi, yawan kwayoyin cuta a saman yatsun hannu ya karu da kashi 194% da 254% a kan yatsun hannu.
An gano cewa wanke hannu da na'urar sarrafa iska mai inganci ya kara yawan kwayoyin cuta a yatsun hannu da kashi 42 cikin dari kuma a cikin yatsun hannu da kashi 15 cikin dari.
Bayan wanke hannu da bushewa da ruwan wanka, an rage adadin kwayoyin cuta zuwa 76% a saman yatsun hannu da 77% a cikin yatsun hannu. Masana kimiyya sun kuma yi gwaji don gano yiwuwar haɗuwa da gurɓataccen abu a cikin wankan hannu tare da yanayin ɗakin kamar sakamakon hanyoyin wanke hannu.
Na'urar wanke hannu mai ci gaba da ke fitar da iska a saurin 180m/s (650km/h;400) tana da ikon kashe kwayoyin cuta daga hannu da bangare kuma ta ɓoye sauran masu amfani da hannayen ta hanyar lalata yanayin ɗakin wanka na 2m.
Yin amfani da na'urar bushewa da iska mai zafi yana fitar da ƙwayoyin cuta zuwa tsayin mita 0.25 daga na'urar.
Toilet cleaning ya nuna cewa babu kwayoyin cuta da ke kamuwa da cutar. A cikin binciken da aka yi a shekarar 2005 ta TUV Proact and Omwelte, an yi la'akari da hanyoyin wanke hannu.
An lura da canje-canje a yawan kwayoyin cuta bayan wanke hannaye:
Akwai masu bushe-bushe masu sana'a da yawa, kuma an kwatanta su da bushe-bushe da yin wanka da ruwan wanka.
Yin wanka da hannu tare da takalmin wanka zai iya sauya rashin ruwa da sabulu a lokacin tafiya.
Abin da ake amfani da shi na tsabtace hannu ya kamata ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa.
Wanke hannu ya zama dole ne bayan likitan Hungary Ignaz Semmelweis ya gano (a 1846) tasirinsa a hana kamuwa da cuta a asibiti.
Akwai na'urorin lantarki da ke sa ma'aikatan asibiti su wanke hannuwansu idan sun manta.
Wani bincike ya nuna cewa wanke hannu yana rage kamuwa da cuta.
Aƙalla a wanke hannuwan likitanci na tsawon dakika 15, ta amfani da sabulu da ruwa mai tsafta ko ruwan sha don wanke dukkan sassan hannu.
Dole ne a wanke hannaye ta hanyar haɗawa da kuma haɗa hannayen hannu.
Idan akwai ƙazanta a ƙarƙashin ƙusa, za a iya amfani da goge mai kaifi don cire shi.
Saboda microbes na iya zama a cikin ruwa a hannuwanku, yana da muhimmanci a wanke sosai kuma a bushe a cikin tsabta.
Bayan an bushe, dole ne a yi amfani da bututun bayan gida don cire ruwa (ko buɗe kofar bayan gida idan ya cancanta)
Wannan zai kare hannaye daga sake gurbatawa ta iska.
Manufar wanke hannu a cikin tsarin kiwon lafiya shine kawar da abubuwan da ke haifar da cututtuka.
Jaridar New England Journal of Medicine ta ba da rahoton cewa rashin wanke hannu ya zama abin ƙyama a cikin yanayin likita, tare da yawancin likitoci da ma'aikatan aikin jinya da ke manta da wanke hannayensu kafin su taɓa marasa lafiya, ta haka ne ake iya yada ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran ayyuka na iya rage kamuwa da cututtukan ƙwayoyin cuta a cikin jini da kashi 66%, kuma Hukumar Lafiya ta Duniya ta haɓaka matakan da za a bi don wanke hannu da tsabtace hannu da ma'aikatan kiwon lafiya ke bayarwa.
Za a iya samun jagorar wanke hannu ta hanyar ma'aikata a shafin yanar gizon jama'a.
An gudanar da bincike mai kyau da Hittby da sauransu.
Masu sana'a na iya auna da kuma tabbatar da tsabtace hannu, idan an buƙaci nunawa don daidaitawa na adsorbent.
WHO ta kafa "lokaci biyar" don wanke hannu:
Bayan an sha ruwa na jini.
Kafin a yi aikin tsabtace ƙwayoyin cuta,
Bayan kula da marasa lafiya. Sabulu masu tsabtace kayan aiki (sabo mai magani ko sabulu mai maganin antimicrobial) suna ba da kisan kai ga aikin wanke hannu.
Ana iya yin amfani da shi a matsayin aikin kashewa don gudanar da aikin tiyata ko kuma a cikin tsarin da ke da ƙwayoyin cuta masu yawa.
Dole ne a cire dukkan kwayoyin cuta.
Wannan aikin yana buƙatar wanke hannaye da hannayen hannu har sai da bushewa, yawanci a cikin minti 2-6.
Ba a buƙatar wanke hannu na tsawon lokaci (minti 10).
Lokacin yin wanka, dole ne a hana ruwan da ke cikin ruwa daga shiga hannayenku.
Bayan an gama wankewa, sai a wanke hannu da kayan wanki, a sa kayan wanki.
Don rage yaduwar cutar, yana da kyau a wanke hannu ko amfani da na'urar wanke hannu kafin da bayan kula da mai cutar.
Don sarrafa cututtukan microbial a asibitoci, an gano cewa mafi girman fa'idar tsabtace hannu shine 20% na farkon wankewa.Wannan fa'idar da aka samu ta hanyar ƙara yawan wanke hannu zuwa 35% ya kasance.
A cikin binciken, an gano cewa wanke hannu da sabulun alkali da sabulun antibacterial na 30 seconds ya rage gurɓatar kwayoyin cuta da kashi 26% idan aka kwatanta da sabulun antibacterial.
Amma sabulu da ruwa sun fi maganin wanke hannu na barasa tasiri wajen rage cutar H1N1. ƙwayoyin cuta da ƙwayoyin cuta na Clostridium bacteria a hannu. Ayyuka don inganta tsabtace hannu a cikin ƙungiyar kiwon lafiya na iya haɓaka ilimi don ƙungiyoyin wanke hannu, ƙara yawan wadatar masu tsabtace hannu, da kuma tsarawa da tsara umarni ga ƙungiyar.
Ana buƙatar ƙarin bincike don gano wane irin ayyuka ne suka fi tasiri a cikin gudanar da kiwon lafiya daban-daban.
A cikin ƙasashe masu tasowa, wanke hannu da sabulu an bayyana shi a matsayin ingantaccen kayan aiki mai mahimmanci don samun lafiya mai kyau, har ma da abinci mai kyau.
Koyaya, karancin ingantaccen ruwa, sabulu da wuraren wanke hannu a gidajen jama'a, makarantu da wuraren aiki sun yi kira ga al'amuran wanke hannu na duniya.
Misali, a yawancin yankunan karkara na Afirka, babu wuraren wanke hannu a kusa da gidajen wanka na jama'a da na masu zaman kansu, kodayake akwai zaɓuɓɓuka masu arha don samar da wuraren wanka.
Koyaya, rashin wanke hannu na iya zama sakamakon halaye na tilastawa saboda ƙarancin sabulu da ruwa.
Ƙara yawan tallafi da tallafi na wanke hannu da sabulu na iya tasiri kan yanke shawara na siyasa da kuma ƙara fadada sani game da fa'idodin wanke hannu a matsayin ɗabi'a ta dogon lokaci a cikin jama'a.
Don wannan ya yi aiki yadda ya kamata, ana buƙatar kulawa da kimantawa.
Wani tsarin nazarin nazarin kimiyya 70 ya nuna cewa hanyoyin zamantakewa sun fi tasiri wajen inganta wanke hannu a cikin LMICs, yayin da kamfen tallan zamantakewa ba su da tasiri. Misali na haɓaka wanke hannu a makarantu a cikin (hanyar taurari uku) ta UNICEF wanda ke ƙarfafa makarantu su ɗauki misali, matakan da ba su da tsada don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu a cikin sauran buƙatun tsabta da tsabta.
Lokacin da aka sami mafi ƙarancin maki, makarantu za su iya canzawa daga 1 zuwa 3 taurari.
A halin yanzu, wanke hannu na iya zama wani ɓangare na ƙarin ayyukan wanke hannu da aka aiwatar don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen din wayar da kan jama'a game da wanke hannu da ke kokarin canza halaye. A sakamakon annobar cutar korona ta 2019-2020, UNICEF ta wallafa wani hoton wanke hannu.
Wasu bincike sun nuna cewa wanke hannu yana da tasiri a ƙasashe masu tasowa dangane da DALY.
Duk da haka, wani bita ya nuna cewa ƙarin sabulu a wanke hannu ya fi tasiri fiye da ruwa da sauran masu tsabtace jiki.
Tasirin wanke hannu ga lafiyar mutum - musamman ga mutane a cikin mawuyacin hali kamar uwaye masu haihuwa ko sojoji da suka ji rauni a asibiti - an fara bayyana su a cikin karni na 19 ta masu binciken wanke hannu biyu: Likitan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, mai binciken tsarin kula da lafiyar Ingilishi.
A wannan lokacin, mutane da yawa sun gaskata cewa cututtuka ne ke haifar da ƙanshin da ake kira ƙanshin ƙanshin ƙanshi.
A cikin 1980, abinci da magungunan da ke haifar da cututtukan da ke haifar da cututtukan cututtuka sun sa Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ƙara yin amfani da wanke hannu a matsayin hanyar hana yaduwar cututtuka.
Cutar mura da aka yi a 2009 da COVID-19 a 2020 sun haifar da ƙaruwar wayewar kai game da mahimmancin wanke hannu da sabulu a ƙasashe da yawa don kare mutane daga cututtukan da ke yaduwa.
Misali, an sanya hotuna "Hanyar wanke hannu mai kyau" kusa da hannayen riga a cikin gidajen wanka na jama'a da kuma ofishin wanka na gine-gine da filayen jirgin sama a Jamus.
Kalmar "wanke hannu" tana nufin a sanar da mutum mai lafiya ya ɗauki alhakin wani abu ko kuma ya yi amfani da shi.
Wannan ya fito ne daga wani nassi na Linjila na Matta inda Bilatus ya wanke hannuwansa a yanke hukuncin gicciye Yesu, amma ya zama sanannen magana a wasu yankuna na Ingilishi.
A cikin littafin Macbeth na Shakespeare, Macbeth ya fara wanke hannunsa a ƙoƙarin kawar da tunanin da ya ɓata, yana jin daɗin laifin da ya aikata da matarsa ta tilasta masa.
An gano cewa mutane bayan sun yi tunanin yin lalata, suna wanke hannayensu fiye da sauran abubuwa, suna wanke hannayensu a cikin kayan wanka.
Bugu da ƙari, waɗanda suka yi amfani da wanke hannu bayan tunani mai zurfi sun kasance ba sa shiga cikin wasu ayyukan tsaftacewa, kamar aikin sa kai.
Addinai suna bayyana wanke hannu don dalilai biyu na tsabta da kuma zama alama. Alamar wanke hannu, amfani da ruwa maimakon sabulu don wanke hannu yana da wani ɓangare na al'adun wanke hannu a cikin addinai da yawa, kamar addinin Baha'i, addinin Hindu, Tiwiliya, da Netela'iyya a cikin addinin Yahudanci, da La'ababi a cikin addinin Kirista, da Wadiyya a cikin Islama, addinai da al'adun wanke hannu musamman bayan yin ayyuka.
Addinin Hindu, Yahudanci da Musulunci suna koyar da wanke hannu bayan bayan gida.
Hakanan, addinan Hindu, Buddha, Sikh, Yahudanci da Islama sun bukaci wanke hannu kafin da bayan cin abinci.
Gudanar da cutar a wurin aiki don COVID-19
Gudanar da cutar ta COVID-19 a wuraren aiki shine shirin da ke ba da shawarar matakan lafiya da lafiya don sarrafa cutar don hana cutar coronavirus 2019 (COVID-19).
Daidaitaccen ikon cutar a wuraren aiki ya dogara da wurin aiki da aikin, dangane da haɗarin da ke tattare da tushen aiki, tsananin cutar a cikin al'umma da haɗarin haɗarin ma'aikata na mutum wanda zai iya zama mai rauni ga COVID-19.
A cewar Hukumar Kula da Lafiya da Kula da Lafiya (OSHA), rage haɗarin aiki ya fi dacewa da jama'a da ma'aikatan kamfanin, don haka an ba da sanarwar matakan kariya na yau da kullun, wanda ya haɗa da wanke hannu da ƙarfafa ma'aikata su koma gida idan suna da rashin lafiya ko matsalar numfashi da tsabtatawa na yau da kullun da kuma maganin rigakafin cututtukan cututtukan a cikin yanayin aiki.
Babban haɗarin aiki ya haɗa da waɗanda ke buƙatar rufewa tare da mutanen da ba a sani ba ko waɗanda ake zargi da COVID-19, amma waɗanda suka kamu da cutar ta hanyar jigilar jama'a ko balaguro na ƙasa da ƙasa.
Wannan ya haɗa da ma'aikata da ke da alaƙa da jama'a kamar makarantu da kuma manyan wuraren aiki, masana'antu da kuma wasu manyan kamfanonin jiragen sama.
Kula da haɗarin da ke tattare da wannan rukunin, da kuma matakan rigakafin kamuwa da cuta, sun haɗa da yin amfani da matattarar iska da na'urar wanke-wanke da kuma samun kayan kariya na sirri idan mutum yana da COVID-19.
OSHA tana ɗaukar ma'aikatan kiwon lafiya da na asibiti waɗanda ke da haɗarin kamuwa da COVID-19 a matsayin masu haɗari, kuma haɗarin zai iya ƙaruwa sosai idan ma'aikacin ya yi amfani da kayan aikin sanyaya iska ko ya tattara samfuran da ake zargi ko kamuwa da COVID-19.
Dacewar kula da lahani ga ma'aikata da ke aiki a bangaren injiniyanci na kula da su kamar ɗakunan musayar iska mai matsi da kayan kariya na mutum da suka dace da aikin.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya yin rashin aiki saboda haɗarin rashin lafiya da buƙatar kulawa da wasu ko tsoron kamuwa da cutar.
Abokan hulɗa na iya canza sha'awar kayayyaki da dalilan da ake buƙata (kamar sayen kaya a lokacin da mutane ke zuwa kasuwa ko bayarwa ko sayarwa).
A kwanan nan, ana iya dakatar da jigilar kayayyaki a yankunan da COVID-19 ya shafa. Ana iya amfani da shirye-shiryen kamuwa da cuta da kuma shirin haɗuwa don aiwatar da ayyukan ceto.
Shirye-shiryen sun bayyana matakan haɗarin da ke tattare da wuraren aiki da ayyukan aiki, gami da tushen kamuwa da cuta da kuma tsarin abubuwan haɗarin haɗari a cikin gida da al'umma da abubuwan haɗari na mutum kamar tsufa ko yanayin rashin lafiya na yau da kullun.
Hakanan suna tsara abubuwan da ake buƙata don sarrafa haɗari da shirye-shiryen gaggawa don yanayin da ke iya haifar da ƙarin yaduwa.
Shirye-shiryen cututtukan cututtuka da shirye-shiryen na iya zama batun batun dokokin ƙasa da na ƙasa.
Manufofin don amsa fashewar cutar sun haɗa da rage yaduwa a cikin ƙungiyar da kuma kare mutanen da ke cikin haɗarin haɗari da kuma rage tasirin cutar a kan sauran waɗanda aka gano tare da haɗin gwiwar su.
Ƙarfin cutar a cikin al'ummomin da abin ya shafa ya sa aka yi ta yin amfani da maganin.
Haɓaka ikon sarrafa lalacewa shine ra'ayi da aka yi amfani da shi a cikin ayyukan kariya da aminci ga ƙungiyoyin da ke sarrafa lalacewar ta hanyar aiki.
Lokacin da cutar ta COVID-19 ba ta da iko, mafi yawan sarrafawa shine sarrafawar injiniya tare da sarrafawar aiki da kayan kariya.
Gudanar da aikin injiniya ya ƙunshi hana ma'aikata daga lalacewa ba tare da la'akari da halayyar ma'aikaci ba kuma yana iya zama mafi dacewa don aiwatar da shi.
Gudanar da sarrafawa shine sauya ayyukan da aka yi ko kuma matakan da ake buƙatar aiki daga ma'aikata.
Kayan kariya na mutum (PPE) ba su da tasiri kamar na injiniyoyi da masu kula da lafiya, amma za su iya taimakawa wajen hana kamuwa da cuta.
Duk nau'ikan PPE dole ne a tantance su dangane da haɗarin ma'aikaci, a cikin hanyar da ta dace kamar yadda aka aiwatar (misali matsalolin numfashi), kiyayewa ta dace, lalacewar doka, tsawo, gyara, kamar yadda ya cancanta, cirewa ta dace, tsaftace, adanawa ko shirya don nisantar da gurɓata.
A cewar Hukumar Tsaro da Tsaro ta Majalisar Dinkin Duniya (OSHA), rashin lafiyar rashin lafiya ya fi dacewa da mutanen da ke cikin jama'a da kuma ma'aikatan kamfanin.
Ta ba da shawarar hanyoyin da za a bi don hana kamuwa da cuta ga duk wuraren aiki da ke wanke hannu da yawa da kuma ƙarfafa ma'aikata su zauna a gida idan suna da rashin lafiya da matsalolin numfashi ciki har da tari da farji, samar da tufafi da turɓaya, shirya don sadarwa ta nesa ko musayar sutura idan ya cancanta, gargadi ga ma'aikata kada su yi amfani da kayan aiki da kayan aiki tare da tsawaita tsaftacewa da tsabtace yanayin aiki.
Inganta ganowa da nisantar mutanen da ke da cutar wani muhimmin mataki ne na kare ma'aikata, abokan ciniki, baƙi, da sauran su a wuraren aiki.
Cibiyar Kula da Cututtuka ta Majalisar Dinkin Duniya (CDC) ta ba da shawarar cewa ma'aikatan da ke da alamun cutar su zauna a gida har sai sun sami sauƙi daga cutar, cutar ta cutar da sauran alamun aƙalla awanni 24 ba tare da amfani da maganin ragewa ko wasu magunguna ba, kuma lokacin da yanayin cutar ya daidaita, ba da damar ma'aikata su zauna a gida don kula da membobin iyalansu da ke rashin lafiya, da ma'aikata da aka sanar da su game da ƙa'idodin.
A cewar OSHA, haɗarin aikin na musamman ya haɗa da waɗanda ke da kusanci ko haɗari ga mutane masu tsawon ƙafa shida (1.8m) waɗanda ba su da COVID-19 ko kuma waɗanda ake zargi da cutar, amma sun kamu da SARS-CoV-2 ta hanyar jigilar jama'a ko ta hanyar tafiya ta ƙasa zuwa wani wuri da ke da COVID-19.
Wannan ya haɗa da ma'aikata da ke hulɗa da wuraren jama'a kamar makarantu, wuraren aiki na masana'antu ko hanyoyin sayarwa da sayarwa. Kula da injiniya don wannan da kuma rukunin haɗari masu haɗari da ke haɗawa da shigar da matatun iska mai inganci da ƙara yawan kayan aikin sanyaya da kuma shigar da hanyoyin kariya na likita kamar filastik mai rai da kuma shigar da sabis na taga mai ba da sabis ga abokan ciniki. Kula da hanyoyin don wannan da kuma rukunin haɗarin haɗari sun sa ma'aikatan da ke cikin gida su zauna a cikin ƙungiyoyi, inda masu kula da gidaje ke fuskantar haɗari, kafa ma'aikata masu canji da kuma kiyaye abubuwan da ba dole ba don kauce wa yiwuwar COVID-19, samar da tsarin kulawa da kuma kula da masu aiki, dabaru don kauce wa haɗarin haɗarin da ke tattare da COVID-19, da kuma samar da horo da horo a cikin ma'aikata da kuma yadda za a iya magance matsalolin da ke tattare da COVID-19 ta hanyar samar da kayan aiki masu dacewa da ke kare lafiyar ma'aikata da kuma kula da yanayin aiki, da kuma horar da ma'aikata da ma'aikatan kiwon lafiya da tsabta.
Ba a buƙatar ma'aikata a cikin waɗannan rukunin haɗarin su yi amfani da na'urar numfashi ba.
Idan mutum ya kamu da rashin lafiya a filin jirgin sama, ana iya yin matakan da suka dace don kare ma'aikata da fasinjoji, wanda ya haɗa da ware mai cutar daga sauran mutane da tsawon ƙafa 6 da kuma sanya wani daga cikin ƙungiyar don kula da mai cutar, samar da abin rufe fuska ga mai cutar, ko kuma neman mai kare baki da baki da mai cutar a asibiti yayin da yake yin cough da kuma shaƙa.
Kungiyar ma'aikata dole ne su sa rigar likitanci idan suna hulɗa da matafiyi mara lafiya ko ya sha ruwa ko ya ji ƙazanta, kuma su ƙara kayan kariya na sirri idan matafiyi mara lafiya yana da ciwon huhu mai tsanani ko na yau da kullum.
Dole ne a shirya kayan aiki da kayan kariya a cikin jakunkuna na roba, kuma dole ne a tsabtace da kuma tsabtace abubuwa masu datti. Don kasuwanni masu yawa, wanda ya haɗa da zirga-zirgar kasuwanci da jiragen ruwa, sarrafa lalacewa wanda ya shafi jinkirta tafiya lokacin da akwai rashin lafiya ko keɓewa na mutum ɗaya da kuma sanar da cibiyar likita kai tsaye idan wani ya kamu da cutar ko wasu alamun a cikin jirgin.
A matsayin misali, ana samun kulawa ta likita a gidan da aka keɓe. Makarantu da sassan kula da yara da CDC sun ba da izinin rufewa na ɗan gajeren lokaci don yin kwaskwarima ko rigakafi idan wanda ya kamu da cutar yana cikin ɗakin makarantar don la'akari da yaduwar jama'a.
Lokacin da akwai ƙananan ƙoƙari don rage ƙaurawar jama'a, ana iya aiwatar da hanyoyin nisantar da jama'a kamar yin jigilar balaguro da sauran manyan taro kamar ilimin likita ko taron addini ko cin abinci tare a cikin gidan abinci, ƙara tsawon lokacin tsakanin teburin da tsara balaguro da hutu na ɗalibai da iyakance balaguro marasa mahimmanci da amfani da wurin ofishin likita ga yara masu alamun cutar.
Lokacin da akwai gagarumar yaduwa a cikin al'umma, duk da kasancewa hanyoyin nisantar da jama'a, za a iya yin la'akari da hutun hutu na makaranta. Don dokar da hukumar ta ba da izinin aiwatar da ayyukan yau da kullun, CDC ta yi watsi da haɗarin lafiya kai tsaye.
An shawarci jami'an tsaro da za su yi hulda da mutanen da ake zargi da COVID-19 da su bi ka'idojin gaggawa na likita, wanda ya haɗa da kayan kariya na sirri.
Idan akwai kusanci a lokacin aiki, ma'aikata ya kamata su tsabtace bel ɗinsu da ƙafafunsu kuma suyi aiki don sake amfani da su, amfani da sabulu da kayan aikin tsabtace gida, da kuma amfani da daidaitattun hanyoyin tsabtace su. rage amfani da PPE da kuma tsabtace da wanke tufafi.
OSHA ta ba da tabbacin cewa ma'aikatan kiwon lafiya da ma'aikatan ɗakin mutuwa suna da haɗarin haɗari.
Babban haɗarin aiki wanda ya haɗa da isar da kulawa da kulawa da tallafi da kuma jigilar likitocin ma'aikata da aka sani ko ake zargi da cutar COVID-19.
Waɗannan ma'aikatan suna cikin haɗari idan ma'aikata suna amfani da kayan aikin iska ko tattara samfuran marasa lafiya ko waɗanda ake zargi da COVID-19.
Inji mai amfani da iska don shiga cikin makogwaro, injin mai motsawa, injin bincike na iska, injin bincike na haƙori, da na'urar gwaji ko kuma na alurar samfurori.
Babban haɗarin aiki a ɗakin gawa shine ma'aikatan da ke shirya gawawwakin da ke da COVID-19 a lokacin mutuwarsu; waɗannan ma'aikatan suna cikin haɗari idan suka yi aikin tiyata, ƙarin kula da injiniya ga waɗannan rukunin haɗarin yana ba da ɗakunan keɓewa ga marasa lafiya da ke da cutar ko kuma ana zargin COVID-19, lokacin da ake amfani da na'urar musayar numfashi.
Na'urar matsi na numfashi na iya zama mai dacewa a wasu wuraren kiwon lafiya da kuma bayan mutuwa.
Dole ne a yi amfani da samfuran da na'urar bincike ta 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawara ga marasa lafiya da su nisanci wuraren da ake jiran gwajin COVID-19 da ake zargi.
A cikin Majalisar Dinkin Duniya, NIOSH Advanced N95 Masks na Filter ko Ingantawa dole ne a yi amfani da su a cikin yankuna masu cikakken ƙarfi, rubutaccen shirin kariya na numfashi wanda ya haɗa da gwajin numfashi da horo da gwajin likita.
Sauran kayan aikin numfashi suna ba da ƙarin kariya da ci gaba ga ma'aikata. Hukumar Lafiya ta Duniya ba ta ba da shawarar rigunan rigar rigakafi ba kamar COVID-19 na numfashi amma ana iya watsa ta ta ruwa.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar kawai abin rufe fuska na tiyata ga kwamitin binciken marasa lafiya.
Ga waɗanda ke tattara samfuran numfashi na numfashi a cikin kulawa da jigilar marasa lafiya na COVID-19 ba tare da na'urar musayar iska ba, WHO ta ba da shawarar abin rufe fuska na tiyata, tabarau, kayan rufe fuska, kayan aikin likita da safar hannu.
Idan ana amfani da na'urar musayar respirator, ana iya canza abin rufe fuska na N95 ko FFP2.
Ganin cewa an yarda da taimakon PPE na duniya, WHO ta ba da shawarar rage buƙatun PPE don aika bayanai, hana hanawa kamar windows, ba da izinin shiga cikin ɗakin marasa lafiya na COVID-19 kawai ga waɗanda ke da alaƙa kai tsaye da kulawa, amfani da kayan PPE na musamman don takamaiman ayyuka, ci gaba da amfani da kayan aikin numfashi iri ɗaya ba tare da cirewa ba yayin lura da marasa lafiya ta hanyar gano cutar, sa ido da daidaita jerin kayan PPE, da ba da shawarar amfani da abin rufe fuska ga waɗanda ba su da alamun bayyanar cutar.
Daga: Kathryn Maher, Wikimedia Foundation Shugaba
Ga: Dukkanin ma'aikatan Gidauniyar Wikimedia.
Batun: [Covid-19] Rage al'amuran da ke faruwa da kuma shirya don nan gaba.
Ranar aikawa: 14/3/2020 a 00:24.
CC BY-NC-ND: Babu haƙƙin mallaka.
Za mu shiga wani yanayi na musamman a wannan wata.
Cutar COVID-19 ta kawo cikas ga haɗin kanmu na duniya da kuma alhakin da ya kamata mu ɗauka ga juna.
Ba mu da wani abin da za mu ce game da wannan ƙalubalen, amma mun san cewa mafi kyawun abin da za mu iya yi shi ne, mu haɗa kai da haɗin kai, kuma wannan shi ne abin da ya fi muhimmanci a wannan shirin.
Muna samun jinkai da kuma kulawa daga dukkan abokanmu a cikin imel da kuma tattaunawa ta waya da kuma tattaunawa ta yanar gizo, wannan babbar gudummawar al'umma ce da muke farin cikin yin aiki tare da ita.
Ba zan iya yin godiya da farin ciki fiye da yadda nake yi ba, a matsayina na abokin aiki.
A makon da ya gabata, wasu mutane sun yaba mana a kan aikinmu.
Kuma na yi tunani game da abin da wannan ke nufi ga duniya don samun Wikipedia a yanzu, don samun wannan alama mai ƙarfi a matsayin tushen yanar gizo da kuma samun damar kowa.
Ayyukanka suna sa abubuwa su faru, ko ta hanyar biyan kuɗin rukunin yanar gizonmu ko biyan kuɗin abokanmu ko kuma ta hanyar gudanar da ayyukanmu.
Duniya na bukatar bayanan da Wikipedia ke bayarwa yanzu fiye da kowane lokaci.
Yanzu ba abin da muke yi ba ne kawai, amma yadda muke yi ne ke yin tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aiki da kuma rawar da kuke takawa, za mu yi wasu muhimman gyare-gyare a yadda za mu yi aiki tare, za mu fara a wannan makon.
Tsarinmu da kuma tsarinmu na aiki
Kamar yadda Robin ya ambata a farkon, a daren jiya Cungiyar C ta haɗu don tattauna hanyarmu da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi tunanin cewa tunaninmu zai zama muhimmiyar amsa ga abin da muke fuskanta kuma zai zama hanya mafi kyau ta ci gaba da kasancewa a cikin ƙungiyarmu a wannan lokacin.
A mafi yawan lokuta, muna son mu ci gaba da wannan aiki na dogon lokaci.
Idan kana bukatar ka rage yawan abin da kake sha, babu matsala.
Ga dukkan ma'aikata, masu ba da gudummawa, da kuma ma'aikata:
A cikin kwanaki, muna aiki kusan awa 4, a cikin mako kuma muna aiki kusan awa 20.
Ba mu da hutu - idan za ka iya yin fiye da awa daya, aikin zai iya amfani da kai.
Ko ta yaya, a halin yanzu duniya tana cikin wani yanayi da ba za a iya tantancewa ba, kuma ko kana bukatar kula da ƙaunatattunka, zuwa kantin magani ko zuwa likita, lafiyarka ita ce babbar damuwarmu.
Ba za mu ɓata lokacinku ba.
Idan kana da rashin lafiya, kada ka yi aiki.
Ya kamata a yi shi ba tare da faɗin ba, amma mu ne muke faɗin haka.
Babu buƙatar rashin lafiya ko rashin lafiya, kawai ka sanar da manajan ka kuma taimaka wa ƙungiyar ka ta hanyar canza jadawalin aiki da jadawalin don tabbatar da cewa an gudanar da aikin yanki.
(Idan kana da COVID-19, ka kira Bryan a T&C Ops, T&C za su iya taimaka maka da tallafi da kuma tabbatar da cewa an kula da yanayin da ya dace da kai.)
Mutane suna samun cikakken kuɗin da suke samu a kowace awa.
Mun faɗi kuma muna maimaita cewa muna alfahari da aikinmu, abokan cinikinmu da abokan aikinmu.
Kowane mutum ana biyan sa a bisa yawan lokacin da yake aiki a lokacin da ake samun albashi na yau da kullum.
Wannan ya haɗa da waɗanda ba su da lafiya ko ba su da ikon yin aiki.
Idan kana son yin aiki, za mu tallafa maka.
Yawancin mutane suna amfani da aiki a matsayin hanyar da za su iya kawar da damuwa na duniya da ke kewaye da su.
Abin da muke iya bayarwa kyauta ne mai ban mamaki, musamman a irin wannan lokaci.
Bugu da ƙari, wannan ya shafi kula da kai.
Muna buƙatar ka yi magana da shugabanka, saboda haka za mu san abin da za mu yi tsammani da kuma abin da za mu iya daidaitawa bisa ga wannan.
Wasu ayyuka ana ɗaukar su a matsayin asali.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
Teams na SRE, HR Ops, Trust&Safety, Fundraising (da sauransu) suna yin mahimman ayyuka waɗanda ke iya buƙatar tallafi.
Za mu fara aiki tare da dukkan sassanmu don daidaita manufofinmu na yanzu kuma mu mai da hankali kan haɗin gwiwar da ke da mahimmanci ga aikinmu.
Dukkanmu muna da ayyuka da yawa da za mu yi, kuma muna mai da hankali ne kawai ga ayyuka masu muhimmanci.
Hutu yanzu ba zai cutar da ku ba nan gaba.
Ba za mu sake yin wani abu ba, "a sake gwadawa" da zarar an kawar da cutar.
Ba za mu yi wani aiki ba don samun lasisi wanda yanzu ya zama abin ƙyama da rashin dacewa.
Mun yarda da cewa yanayin ya canza, kuma muna aiki don kafa sabbin manufofi da kuma lokacin da ya dace.
Me ke faruwa da APP?
Don daidaita sabon aikinmu da lokutan aiki na yau da kullun, muna buƙatar daidaita jadawalin lokaci don isar da shirinmu na shekara-shekara na 2020-2021.
Muna da niyyar bayar da shawarar inganta tsarin 2019-2020 wanda zai ba mu ƙarin lokacin da za mu iya tattara kuɗi don ba da damar ma'aikata suyi aiki mai mahimmanci da kula da kansu da kuma kula da ƙaunatattunmu yayin taimaka wa waɗanda suke cikin buƙata su rage jadawalin aikin su na makonni masu zuwa.
Wannan tsari na haɓaka yana rage nauyin tsarin aiki na yanzu da kuma sanya matsi a kan dukan ƙungiyoyi.
Za mu gabatar da shawarwarinmu ga majalisar a mako mai zuwa, kuma za mu yi gyare-gyare ga wakilanmu da kuma tawagarmu a mataki na gaba.
Godiya ga ƙungiyar APP don gudanar da wannan.
Ofishin Yanayi, Hadari da Tsarkakewa
A makon da ya gabata, mun sami labarin cewa ɗaya daga cikin abokan aikin FS-based na iya kamuwa da COVID-19.
Ba tare da saninmu ba, mun kafa wata tawagar tsabtace muhalli don su tsabtace dukkan fuskokin ofisoshinmu na San Francisco.
Sun yi amfani da maganin rigakafin cutar a asibiti don tsabtace dukkan fuska, da dakunan jiran aiki da kuma ɗakunan ɗakunanmu.
Gidan yana da masu kula da lafiyar da ke kula da lafiyar ma'aikatansa.
Mun samu kwanciyar hankali cewa ofishin yana shirye sosai a lokacin da muka yanke shawarar dawowa.
Ofishinmu na DC yana cikin WeWork, wanda ya ba mu da duk ma'aikatan DC umarnin likita na COVID-19.
A cikin makon da ya gabata, ofishin DCman ya koma zuwa wani sabon wurin da aka gina a San Francisco.
Kamar yadda wasu daga cikin abokanmu a NYS suka sani, muna tattaunawa kan batun hayar wani wuri a Brooklyn.
Ana ci gaba da wannan tattaunawar amma ana iya jinkirta ta.
Wasu abokanmu suna aiki daga gida a karon farko.
Ma'aikata na dogon lokaci da ke aiki daga gida sun san cewa hakan na iya zama matsala, kuma muna so mu ba ku wasu shawarwari:
Ka ƙayyade lokacin da za ka yi aikinka ya zama sa'a ɗaya ko biyu.
Idan ana buƙatar taro mai tsayi, yi la'akari da yadda za a kammala karatun a cikin kwanaki da yawa.
Bayyana taron a fili, yi taswirar yadda za a yi, da kuma gabatar da darasin.
Matsaloli suna da sauƙi ta hanyar bidiyo, tare da Google Docs da Xoom don sauƙaƙe haɗin kai da sadarwa kai tsaye.
Sanya mai gudanarwa don sauƙaƙe duk tarurruka, sanya mutum don kula da hira don tambayoyi da kuma yin rajistar masu magana, da kuma wani don karɓar bayanan kula (ko taimakawa karɓar bayanin kula).
Aika imel zuwa ga masu goyon bayanmu idan kana bukatar wani wurin zama mai kyau.
Yi amfani da abubuwan da aka sa a gaba don kiyaye abinci.
Yi amfani da tashoshin Stack don tattaunawa da ma'aikatanka game da aiki mai rarraba.
HR aiki tawagar yana da wani m e-aiki tsari don taimaka wajen bunkasa hadin gwiwa aiki a cikin wani ma'aikata.
A cikin makon da ya gabata, mun yi kira ga dukkan masu ba da gudummawa da su guji duk wani aikin tallafi na jama'a na Wikimedia, kamar gyara bayanai, har sai WHO ta sanar da ƙarshen annobar.
Muna gaya musu cewa mun fahimci cewa buƙatarmu don ƙin yarda da sauran alƙawura na iya sa ya zama da wuya a kammala ayyukan ba da gudummawa, kuma babu wanda zai iya jinkirta ko canza burin su.
A cikin makonni masu zuwa, za mu ci gaba da bin ƙa'idodin da aka ƙara wa Wikimedia, taron yanki da sauran labarai.
Babban jami'in a cikin kungiyar ta duniya ya ce yana bakin ciki da halin da ake ciki amma yana jin daɗin samun damar mayar da hankali ga ƙungiyoyin su da Wikimedia da kuma akasin haka.
A ci gaba, CRT na aiki don sanya shafi a kan Meta-Wiki don samar da sarari ga ƙungiyar don lura da tasirin da kuma raba hanyoyin sadarwa tare da su.
Rashin aiki a cikin al'amuran da suka shafi COVID-19
Za mu gayyaci mai lissafin ku zuwa taron ma'aikata na musamman kowace Alhamis da ƙarfe 14:00UTC ko 07:00PT.
Za mu yi amfani da wannan lokacin don tura muku sabuntawa, amsa tambayoyinku, da kuma yin hira da juna.
Muna nan tare, kuma muna nan don mu taimaka yadda za mu iya.
A lokacin da ya dace, za mu iya ci gaba da neman bayanai a cikin wannan imel ɗin, da kuma duk bayanan da suka shafi COVID-19 a ofishin Wikimedia.
CRT tana sabunta waɗannan shafuka da bayanai a kai a kai a wuri guda.
Muna kuma aiki don ci gaba da hulɗa da hukuma tare da ma'aikatan da za su kasance a ƙasashen da cutar ta auku.
Idan kana da wata tambaya game da tafiye-tafiye, abubuwan da suka faru, nau'ikan ayyukan e-commerce ko ƙididdigar ƙira ko wani abu da za ka iya buƙatar taimako, don Allah kada ka yi jinkirin tuntuɓar CRT.
Muna nan don taimaka maka wajen samar da tallafi da taimako kamar yadda ake bukata.
Idan kana da wata matsala mai mahimmanci ko sirri, don Allah a aika imel zuwa ga mai kula da ayyukan HR na Kamfanin New Nation Global.
Babu wani daga cikin waɗannan canje-canje da ya kamata a ɗauka a matsayin barin aikinmu.
Maimakon haka, sun manta cewa a wannan lokacin, aikinmu da kuma son kai ya zama dole don mu iya yin aiki da yanayin da ba mu taɓa gani ba.
Waɗannan su ne matakan da muka yi imanin ya kamata mu ɗauka don mu tallafa wa juna, don mu ci gaba da aiki, don ba da taimakon da ake bukata, da kuma ayyukan da duniya ta dogara da shi.
Aikin da muka tsara zai yi daidai da lokacinsa.
Yanzu ne lokacin da za mu hada kai da juna, mu samar da wani wuri don muhimman ayyukan da za a yi a cikin kwanaki da watanni masu zuwa.
Muna bukatar ku don yin wannan aiki, kuma muna bukatar ku don kula da kanku da kuma iyalanku, don haka ya kamata ku kasance a cikin mafi kyawun yanayin da za mu iya kasancewa a lokacin da muke bukatar ku.
Yanzu, don Allah ku wanke hannuwanku kuma kada ku shafa fuskarku.
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gergory V, Jamine V, Lynette L, Ryan M, da Tony S), da sauran masu gudanarwa na ƙungiyar (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Ryan M, da Toby N)
Angiotensin-converting enzyme 2 (ACE2) wani enzyme ne wanda aka kafa a cikin farfajiyar sel na huhu, jijiyoyin jini, zuciya, koda da hanji.
ACE2 yana hana ayyukan ACE mai haɗin gwiwa ta hanyar rage yawan angiotensin II da haɓaka Angiotensin-1-7 wanda ke sa shi zama magani mai mahimmanci don magance cututtukan zuciya. ACE2 kuma yana da amfani a matsayin ƙofar shiga cikin sel don wasu coronaviruses.
Tsarin ɗan adam na enzyme ana yawan bayyana shi azaman hACE2.
An bayyana zinc-containing angiotensin-beta-enzyme a kan ciki na ciki na tubules da sauran kwayoyin halitta.
ACE2 yana ƙunshe da N-transferase na M2 protein peptide da C-transferase wanda ke haɗe da amino acid mai mahimmanci.
ACE shine kawai nau'in I na furotin, tare da enzyme mai aiki a kan mai karɓar mai karɓar mai karɓar a cikin ƙwayoyin huhu da sauran nama.
An cire mai karɓa daga ACE2 daga mai karɓa mai karɓa, mai karɓa mai karɓa, wanda ake kira P-enzyme, kuma ya zama furotin mai mahimmanci a cikin jini kuma ya fita daga cikin fitsari.
ACE2 yana samuwa a cikin yawancin kwayoyin halitta: ACE2 yana da alaƙa da ƙwayoyin cuta na ƙwayoyin cuta na musamman na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, da ƙwayoyin cuta na ƙwayoyin cuta.
Hakanan ana samun bayanin ACE2 na mRNA a cikin gaba na kwakwalwa, a cikin tsakiyar kwakwalwa, a cikin kwakwalwa, da kuma a cikin kwakwalwa.
Ainihin aikin ACE2 shine daidaita daidaito na ACE.
ACE yana haifar da karuwar angiotensin II a cikin jini.
ACE2 yana ɗaukar carboxyl-termial amino acid phenylalanine daga angiotensin II (Asp-Arg-Bal-Tyr-IIe-His-Pro-Phe) yayin aiki biyu kuma yana haɗa shi cikin hydrolyses na angiotensin vasodilator (1 - 7, H-Asp-Arg-Val-Tyr-Lle-His-Pro-OH).
ACE2 kuma na iya haɗuwa da wasu wasu peptides kamar su -[des-Arg9] bradykinin, apelin neurotensin, dynorphin A, ghrelin.
ACE2 kuma yana daidaita yawan amine acid mai narkewa SLC6A19 kuma an gano shi a cikin cutar Hartnup.
A matsayin furotin mai ɗaukar hoto, ACE2 yana aiki a matsayin babban hanyar shiga cikin ƙwayoyin cuta don wasu coronaviruses, kamar HcoV-NL63; SARS-CoV (wannan kwayar cuta ce ke haifar da cutar SARS); da SARS-CoV-2 (wannan kwayar cuta ce ke haifar da COVID-19).
Aƙalla, haɗuwa da rubutun S1 na SARS-CoV da SARS-CoV2 sunadaran don rage ACE2 a kan sel, yana haifar da canjin babban mai maye gurbin duka biyu da kwayar cutar da kuma enzyme a cikin endosomes na cikin sel.
Ana tsammanin rage matakan ACE2 a cikin ƙwayoyin zai iya taimakawa wajen yaki da cutar.
Koyaya, wasu ƙungiyoyin kwararru da masu motsa jiki suna ba da shawarar ci gaba da daidaitaccen rage ACE da maganin ARB.
An yi amfani da hanyar bincike da haɓaka mai zurfi wanda aka buga a ranar 11 ga Satumba, 2020, inda aka gano "amfani da ACE mai haɓaka yana da mahimmancin kashi 34% na haɗarin haɗarin haɗari idan aka kwatanta da iko".
Bugu da ƙari, " haɗarin kamuwa da cutar huhu mai tsanani ya ragu a cikin marasa lafiya da aka yi wa maganin ACE inhibitors, musamman waɗanda suka kamu da bugun jini da rashin zuciya.
Yin amfani da ACE inhibitors ya taimaka wajen magance cutar huhu ta huhu da ke da alaƙa da cutar AIDS, kodayake sakamakon ba shi da lafiya fiye da haɗarin cutar huhu.
Halitta na mutum (rhACE2) an bada shawarar zama sabon magani don raunin huhu mai tsanani, kuma an nuna cewa yana da tasiri ga cutar huhu da rashin iskar oxygen a cikin jariri tare da lipopolysaccharide- yana da tasiri a cikin alamun cututtuka na matsanancin numfashi.
Rabin rayuwar ErhACe a cikin mutum yana da kusan awanni 10 tare da aiki ɗaya na minti 30 da kuma tsawon lokaci na aiki na awanni 24.
Wasu daga cikin binciken sun yi hasashen cewa rhACE2 zai iya zama tabbataccen magani ga waɗanda ke da rigakafin tsarin angiotensin-α (RAS inhibitor) ko kuma an yi musu allurar rigakafin cutar cikin asibiti don cutar ta tsananin cutar huhu.
COVID-19 Apps aikace-aikace ne na wayar hannu da aka tsara don taimakawa wajen bin diddigin mutane a cikin hulɗa da cutar ta 2019-20 coronavirus, misali gano mutanen da suka yi hulɗa da waɗanda suka kamu da cutar.
An haɓaka da kuma samar da shirye-shirye da yawa, tare da tallafin gwamnati a wasu yankuna da wuraren da doka ta tanada.
An kuma inganta wasu daga cikin ayyukan da aka yi don gina haɗin gwiwar haɗin gwiwar.
An tayar da damuwa ta musamman, musamman game da tsarin da ke da mahimmanci don gano wurin da masu amfani da software suke.
Ƙananan keɓaɓɓun abubuwa da matakai kamar amfani da siginar Bluetooth don shiga cikin abubuwan sirri da sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su yi aiki tare don tallafawa aikace-aikacen Bluetooth da aka sanya don aiki cikakke a kan Android da iOS.
A China, gwamnatin China, tare da kamfanin Alibaba, sun haɓaka aikace-aikacen da ke ba da damar jama'a su bincika ko sun yi hulɗa da mutanen da suka kamu da cutar COVID-19.
Ana amfani da su a birane sama da 200 na kasar Sin. A Singapore, ana amfani da wani shiri mai suna Trace the Extension.
An haɓaka, an shirya kuma an gabatar da shi ga ƙungiyar IT, kuma nan ba da daɗewa ba za a gabatar da shi ga gwamnati. Kamfanin Arewacin Macedonia na "Stop Corona" Bluetooth shine babban aikace-aikacen don gano mutanen da suka kamu da cutar da kuma samar da saurin amsawa ga hukumomin kiwon lafiya.
An haɓaka shirin ne ta hanyar Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya.
A ranar 14 ga Afrilu, 2020, an cire shi daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta ba da sanarwar cewa shirin bincike na baya-bayan nan na baya-bayan nan na ci gaba ne, kuma zai kasance ga masu amfani a cikin mako guda. Irin wannan an shirya a Ireland da Faransa (a "Covid Prevention").
Australia da New Zealand suna yin shirye-shirye na bin Singapore da yarjejeniyar Bluetooth.Rashawa na son gabatar da shirin gano wuri ga marasa lafiya da aka gano da COVID-19 da ke zaune a Moscow, an tsara shi don tabbatar da cewa ba a bar marasa lafiya a gida ba.
Ross Anderson, injiniyan tsaro a Jami'ar Cambridge, ya bayyana wasu daga cikin matsalolin da ke tattare da tsarin tsarin, ciki har da, rashin daidaituwa da kuma rashin yiwuwar tasiri idan an ƙayyade aikin da aka ba da shi ga ƙananan ƙananan mutane.
Da yake akwai damuwa game da ɓacewar ko kuma ɓarna na aikace-aikacen da ke da nasaba da cutar coronavirus, Apple ya sanya ƙuntatawa ga nau'ikan kamfanoni da ke ƙarawa da kuma sauke aikace-aikacen da ke kama da cutar ta coronavirus a kan App Store. Wannan ƙuntatawa ya shafi "mafi yawan" kamfanoni da kuma "mafi yawan" kamfanoni.
Google da Amazon sun haɗa kai don hana irin wannan.
Masu fafatawa sun nuna damuwa game da matsalolin da ke tattare da kula da amfani da shirin coronavirus, musamman game da ko kula da ingantattun kayan aikin da aka gina don magance cutar ta coronavirus zai iya zama mai sauƙi da zarar barazanar ta ƙare.
Kungiyoyin kasa da kasa da kungiyoyi 100 sun sanar da abin da ake kira da'awar da za a takaita irin wannan takaitawa.
Kungiyoyin sun bayyana sharudda guda takwas kan ayyukan gwamnati:
Dole ne a yi daidai da "doka ta cika. Bukatar daidai".
Ƙarin kulawa da hankali ya kamata a bayan faɗuwar rana;
Ya kamata a takaita amfani da bayanai saboda COVID-19;
Tsaron bayanan da rashin suna dole ne a kiyaye su kuma a tabbatar da cewa an kiyaye su;
Masu sa ido na dijital dole ne su guji yin ɓarna da nuna wariya da nuna bambanci;
Duk wani bayar da bayanai ga wani ɓangare na uku dole ne a bayyana a cikin dokoki;
Dole ne a sami jami'an tsaro don amsa zalunci da kare 'yancin jama'a;
Ana buƙatar sa hannun mai ma'ana daga dukkan "masu ba da bashi", tare da ƙwararrun masu ba da agaji na kiwon lafiyar jama'a da ƙungiyoyi marasa ƙarfi. Kwamfuta ta ƙungiyar CCC ta Jamus, da kuma Reporters Without Borders (Reporter von Greinzen) (RSF) an kuma shirya su don yin kuskure.
A cikin shirin da Google da Apple suka gabatar, an yi imanin cewa za su magance matsalar sa ido ta hanyar cire tsarin sa ido daga tsarin aikin wayoyin hannu lokacin da ba a buƙatarsa.
Wasu ƙasashe suna amfani da intanet na tushen saka idanu maimakon aikace-aikace, cire duka biyun yana buƙatar saukar da software, da ikon dakatar da sa ido.
An ba da izinin amfani da intanet mai sarrafawa a Isra'ila.
Intanet ta dogara ne akan magance matsalar ɓoye bayanan bayanai na sararin samaniya da kuma matsala na ɓoye bayanan sirri.
Duk da haka, ba kowane tsarin da cibiyar sadarwar uwar garken da ake amfani da su ba ne ke da damar samun bayanan wurin mutum; an tsara tsarin tsare sirri da yawa wanda ke amfani da cibiyar sadarwar uwar garken don sadarwa da juna (duba ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba na software ba don gudanar da ayyukan sa ido na sadarwa.
Maimakon yin amfani da wani software, tsarin zai tattara bayanan da aka sa ido daga wasu kafofin daban-daban kamar bayanan wayar da aka sa ido da kuma bayanan katin da aka sarrafa, kuma ya haɗa su don gano wani bayanin kula a cikin wasikun da aka rubuta ga mutanen da aka sa a ɓoye.
Baya ga amfani da wannan bayanan don sanin hanyoyin sadarwa na sirri, gwamnati ta kuma sanya bayanan bayanan ta ga jama'a, wasu abubuwa an ba da izini don samun damar canje-canje a cikin dokokin bayanan sirri bayan ɓarkewar MERS a cikin ƙasar.
Wannan bayanin yana samuwa ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo da yawa. Kasashen da suka yi amfani da su kamar Jamus suna amfani da duka masu amfani da masu amfani da masu amfani da masu amfani da masu amfani da masu amfani da su.
Wannan ya faru ne a ranar 6 ga Afrilu, 2020, ba a ba da cikakken bayani ba.
Kula da kiyaye alaƙar sirri yana da kyau a kafa, tare da babban rukunin bincike na adabi wanda ya koma aƙalla 2013. A ranar 7 ga Afrilu 2020, ƙungiyoyi da yawa na ƙwararru suna aiki don magance ƙarancin abokantaka, kamar amfani da Bluetooth Low Energy (BLE).
Duk da haka, PEPP-PT ne mai tsarawa damar da cewa yana da biyu mai tarawa da kuma na'urar sarrafawa, da kuma daya ba daftarin aiki. The na'urar sarrafawa daftarin aiki sun hada da m tsare-tsaren (DP-PPT / D-3t), na wucin gadi lamba lambobin sadarwa (TCN, bazuwar lamba lambobin sadarwa (FKA), FKA, CEN), da kuma na'urar sarrafawa da kuma na'urar sarrafawa da lambar sadarwa ta hannu (PACT) da sauransu.
A cikin waɗannan ƙa'idodin, bayanan sirri ba ya fita daga na'urar, duk abubuwan da aka daidaita suna faruwa a cikin na'urar.
Groupungiyoyin masu zaman kansu a MIT Media Lab suna haɓaka "Safety Ways", dandamali don amfani da dabarun adana bayanan sirri yayin tattarawa da amfani da bayanan wuri ko hanyoyin da aka tsara don lura da yaduwar COVID-19.
Wani bincike da White House ya samo daga wani littafi mai suna "The Walking Dead Program: Protecting Privacy in the ... " da aka buga a watan Maris na 2020. Wani irin wannan bayani shi ne tsarin tsaro na Enigma MPC, kamfanin da ke samar da fasahohin sirri wanda aka kafa a MIT Media Lab.
Tsare-tsaren tsaro yana amfani da fasahar tsaro ta tsaro don bawa masu amfani damar raba bayanai masu mahimmanci da kuma bayanan kiwon lafiya tare da sauran masu amfani da hukumomi, ba tare da yin watsi da bayanan sirri ba.
A ranar 5 ga Afrilu 2020, an kafa TCN ta duniya ta ƙungiyoyi waɗanda ke aiki a kan abin da ke da mahimmanci iri ɗaya na ƙa'idodin ƙa'idodi masu yawa, tare da manufar rage haɓakawa da kiyaye duniya don amfani da musayar bayanai ta tsarin software zuwa software mai sa ido da masu faɗakarwa,
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta ba da sanarwar cewa ta buɗe tushen * BlueTrace, yarjejeniyar da software na hukuma ke amfani da ita.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke kula da Android da iOS, sun ƙaddamar da wani sabon tsarin sa ido na haɗin kai, wanda suka yi imanin yana kare sirri, bisa haɗin haɗin Bluetooth Low Energy da kuma kiyaye ɓoye.
Sun kuma bayyana fasalin fasahar da ke cikin tsarin da aka yi amfani da shi.
A cewar Apple da Google, an tsara tsarin don yin aiki a matakai uku:
Matsayin da za a iya amfani da shi don hana gwamnati ta aiwatar da shirye-shiryen kula da lafiyar lafiyar da ke tattare da cutar coronavirus
The sikelin da aka kai tsaye alaka da ISO da Android, da kuma Apple ya shirya ya dauki shugabanci ga inganta da kuma ci gaba da m lura da matsaloli da farko shiga cikin tsarin ta hanyar da sabon browser, sa'an nan kuma sake dawo da shi a cikin wannan hanya a lokacin da barazana ne tafi.
Magungunan maye gurbin magani (wanda aka fi sani da sake amfani da shi, sake amfani da shi, sake amfani da shi ko kuma sake amfani da shi) yana nufin sake amfani da maganin da aka yarda da shi don magance wata cuta ko yanayin kiwon lafiya daban-daban, wanda aka tsara shi da farko.
Wannan shine ɗayan binciken kimiyya da ake bi yanzu don ƙirƙirar ingantaccen magani mai inganci ga COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka allurar rigakafi da kuma yin amfani da jinin da aka warke. SARS-CoV-2 ya ƙunshi kusan 66 na sunadarai masu iya zama magani, wanda ya ...
Nazarin wannan rukunin yanar gizon yana ba mu damar haɓaka aikin don haɓaka magungunan rigakafin da ke da tasiri ga sunadarai na COVID-19
Abubuwan da aka gano sun fi dacewa da SARS-CoV-2 sun hada da Papilin-like, RNA mai ɗaure RNA mai ɗaure RNA, Heli-case, S-protein, da ADP ribophosphate.
All A, ET all studies with selected compounds are then optimally used and analyzed to approximate their skeletal function with the strongest analogues available. Anan an yi amfani da maganin da aka samu na anti-SARS-CoV2 a cikin ci gaban cibiyar kiwon lafiya don a ba da shawarar a cikin tsarin binciken cibiyar kiwon lafiya.
Chloroquine magani ne na antimalarial wanda kuma ana amfani dashi don magance wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine sun kasance cikin magunguna huɗu da ake bincika a matsayin ɓangare na tallafawa gwajin asibiti.
Gwamnan New York Andrew Cosmo ya sanar da cewa jihar New York za ta fara gwajin chloroquine da hydroxychloroquine a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da sulfur hydroxychloroquine da chloroquine phosphate a ƙarƙashin Dokar Amfani da Gaggawa (EUA).
Ba a yarda da maganin ba ta hanyar gwajin asibiti na FAD, kuma an ba da izinin EUA kawai don magance gwaji na gaggawa na marasa lafiya waɗanda aka yi wa allurar rigakafi amma ba za a iya magance su ba a cikin gwajin asibiti (a cikin hanyar gwaji).
CDC ta ce "Amfani, magani, ko lokacin hydroxychloroquine don kariya ko murmurewa daga SARS-CoV-2 cutar" ba a tantance ba.
Likitocin sun ce suna amfani da magunguna ne kawai idan "babu wani zabi".
Wata ƙungiyar bincike a Turkiyya tana gudanar da wani bincike a kan amfani da chlorine a haɗe da zinc, bitamin A, bitamin C, da kuma wani bincike a kan amfani da chlorine a haɗe da zinc, bitamin A, bitamin C, da kuma bitamin D.
Akwai babban bincike da ake yi a jami'ar Duke da kuma jami'ar Oxford.
Makarantar Likitancin NYU na Langone tana gudanar da gwaji kan aminci da ingancin maganin hydroxychloroquine.
Gwajin da aka yi a dakin gwaje-gwaje na kasar Sin a Wuhan da Shenzhen
35 daga cikin marasa lafiya a Shenzhen sun nuna rashin lafiya a cikin kwanaki 4, yayin da tsawon lokacin cutar ya kai kwanaki 11 a cikin marasa lafiya 45 da ba a yi musu magani ba.
A wani binciken da aka gudanar a Wuhan na masu fama da ciwon huhu 240, rabi sun sha favipiravir, rabin kuma sun sha umifenovir. (Lura: Waɗannan magungunan ƙwayoyin cuta ne.)
Ƙungiyar Kula da Magungunan Italiya ta Italiya ta ba da tabbaci ga jama'a cewa ba a ba da isasshen magani ba.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magungunan daga Japan don ajiyar su, kuma za ta yi amfani da sojojinta don kai magungunan zuwa asibitocin jami'o'i, inda za a yi amfani da su don kula da masu cutar COVID-19.
A cewar wani rahoto da aka samu a safiyar yau, Shugaba Shenzhou Abe ya gargadi shugaban kasar Trump game da sayar da maganin. Wannan maganin zai iya zama mai saukin kamuwa da cutar a lokacin da cutar ta fara bulla.
Saboda haka, ba zai iya zama lafiya ga mata masu ciki ko waɗanda suke son zama masu ciki ba.
Labari game da Lipinavir/Ritonavir (Calitra) Bayani game da: Lipinavir/Ritonavir wani nau'in magani ne wanda aka sayar a ƙarƙashin sunan Calitra wanda aka yi amfani da shi a cikin maganin cutar kanjamau da sauran cututtukan da ke haifar da ƙwayar cuta, ana samar da haɗin magungunan kwayar cutar Lopinavir da Ritonavir, wanda aka nuna "Ba a lura da fa'idodi masu yawa ba"
An tsara kwayoyi don magance nau'ikan kwayar cutar HIV ta hanyar sanyawa a cikin kwayoyin da ke ɗaure da ƙwayoyin cuta.
Wata ƙungiyar masu bincike a Jami'ar Colorado tana ƙoƙarin canza magungunan don gano wani fili wanda ke rubuta kwayar cutar SARS-CoV-2 proteinase enzyme.Akwai wasu zargi a cikin ƙungiyar kimiyya game da tura albarkatu zuwa sababbin magunguna musamman waɗanda aka haɓaka don HIV/AIDS.
WHO ta ɗauki lopinavir/ritonavir a cikin gwajin gwajin duniya.
Glided Science ya kirkiro Remdesivir kuma ya ci gaba da shi a matsayin maganin cutar Ebola da cutar Marbaugh. Glided Science ya gano cewa Remdesivir yana da aikin antiviral a cikin in vitro akan cutar Fila, Pneumonia, Paramyxovir, da kuma Coronavirus.
Matsalar da ke tattare da maganin ƙwayoyin cuta ita ce, haɓakar rigakafin da ke faruwa a cikin kwayar halitta a kan DNA na iya haifar da cututtuka da cututtuka masu haɗari.
Wasu daga cikin binciken farko sun ba da shawarar cewa Remdesivir yana da tasiri sosai a cikin rigakafin. Akwai wasu gwaji da ke gudana, biyu daga cikinsu an ba da shawarar ta Cleveland University Hospital; ɗaya don mutanen da ke da matsakaicin rauni, ɗayan kuma don waɗanda ke da rauni.
Akwai gwaji uku na asibiti don bitamin C don amfani da jini ga mutanen da ke cikin asibiti ko marasa lafiya saboda COVID-19; biyu ana sarrafawa (Cina, Kanada) da kuma wanda ba a sarrafawa (Italiya).
Jihar New York ta fara gwajin gwajin cutar Azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya ta Japan (NCGM) tana shirin gudanar da gwajin asibiti na Alvesco's Teijin's cyclesonide, wani maganin inhalating corticosteroid na huhu, don magance marasa lafiya da ke da alamun farko na kamuwa da sabon coronavirus.
An yi amfani da angiotensin-like enzyme-mutuwa 2, maganin na 2 don gano yadda marasa lafiya 200 ke da mummunan yanayi, a asibitocin Denmark, Jamus da Austria don gano tasirin maganin.
Masu bincike a Cibiyar Kula da Jini ta Montreal a Kanada suna ci gaba da gwaji kan rawar colchicine a rage kumburi da cututtukan huhu a cikin marasa lafiya da ke fama da alamun COVID-19 na rashin lafiya.
An kira gwajin COLCORONA, wanda ke kula da mutane 6,000 masu shekaru 40 ko sama da haka waɗanda aka gano suna da COVID-19 ko kuma suna da alamun bayyanar cututtuka waɗanda ba sa buƙatar asibiti.
Mata masu juna biyu ko masu shayarwa ko waɗanda ba su da maganin hana daukar ciki mai inganci ba za su iya yin amfani da wannan maganin ba.
Ana gwada magungunan anticoagulants da yawa a Italiya.
Antimetabolic an yi amfani da shi don magance cututtuka, kuma ci gaba da likitocin Italiya ya kafa dokoki don yadda ake amfani da shi.
An sanar da gwajin gwaji na 300 na marasa lafiya don nazarin ingancin enoxaparin sodium a cikin kulawa da amfani da magani a Italiya a ranar 14 ga Afrilu.
Tun lokacin da aka gano SARS-CoV-2 a matsayin kwayar cuta, binciken kimiyya ya mai da hankali kan sauya magungunan rigakafin rigakafi da aka amince da su a lokacin barkewar cututtuka kamar MERS, SARS, da West Nile.
Ribavirin: Ribavirin an ba da shawarar don maganin COVID-19 bisa ga umarnin da aka bayar a cikin littafin 7.
Amfenovir: Amfenovir an ba da shawarar don maganin COVID-19 a ƙarƙashin Dokar SENI shafi na 7.
Wasu daga cikin maganin rigakafin da aka gano a matsayin maganin ɓoye na COVID-19:
Toselisamide (IL-6 anti-receptor): An karɓa daga Sin.
Hakanan duba gwaji a Italiya da China. da Tocilizumab # COVID-19
Allurar COVID-19 allurar rigakafi ce da ake tsammani don cutar coronavirus 2019 (COVID-19).
Duk da cewa babu wata riga-kafi da ta kammala gwajin asibiti, akwai wasu da yawa da ke kan ci gaba don samar da allurar rigakafi.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ba da sanarwar cewa ba za ta yi tsammanin samun allurar rigakafin SARS-CoV-2, cutar da ke haifar da cutar ba, a cikin ƙasa da watanni 18.
An zaɓi alluran rigakafi biyar a cikin binciken farko na aminci a watan Afrilu.
An gano COVID-19 a cikin Disamba 2020.
Yawancin barkewar cutar a duniya a cikin 2020 zai haifar da saka hannun jari da bincike don haɓaka allurar rigakafi.
Yawancin ƙungiyoyi suna amfani da ilimin halittar halitta da aka kafa don haɓaka allurar rigakafin SARS-CoV-2.
A watan Afrilu, an sanar da mahimman buƙatun ci gaban CEPI don haɓaka allurar rigakafi wanda ya haɗa da saurin, iyawa, sarrafa kayan aiki da haɗin kai na duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da sanarwar cewa an gudanar da bincike kan fasahohi 10 daban-daban na dandamali don samar da ingantaccen allurar rigakafin COVID-19 a farkon 2020.
Akwai dandamali da yawa da aka ƙaddamar da su a cikin binciken lafiya na 1 wanda ya haɗa da:
Kwayoyin DNA da RNA (Mataki na 1 mai haɓaka da zaɓi na zaɓi: moderna, mRNA-1273)
Kwayar cutar mai niyya (mai haɓaka matakin 1 da allurar rigakafi: CanSino Biologics, adenovirus mai niyya na 5.
Kamar yadda masana kimiyya na CEPI suka sanar a watan Afrilu, an zaɓi adadin allurar rigakafi 115 a farkon matakan ci gaba, kuma an ƙaddamar da 78 a matsayin ayyukan aiki (da aka yi a Cibiyar Milken), tare da wasu 37 da ba a sanar da su ba, amma tare da karancin wadatar jama'a (wanda aka shirya ko tsara).
Mataki na 1-2 gwajin gwaji yana samar da aminci na farko da gwajin rigakafin cutar, yawanci gwajin gwaji, magani mai aminci da kuma samun nasara a bangarorin biyu, yayin da aka tsara magunguna a cikin mafi ƙayyadadden tsari, mafi inganci.
Gwajin lokaci na 3 yawanci yana da ƙarin mahalarta, wanda ya haɗa da rukunin kulawa da kuma nazarin tasirin allurar rigakafi don hana cutar yayin da ake lura da illa daga shan magungunan.
Daga cikin alluran rigakafin da aka zaɓa 79 a cikin ci gaba mai aiki (an ƙaddamar da su a farkon Afrilu 2020), 74 ba su kasance a matakin kimantawa na ɗan adam ba (har yanzu suna cikin bincike).
A ranar 24/1/2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken wani ɓoyayyen ƙwayar cuta na allurar rigakafi wanda ke canza sunadarai na ƙwayoyin cuta don haifar da amsa mai karewa.
A ranar 24 ga watan Janairun 2020 a Kanada, Cibiyar Alurar riga kafi ta duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aiki a kan allurar rigakafin, da nufin fara allurar rigakafin mutane a 2021.
An sanar da ayyukan ci gaban allurar rigakafi daga Cibiyar Kula da Cututtuka da Cututtuka na Sin City a ranar 26/1/200, da kuma Jami'ar Hong Kong a ranar 28/1/2020.
A ranar 29 ga watan Janairun 2020, Janssen Pharmaceutical, wanda Hanneke Schuitemakr ya jagoranta, ya sanar da cewa ya fara aiki a kan samar da rigakafin.
Janseem shine kamfanin da ke haɓaka allurar rigakafi mai aiki tare da abokin haɗin gwiwar fasahar kere kere, Vaxart.
A ranar 18 ga Maris, 2020, New Biotherapy ya sanar da haɗin gwiwar kasuwanci tare da Vaxart don haɓaka Peguta.
A ranar 8 ga Fabrairu, dakin gwaje-gwaje na OncoGen a Romania ya ƙaddamar da allurar rigakafi mai fasahar kama da wacce aka yi amfani da ita don magance cutar sankara a cikin jarirai.
A ranar 25 ga watan Maris, darektan hukumar bincike ya sanar da cewa sun kammala aikin karshe na samar da allurar rigakafin kuma za su fara bincike.
A ranar 27/2/2020, wani kamfani mai suna Generex - NuGenerex Immuno-Oncology ya sanar da cewa sun fara aikin allurar rigakafi don ƙirƙirar allurar rigakafin li-key peptde don COVID-19.
Sun so su samar da wani maganin da za a iya gwadawa a cikin mutane cikin "kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirin samar da rigakafi.
A ranar 5 ga watan Maris na shekarar 2020, rundunar binciken likita ta Majalisar Dinkin Duniya da rundunar bincike ta rundunar soja a Fort Detrick da rundunar binciken Walter Reed a Silver Spring, dukansu a yammacin Maryland, sun ba da sanarwar cewa suna aiki a kan maganin.
A ranar 10 ga Maris, 2020, Biotherapy ta sanar da cewa tana da alaƙa da kamfanin Novavax.
An yi amfani da maganin alurar riga kafi don magance cutar.
Babban abokan haɗin gwiwar sun ba da sanarwar shirin don gwajin asibiti na farko da na farko a cikin watan 7 na 2020.
A ranar 21 ga Maris, 2020, Ministan Lafiya na Indiya ya ba da sanarwar cewa suna aiki a kan 11 daban-daban, kuma ko da a cikin sauri zai ɗauki aƙalla shekara ɗaya da rabi zuwa shekaru biyu don haɓaka allurar rigakafi.
A ranar 12 ga watan Maris, 2020, Medicago, wani kamfani na fasahar kere-kere na Quebec, ya sanar da ci gaban kwayar cutar corona a matsayin wani karamin bangare a wani bangare na tallafi a Cibiyar Nazarin Kiwon Lafiya ta Kanada.
Allurar rigakafin da aka zaɓa tana cikin binciken dakin gwaje-gwaje, tare da shirye-shiryen gwajin ɗan adam da aka tsara don Yuli da Agusta 2020.
A farkon wannan makon, Guardian ta ruwaito cewa shugaban Majalisar Dinkin Duniya Donald Trump ya ba CureVac "babban kuɗi" don neman hanyar yin allurar rigakafin COVID-19, duk da rashin amincewar Jamus.
A ranar 17 ga Maris, 2020, kamfanin Pfizer na Amurka ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
A mRNA-based allurar rigakafi BNT162 yana cikin gwaji na gwaji kuma ana sa ran gwajin gwaji zai fara a watan Afrilu na 2020.
A Italiya a ranar 17/3/2020, kamfanin fasahar kere-kere na Italiya Takis Biotech ya sanar cewa sakamakon gwajin da ba a kammala ba zai kasance a watan Afrilu 2020 kuma za a iya gwada allurar rigakafin karshe a cikin mutane kyauta.
A Faransa a ranar 19 ga Maris, 2020, Cibiyar Innovation a Shirye-shiryen Cutar (CEPI) ta ba da sanarwar dalar Amurka miliyan 4.9 ga ƙungiyar bincike na allurar rigakafin COVID-19 ta haɗin gwiwa tsakanin Pasteur Institute, Thems Bioscience (Vienna da Austria) da Jami'ar Pittsburgh.
Sauran abokan haɗin gwiwar CEPI don haɓaka allurar COVID-19 sune Moderna da Curevac da Inovio da Novavax da Jami'ar Hong Kong) da Jami'ar Oxford da Jami'ar Queensland
A ranar 20 ga watan Maris, 2020, hukumomin kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin alluran rigakafi guda shida a kan dabbobi.
Masu bincike a Kwalejin Imperial na Landan sun ba da sanarwar a ranar 20 ga Maris, 2020 cewa suna haɓaka allurar rigakafin COVID-19.
An kirkiro allurar rigakafin cikin kwanaki 14 ta hanyar aiwatar da shirye-shiryen a cikin ciwon daji.
A ƙarshen Maris, Gwamnatin Kanada ta ba da sanarwar $ 275 miliyan don ayyukan bincike na likitanci na 96 don COVID-19, wanda ya haɗa da wasu ƙwararrun ƙwararrun likitoci daga kamfanonin Kanada da jami'o'i, kamar Medicago da Jami'ar Saskatchewan.
A lokaci guda, gwamnatin Kanada ta sanar da cewa ta ware dala miliyan 192 musamman don ci gaban allurar COVID-19, tare da shirye-shiryen kafa "tallafin rigakafin" don sabbin alluran rigakafi na duniya da za a iya amfani da su idan wani cutar coronavirus ta sake yaduwa.
A ranar 2/4/2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton cewa Pittsburgh ta yi gwajin rigakafin COVID-19 a kan beraye, suna ba da rahoton cewa "MNA-tushen allurar rigakafin SARS-CoV-2 S1 ya haifar da karɓar rigakafin rigakafin rigakafi mai ƙarfi [a cikin beraye] wanda ya fara a fili makonni 2 bayan rigakafi.
A ranar 16 ga Afrilu, 2020, Jami'ar Pharmaceutical University of Waterloo ta Kanada ta sanar da shirin rigakafin DNA na zaɓaɓɓu ta hanyar yin allurar rigakafi.
Yin amfani da kwayar cuta, DNA da aka tsara don yin amfani da kwayoyin cuta na mutum don samar da ƙwayoyin cuta marasa cutarwa kamar ƙwayoyin cuta, don ƙarfafa tsarin rigakafin don samar da ƙwayoyin rigakafi ga SARS-CoV-2.
A watan Maris na 2020, gwamnatin Majalisar Dinkin Duniya, masana'antu da jami'o'i uku sun haɗu da kayan aiki don kama kwamfutar IBM, wanda aka haɗa tare da kayan aikin ƙididdiga daga Hewlett Packard Enterprise da Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako daban-daban, wanda ake kira sakamako wanda ba a sani ba.
Wannan yana nufin cewa za su iya samun fa'ida bayan an dakatar da cutar.
Wani babban ma'aikacin kiwon lafiya a Australia ya nemi ya yi wa ma'aikatan kiwon lafiya 4,170 rajista.
Alluran rigakafin da aka samar na iya zama ba su da lafiya ko kuma ba su da tasiri.
Gwajin farko don gano ingancin maganin yana amfani da samfuran COVID-19 daga dabbobi na musamman, misali, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta (ACE2), buƙatar matakan aminci na Level 3 don magance ƙwayoyin cuta masu rai, gudanar da ƙasa don tabbatar da ƙimar aminci na gwaji.
An gwada allurar rigakafin SARS da MERS a kan dabbobi fiye da mutane.
A cikin 2020, babu wani magani ko rigakafin rigakafin SARS da aka tabbatar da cewa yana da aminci da tasiri a cikin mutane.
Bisa ga takardun binciken da aka buga a cikin 2005 da 2006, ganowa da kuma bunkasa sabon maganin rigakafi da magunguna don magance SARS shine babban abin da gwamnatoci da al'amuran kiwon lafiyar jama'a suka fi mayar da hankali a duniya. Babu wani sabon maganin rigakafi da aka tabbatar da shi a kan MERS.
Lokacin da MERS ya zama ruwan dare gama gari, an yi imanin cewa binciken SARS na iya ba da gudummawar mai amfani don haɓaka allurar rigakafi da maganin rigakafi don MERS-CoV.
A watan Maris na 2020, akwai allurar rigakafin MERS ta DNA wacce ta kammala gwaji na farko a cikin mutane, da kuma wasu uku a ci gaba, duk an tsara su ne don ƙwayoyin cuta, biyu daga cikinsu an tsara su don adenovirus (ChAdOx1-MERS da BVRS-GamVac), da kuma an tsara su don MVA-MERS-S.
Kafofin watsa labarai na yanar gizo sun ba da labarin yadda aka tsara dabarun ƙirƙirar kwayar cutar a bayan COVID-19 wanda aka riga aka riga aka samu.
Abubuwan da aka gano sun haifar da alamun da aka buga game da cutar a kan kafofin watsa labarun saboda rashin ƙwarewa a aikin kwayoyin halitta da kuma maganin alurar riga kafi ga sauran ƙwayoyin cuta na corona kamar SARS coronavirus.
Cutar kwayar cutar coronavirus b ta 2019 (COVID-19) cuta ce ta kamuwa da cuta mai saurin kamuwa da cuta mai saurin kamuwa da cuta mai saurin kamuwa da cuta mai saurin kamuwa da cutar coronavirus 2 (SARS-CoV-2).
Abubuwan da ake yawan gani a ciki sun hada da tari, tari, da kuma rashin isashen numfashi.
Sauran alamun na iya haɗawa da gajiya, ciwon tsoka, tashin zuciya, maƙarƙashiyar maƙarƙashiya, rashin jin ƙanshi, da ciwon ciki.
Lokacin bayyanar farko na alamun cutar shine kusan kwanaki biyar, amma yana iya bambanta daga kwana biyu zuwa goma sha huɗu.
Duk da yake mafi yawan cututtukan suna da alamomi masu sauƙi, wasu suna da alamomi masu tsanani da kuma cututtuka na jiki biyu.
A ranar 17 ga Afrilu, 2020, an ba da rahoton sama da miliyan 2.24 a cikin ƙasashe da yankuna 210, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Cutar ta kamu da mutane musamman lokacin da suke cikin kusanci, galibi ta hanyar ƙananan ƙanƙan numfashi da ke haifar da tari, numfashi, da magana.
Duk da yake ana samar da waɗannan ƙananan ɗigon ruwa yayin numfashi, yawanci suna sauka a ƙasa ko a kan fuska, akasin haka, suna yaduwa daga nesa.
Mutane kuma suna kamuwa da cutar ne daga taba wani abu da ya ƙazanta, da kuma taba idanunsu, hancinsu, da bakunansu.
Kwayar cutar na iya rayuwa a kan farfajiyar fiye da sa'o'i 72.
Matsakaicin matsakaici na watsawa yana faruwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya samun yaduwar cutar kafin bayyanar cututtuka ko a cikin matakan baya na cutar. Hanyar da aka saba amfani da ita don gano cutar ta hanyar yin amfani da lokacin da aka dace da ɗaukar matattarar polymerase chain reaction (rRT-PCR) a cikin hanci da kuma hancin hanci.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda ake zargi da cutar da masu kula da su.
Shawarwarin likita don amfani da abin rufe fuska ta jama'a sun bambanta, wasu gwamnatoci suna ba da shawarar a kan amfani da su, wasu suna ba da shawarar amfani da su wasu kuma suna buƙatar amfani da su.
A halin yanzu, babu rigakafi ko magani na musamman don COVID-19.
An samu yaduwar cutar a cikin yawancin ƙasashe a cikin yankuna shida na WHO.
Wadanda suka kamu da cutar za su iya nuna alamun rashin lafiya ko kuma su nuna alamun cutar kamar gudawa, tari, gajiya, da kuma rashin numfashi.
Alamun cututtukan cututtuka na ciki sun haɗa da rashin numfashi na gaggawa, ciwo na ciwo ko ciwo, damuwa, rashin damuwa, da kuma fuska mai launin fata ko kuma lebe: an shawarci kulawa na likita idan waɗannan alamun sun bayyana.
A takaice dai, ana iya samun alamun cututtukan numfashi na sama kamar su tari, sanyi ko kuma ciwon makogwaro.
An lura da alamun cututtukan numfashi kamar su tashin zuciya, amai da gudawa a cikin kididdigar.
Wasu lokuta, cutar hanta da farko tana da saurin hanta da kuma saurin bugun zuciya.
A wasu, cutar na iya kaiwa ga shanyewar jiki, raunin gabobin jiki, da mutuwa.
Wannan shi ake kira lokacin bayyanar cututtuka.
Daga kwana biyar zuwa shida, zai iya zama daga kwana biyu zuwa 14.
Saboda haka, bayan kwana 11.5 na kamuwa da cutar, rahotannin sun nuna cewa ba duk wadanda ke dauke da cutar ba ne ke samun ci gaba a cikin alamun cutar.
Ba a san rawar da masu karɓar marasa alama a cikin watsa kwayar cutar ba, kodayake shaidun farko sun ba da shawarar cewa su ne ke iya haifar da yaduwar cutar.
Ba a san adadin mutanen da ke da alamun cutar ba kuma ana ci gaba da binciken su, a cewar Cibiyar Kula da Cututtuka ta Koriya (KCDC), kashi 20% na mutanen da aka tabbatar ba su da alamun cutar a lokacin da suke asibiti.
Hukumar Lafiya ta Duniya ta fara bincike wanda ya hada da wadanda ba su da alamun cutar a cikin wadanda suka kamu da cutar a ranar 1 ga watan Afrilu: 166 sun kamu da cutar a ranar, 130 (78%) ba su da alamun cutar a lokacin fashewar.
Dukansu leaks da kuma kwari suna iya ɗaukar manyan nau'in kwayar cutar
Yin magana da ƙarfi yana haifar da ƙarin ɗigon ruwa fiye da yadda ake yi a magana.
Wani bincike a Singapore ya gano cewa wani kwalliyar kwalliya ba tare da kwalliya ba zai iya ɗaukar ƙananan ƙwayoyin cuta zuwa tsawon mita 4.5 (15 ft).
Kodayake cutar ba ta yaduwa a cikin iska, masana kimiyya na kasa da kasa sun ba da shawarar cewa yaduwar iska na iya zama mai dacewa ko kuma masu ba da izini a cikin hanyoyin ɗakin mutane suna haifar da kwayar cutar RNA.
Wasu hanyoyin kiwon lafiya kamar su yin allurar rigakafi da kuma bugun zuciya (CPR) na iya haifar da hana numfashi don yin iska mai tsabta kuma hakan yana haifar da yaduwar iska.
Yayinda ake tunanin cewa ana iya yada shi ta fuska, an yi watsi da wannan tsoron. Kwayar cutar ta fi karfi yayin da mutane ke da alamun cutar; yayin da yaduwa na iya faruwa kafin bayyanar cututtuka, tsoronsa ya yi kadan.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce a halin yanzu ba a san yadda cutar ke yaduwa da sauri ba. "Mutum ɗaya zai iya kamuwa da mutane biyu ko uku.
Musamman, ana iya gano kwayar cutar a cikin kwanaki ɗaya a kan kwali, fiye da kwana uku a kan filastik (fiber-reinforced polymer) da kuma takarda mai tsabta, kuma fiye da awanni huɗu a kan 99% na jan ƙarfe.
Duk da haka, nauyin nauyi ya dangana ne akan zafi da zafin jiki.
Sabulu da sabulu suna da tasiri idan aka yi amfani da su daidai, samfurori na sabulu suna lalata matakan kariya na ƙwayoyin cuta, suna hana su, kuma suna sakin su a kan fata da sauran wurare.
Sauran hanyoyin, kamar su tsabtace sinadarai da tsabtace anti-virus (anti-inflammatory) sun fi tasiri. A cikin binciken Hong Kong, an karɓi samfuran leaks a cikin jadawalin kwana biyu bayan fara asibiti.
A cikin marasa lafiya shida, biyar sun nuna mafi yawan kwayar cutar, kuma na shida ya nuna mafi yawan kwayar cutar a ranar gwaji na biyu.
SARS-CoV-2 wani sabon kwayar cutar ce da ke haifar da cututtukan numfashi, an fara ware ta daga mutane uku da suka kamu da cutar huhu mai saurin kamuwa da cutar a birnin Wuhan.
Dukkanin halayen sabon SARS-CoV-2 sun samo asali ne daga wasu coronaviruses masu alaƙa da ke cikin yanayi.
A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, yana lalata ɓoyayyen ɓoye. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Gwargwadon huhu sune sassan da COVID-19 ke haifar da ƙwayoyin cuta mafi yawa saboda ƙwayar cuta ta shiga cikin ƙwayoyin cuta ta hanyar angiotensin-converting enzyme 2 (ACE2), wanda shine mafi yawan nau'in ƙwayoyin cuta na huhu na alveolar na 2.
Kwayar cutar tana amfani da wani nau'in sukari na musamman na kwayar cutar da ake kira "peplomer" don yin hulɗa da ACE2 da kuma shiga cikin kwayar halitta.
An gano karuwar cututtukan zuciya a kashi 12% na mutanen da aka kwantar a asibiti a Wuhan, China, kuma ya fi yawaitarwa a cikin cututtukan cututtukan zuciya.
Hanyoyin cututtukan cututtukan zuciya suna da yawa, suna haifar da rikice-rikice na tsarin tsarin rigakafi, amma cututtukan zuciya na iya zama masu haɗuwa da masu karɓar ACE2 a cikin zuciya.
ACE2 masu karɓa suna da ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙwayoyin cuta a cikin zuciya kuma ana amfani da su a cikin umarnin zuciya.
An gano babban adadin cutar hawan jini (31%) da kuma hawan jini (25%) a cikin marasa lafiya na ICU tare da cututtukan COVID-19 kuma ana iya danganta su da rashin yiwuwar murmurewa.Binciken mutanen da suka mutu daga COVID-19 sun nuna cutar alveolar da cutar lymphoma ta kamu da cutar a cikin mahaifa.
Kodayake SARS-CoV-2 yana da alamun ACE2 masu nuna ƙwayoyin epithelial na respiratory na dole, marasa lafiya da suka kamu da COVID-19 suna da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka.
Musamman, an nuna cewa kwayoyin T-cell na asibiti na GM-CSF suna da alaƙa da haɗuwa da IL-6-secreting mononuclear infections da kuma cutar huhu mai tsanani a cikin marasa lafiya COVID-19.
An kuma ba da rahoton ƙwayoyin lymphocyte masu karɓar jini a cikin binciken.
WHO ta wallafa wasu hanyoyin bincike na cutar.
Hanyar gwajin da aka saba amfani da ita ita ce gwajin rRT-PCR.
Ana yin gwajin ne a kan samfuran numfashi da aka samu ta hanyar samfurin hanci da kuma hanci; duk da haka, ana iya amfani da samfurin hanci ko samfurin hanci.
Ana samun sakamakon a cikin sa'o'i kadan zuwa kwana biyu.
Ana iya amfani da gwajin jini, amma suna buƙatar a ɗauki samfuran jini biyu a cikin makonni biyu kuma sakamakon yana da ƙimar kai tsaye.
Masana kimiyya na Sin sun iya ware wani nau'in kwayar cutar coronavirus kuma sun rarraba kwayoyin halittun sa don haka dakunan gwaje-gwaje na duniya za su iya haɓaka gwajin gwajin polymerase chain reaction (PCR) don lura da kamuwa da cutar.
A ranar 4/4/2020, gwajin rigakafi (wanda zai iya gano cutar da ke aiki da kuma ko mutum ya kamu da cutar a baya) yana cikin ci gaba, amma ba a amfani da shi sosai.
Gwajin da aka yi da tsutsa ya nuna cewa an yi daidai da kashi 60 zuwa 70 cikin dari.
FDA ta amince da gwajin farko na cibiyar kulawa a cikin Amurka a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan.Sarrafa hanyoyin gano cututtukan da aka buga ta Cibiyar Kula da Lafiya ta Zhongnan a Jami'ar Wan ta ba da shawarar hanyoyin gano cututtukan da suka danganci yanayin likita da haɗarin cutar.
Na'urar gilashi mai kwakwalwa ta biyu tare da tsinkaye, rashin daidaituwa da kuma bayanan bayanan da aka yi a farkon cutar.
Rashin numfashi, hoto na radiyo (ciwon huhu tare da canzawar ƙwayar cuta) da kuma rigar jiki na iya nunawa kamar ci gaba.
Akwai karancin bayanai game da haɗarin COVID-19 da ke tattare da rashin abinci mai gina jiki.
Abubuwan da suka fi sa mutum ya kamu da cutar a cikin cututtukan cututtuka sune:
Cutar: cututtukan huhu, cututtukan zuciya, ƙwanƙwasawar huhu da kuma huhu.
Akwai nau'i hudu na cutar da ake iya ganewa:
Cutar huhu mai sauƙi: Cutar ciki, cutar huhu, rashin ƙarfi mai yawa, kumburi na tsakiya tare da lymph nodes da kuma babban tsarin ƙwayoyin cuta ba tare da sutura ba.
C. mai ƙarfi: cutar da ke tattare da cutar alveolar (DAD) tare da fitowar alveolar.
DAD yana haifar da matsanancin ciwon ƙwayar cuta (ARDS) da kuma rashin iskar oxygen.
Cissary hydrotherapy: ƙwayoyin cuta suna fitowa daga alveolar da kuma na tsakiya na tsakiya na cissary.
Jini: Rashin ƙwayoyin jini a cikin jini (DIC): Rashin ƙwayoyin jini.
Hanyoyin da za a iya amfani da su don rage yiwuwar kamuwa da cuta sun haɗa da kasancewa a gida, guje wa wuraren da jama'a ke, wanke hannu da sabulu da ruwa da kuma yin wanka na tsawon dakika 20, yin gyare-gyare na numfashi mai kyau da kuma guje wa taɓa fuska, fuska da baki da hannayen da ba a shafa ba.
CDC ta ba da shawarar rufe baki da hanci da safar hannu lokacin da ake cusawa ko yin wanka, kuma ta ba da shawarar yin amfani da Anishikta idan ba a sami safar hannu ba.
Ana ba da shawarar wanke hannu bayan kowane koka ko magani.
CDC ta ba da shawarar yin amfani da takunkumi a wuraren da jama'a ke, don iyakance motsi daga mutanen da ba su da alamun cutar. Tsarin nesantawar zamantakewa yana da nufin rage hulɗar masu cutar a cikin manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, dakatar da balaguro da kuma hana manyan tarurrukan jama'a.
Dokokin tazara sun haɗa da cewa mutane su kasance aƙalla ƙafa 6 (1.8m) daga juna.
Babu wani magani da aka gano da zai iya hana COVID-19. Ba a sa ran samun allurar rigakafi har zuwa farkon 2021, saboda haka, babban ɓangaren gudanar da COVID-19 shi ne ƙoƙarin rage saurin cutar, wanda aka sani da "taƙaitaccen layin".
CDC ta kuma bada shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na tsawon dakika 20, musamman bayan sun yi amfani da banɗaki ko kuma idan hannayensu sun kasance masu laushi, kafin cin abinci da kuma bayan an sha ruwa, ko kuma an yi amfani da maganin kwantar da hanci ko koken.
Ya kuma bada shawarar amfani da sabulun hannu wanda ya ƙunshi aƙalla kashi 60% na barasa, amma kawai lokacin da ruwa da sabulu ba su da sauƙi. Ga yankuna da ba su da sabulun hannu, WHO ta ba da ƙa'idodi biyu don samar da gida.
A cikin waɗannan ka'idoji, aikin antimicrobial yana ƙaruwa a cikin ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa cire spores na kwayoyin daga barasa; wannan "ba wani abu mai aiki ba ne don maganin ƙwayoyin cuta na hannu".
An kara glycerin a matsayin mai sanyaya.
Ana gudanar da kulawa ta tallafi ga mutane, wanda zai iya haɗawa da maganin ruwa, tallafin oxygen, tallafi ga sauran membobin da ke fama da cutar.
CDC ta ba da shawarar yin amfani da abin rufe fuska mai sauƙi ga waɗanda ake zargin suna dauke da cutar.
An yi amfani da ƙarin oxygenation (ECMO) don tantance matsalar rashin ƙarfi, amma amfaninsa har yanzu ana bincika shi.
Tsabtace jiki, rayuwa mai kyau da tsarin abinci mai kyau ana iya samun su don haɓaka rigakafi.
Magungunan tallafi na iya zama da amfani ga mutanen da ke da alamun bayyanar cututtuka a farkon matakan kamuwa da cuta. WHO da Hukumar Lafiya ta Duniya sun ba da shawarwari na likita don kula da mutanen da ke asibiti da COVID-19
Masu sa ido kan lafiyar da masana kimiyyar cutar huhu a Majalisar Dinkin Duniya sun tattara shawarwarin magani daga masu cin nasara na kwayar cutar a cikin wani samfurin kyauta, IBCC.
Ya zuwa Afrilu 2020, babu wani magani na musamman na COVID-19.
Don alamun, wasu ƙwararrun likitocin suna ba da shawarar paracetamol a kan ibuprofen don layin farko na amfani.
Ya kamata a ɗauki matakan kariya don rage haɗarin watsa kwayar cutar, musamman a wuraren kiwon lafiya inda aiwatar da ayyuka na iya haifar da hawan hawan iska, kamar yin amfani da bututun iska ko kuma canja iska ta hannu.
Don kula da ƙwararrun likitocin da ke kula da mutane tare da COVID-19, CDC ta ba da shawarar sanya masu cutar a cikin ɗakin keɓewa (AIIR) tare da amfani da daidaitattun masu kiyayewa, masu rarrabuwar sadarwa da masu kula da iska. CDC na shirin kafa ƙa'idar amfani da kayan kariya na mutum (PPE) yayin annobar.
Abubuwan da aka ba da shawarar: PPE, respirator ko abin rufe fuska, mai kare ido, da kuma kayan aikin likita. Lokacin da aka samu, respirators (a madadin abin rufe fuska) an yarda da su.
An tsara N95 don amfani a masana'antu, amma FDA ta ba da izinin amfani da shi a ƙarƙashin Dokar Amfani da Gaggawa (EUA).
An tsara shi don karewa daga ƙwayoyin iska kamar su ƙura amma tasirinsa akan wani takamaiman abu na halitta ba a tabbatar da shi ba don amfanin da ba a tabbatar da shi ba.
Lokacin da ba a sami abin rufe fuska ba, CDC ta ba da shawarar yin amfani da abin rufe fuska, ko abin rufe fuska da aka yi da hannu a matsayin makomar ƙarshe.
Yawancin cututtukan COVID-19 ba su da ƙarfi da za su buƙaci a haɗa su da masu sanyaya iska ko masu musanyawa, amma suna da wani matakin da ake buƙata.
Nau'in taimakon numfashi ga mutanen da ke da COVID-19 ya danganta da yin amfani da gajeren numfashi a cikin asibiti, tare da wasu shaidar cewa za a iya guje wa yin amfani da gajeren numfashi tare da gajeren numfashi ko matsin lamba.
Ba a san ko kowanne daga cikin waɗannan zai iya ba da irin wannan fa'ida ga waɗanda ke da mummunar cuta ba.
Wasu likitoci sun ba da shawarar yin amfani da na'urar mai saurin sauƙaƙa iska idan akwai, saboda wannan hanya ta iyakance yaduwar ƙwayoyin aerosol (aerosol) idan aka kwatanta da na huhu. Abubuwan da suka fi dacewa sun fi dacewa da tsofaffi (waɗanda suka wuce shekaru 60, musamman ma waɗanda suka wuce shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isasshen ɗakunan marasa lafiya a asibitoci, wanda ke iyakance tsarin kiwon lafiya na sarrafa ƙididdigar ƙaruwa na masu kamuwa da cutar ta COVID-19 waɗanda ke buƙatar zama a asibiti.
Wani bincike a Sin ya gano cewa kashi 5% sun shiga cikin dakin kulawa, kashi 2.3% na buƙatar taimakon iska, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na mutanen da aka kwantar da su a asibiti saboda COVID-19 sun shiga ICU.
A cikin yanayin COVID-19, ana ƙara rikitarwa da na'urorin kwandishan saboda ci gaban alamun cutar ta ARDS (Acute Respiratory Distress Syndrome) da kuma ƙwarewar aikin oxygenation.
Air-converters suna da ikon sarrafa matsi kuma ana buƙatar babban PEEP don haɓaka iskar oxygen yayin rage haɗarin haɗari na iska da ke tattare da lalacewar iska a cikin huhu.
Ba a samun PEEP mai ƙarfi a asibiti na tsofaffi.
Bincike don ingantaccen magani ya fara ne a cikin Janairu 2020, kuma akwai magungunan antiviral da yawa a cikin gwajin likita.
Magungunan rigakafi sun fi saurin kamuwa da cutar.
Kodayake sabbin magungunan suna buƙatar lokaci har zuwa 2021 don haɓaka, an yarda da magungunan da yawa don amfani da su ko a cikin gwaji na ci gaba.
Ana iya gwada maganin antiviral a cikin mutane don magance cututtukan da suka fi tsanani.
WHO ta ba da shawarar yin amfani da sa kai a gwajin lafiya da inganci. FDA ta ba da izinin dawo da plasma na ɗan lokaci a matsayin magani na gwaji a cikin yanayin da rayuwar mutum ke cikin haɗari kai tsaye.
Ba a buƙatar ƙwarewar binciken likita don tabbatar da inganci da aminci ga cutar ba.
A watan Fabrairun 2020, Sin ta ƙaddamar da aikace-aikacen wayar hannu don rage yaduwar cutar.
An nemi masu halarta su shigar da sunayensu da lambar ID.
Shirin na iya gano "abokan hulda" ta amfani da bayanan kula da marasa lafiya da kuma haɗarin kamuwa da cuta.
Kowane mai amfani zai iya bincika matsayin wasu masu amfani guda uku.
Idan aka gano babban haɗari, ba kawai za a ba da shawarar a zauna a gida ba, amma har ma za a ba da sanarwar ga jami'an kiwon lafiya na gida. Ana amfani da bayanai masu yawa na bincike na wayar hannu, fasahar gane fuska, gano wurin wayar hannu ta AI don gano mutanen da suka kamu da cutar da kuma mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba jami'an tsaro damar yin amfani da bayanan wayar hannu na mutanen da ke da yiwuwar kamuwa da cutar coronavirus.
An yi amfani da wannan hanyar don tilasta keɓancewa da kuma kare waɗanda suka yi hulɗa da waɗanda suka kamu da cutar.
A watan Maris na 2020, Deutsche Telekom ta ƙaddamar da aikace-aikacen wayar hannu don tattara bayanan wuri tare da Gwamnatin Tarayyar Jamus ta Koch, wanda ke jagorantar binciken da kuma dakatar da yaduwar cutar.
Rasha ta ƙaddamar da fasahar gane fuska don gano waɗanda ke keta dokar keɓewa.
"An sanar da shi a cikin GILIO GALLERA, wani yanki na Italiya, mai haɓaka wayar hannu, cewa kashi 40% na 'yan ƙasa suna ci gaba da damuwa da kansu ta kowace hanya".
Gwamnatin Jamus ta sanar da hutun mako na 48 tare da masu shiga sama da 42,000.
Shugaban Estonia, Kristi Kjellinlaid, ya kuma sanar da Global Call a matsayin wata hanya mai kyau ta magance cutar ta coronavirus.
Mutane na iya zama masu baƙin ciki sakamakon keɓewa, ƙuntatawar balaguro, mummunan sakamako na magani ko tsoron kamuwa da cuta
A cewar Roy O. Corner, "Rashin zaman lafiya, rashin lafiya, rashin jin daɗi, da kuma koma bayan tattalin arziki duk suna haifar da mummunan tasirin da ke shafar lafiyar zuciya".
Cutar na iya zama mai saukin kamuwa da cutar tare da wasu alamomi ko babu alamomi, kamar yadda yake da sauran cututtukan numfashi masu tsanani kamar mura.
Matsakaicin matsakaici yana ɗaukar kimanin makonni biyu don warkewa, yayin da matsanancin yanayi ko yanayin haɗari na iya ɗaukar makonni 3 zuwa 6 don warkewa.
Mata masu juna biyu sun fi kamuwa da cutar COVID-19 mai saurin kamuwa da cutar, kamar SARS da MERS, amma ba a san da yawa game da COVID-19. A cikin ƙananan mata, COVID-19 na iya haifar da cutar huhu.
A cikin irin wannan yanayi, COVID-19 na iya saurin canzawa zuwa bayyanar cututtukan cututtukan cututtukan SARS, wanda ke haifar da rashin numfashi, rashin isashshen oxygen ko kuma jinkirin ci gaba a cikin jiki.
Abubuwan da suka shafi COVID-19 sun haɗa da rashin ƙarfi na jiki, ƙuntataccen jini, da kuma ciwo na zuciya, koda, da hanta.
Hematopathy, musamman ma, yana haifar da haɓakar lokaci na proceraminin (wani furotin a cikin ƙwayar plasma na ƙwayar ƙwayar ƙwayar ƙwayar cuta) wanda aka gano a cikin 6% na waɗanda aka shigar da su asibiti tare da COVID-19, yayin da rashin lafiyar rashin aiki na renal ya kasance 4% na yanayin kansa.
Kusan kashi 20-30% na mutanen da aka gano suna da COVID-19 suna da ƙwayoyin cuta na enzyme.
A cewar wannan rahoto, matsakaicin lokacin da aka samu alamun cutar da kuma mutuwar mutum ya kai kwanaki 10, tare da sauran mutane biyar da suka rage.
Koyaya, marasa lafiya da aka tura zuwa ICU suna da matsakaicin lokacin rayuwa na kwanaki bakwai tsakanin mutuwa da rayuwa.
A cikin binciken da aka yi na yanayin da aka riga aka samu, matsakaicin lokacin bayyanar alamun farko na mutuwa ya kai kwanaki 14, tare da matakan daga shida zuwa 41.
A cikin binciken da Hukumar Lafiya ta Kasa (NHC) ta yi, yawan mace-macen maza ya kai kashi 2.8% yayin da mace-macen mata ya kai kashi 1.7%.
Binciken da aka yi a kan canje-canje a cikin samfurin C-Murth ya nuna cewa alveolar (wanda ke nuna cewa mutum yana da alveolar) yana haifar da lalacewar fibromycoid (wanda ke nuna cewa dabba tana da fibromycoid) a cikin kwayoyin halitta.
An gano ƙwayoyin ƙwayoyin cuta a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Hoton da ke ƙasa ya nuna alamun cutar ta ARDS.
A cikin kashi 11.8 cikin dari na mutuwar da aka ruwaito ta Hukumar Lafiya ta Sin, an gano cutar zuciya ta hanyar yawan sinadarin furotin ko kuma bugun zuciya.
A cewar bayanan watan Mayu daga Majalisar Dinkin Duniya, kashi 89 cikin dari na waɗanda aka kwantar da su asibiti sun kasance masu cutar.Samun magani da tattalin arzikin al'umma na yankin yana da tasiri sosai a kan mutuwar.
Yawan mutuwar ya bambanta saboda bambancin da ke tsakanin yankuna, amma kuma saboda wahalar da aka samu.
Yawan adadin cututtuka na iya haifar da rashin mutuwa
Amma gaskiyar ita ce, yawan mutanen da suka mutu sakamakon kamuwa da cutar a baya ne, kuma ba a iya tantance yawan mutanen da suka mutu ba.
Masu shan sigari suna da damar kamuwa da cutar COVID-19 sau 1.4 fiye da na sauran mutane, kuma kusan sau 2.4 sun fi buƙatar kulawa ta musamman fiye da waɗanda ba su sha sigari ba.
Asibitin Hong Kong ya gano wata magungunan da ke iya kashe mutum 20 zuwa 30 daga cikin mutanen da suka warke daga cutar, da kuma wasu da suka kamu da cutar.
Wannan na iya zama mahimmanci don kula da lafiyar lafiya don dawowa.
A watan Mayun 2020, ba a san ko mutanen da suka kamu da cutar sun sami ci gaba mai dorewa da kuma na dogon lokaci ba a cikin mutanen da suka warke daga cutar.
Ana iya samun rigakafi ta wannan hanyar, dangane da halayyar wasu ƙwayoyin cuta, amma sauran waɗanda suka warke daga COVID-19 sun nuna sakamakon gwajin coronavirus mai kyau wanda aka bayyana a cikin kwanaki na gaba.
Ana ganin waɗannan cututtukan sun fi muni ne bayan kamuwa da cutar na tsawon lokaci fiye da sake kamuwa da cutar.
An yi amannar cewa kwayar cutar ta samo asali ne daga dabba, wato Spiloveria.
Ba a san asalin farko ba, amma a watan Disamba na 2020 cutar ta bazu gaba ɗaya ta hanyar watsawa daga mutum zuwa mutum.
Nazarin kan farkon shari'o'i 41 na COVID-19, wanda aka buga a watan Janairun 2020 a The Lancet, ya nuna cewa farkon bayyanar alamun cutar ya kasance a ranar 1 ga Janairu 2019.
Sanarwar hukuma ta WHO ta ba da sanarwar bayyanar cututtuka na farko da aka gani a ranar 8 ga Disamba, 2019.
Ana amfani da ma'auni iri-iri don ƙididdige yawan mutuwar.
Wadannan lambobin sun bambanta dangane da yanki da kuma lokacin da aka shafe, kuma suna da tasiri ga girman gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da cutar ta fara yaduwa da halaye na yawan jama'a kamar shekaru, jinsi, da kuma lafiyar jama'a gaba ɗaya.
A ƙarshen 2019, WHO ta sanya hannu kan lambar ICD mai lamba U07.1 don mutuwar a cikin dakin gwaje-gwaje da kuma gano cutar SARS-KOV-2 da U07.1 don mutuwar a cikin asibiti ko kuma a cikin asibiti COVID-19 ya kamu da cutar SARS-CoV-2 ba tare da samun labaran gwaje-gwaje ba.
Dangane da ƙididdigar Jami'ar Johns Hopkins "Johns Hopins", yawan mutuwar duniya a kowace shekara shine 6.9% (153,822/2,240,191) kamar yadda aka yi a ranar 17 ga Afrilu, 2020.
Yawan ya bambanta a yankuna, tare da wasu ma'auni kamar su yawan mutuwar cutar (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar masu kamuwa da cutar (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (an gano su ko ba a gano su ba) sun mutu daga cutar.
Wadannan ƙididdigar ba su da tasiri ta lokaci kuma ba sa neman takamaiman mutanen da ke fama da cutar yayin yanke shawara kan al'amuran.
Duk da yake ba duk wanda ke dauke da cutar ke samar da maganin ba, kasancewar akwai maganin na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar Italiya, Castiglione d'Adda, ƙauye mai yawan mutane 4,600, mutane 80 (%) suka mutu.
A cikin Gangelt, cutar ta bazu ta hanyar bikin Carnival, ya zama sananne a cikin matasa, ya haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 za a iya rarraba su ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai riga ya fara aiki ba.
A cikin Netherlands, kashi 3% na maganin rigakafi ne, wanda aka samo daga masu ba da jini.
An tabbatar da mutuwar 69 (0.004% na yawan jama'a) daga COVID-19.
Sakamakon cutar da yawan mace-mace da ke mutuwa sun bambanta tsakanin maza da mata.
Yawan mutuwar maza ya fi girma a cikin binciken da aka yi a China da Italiya.
Mafi tsoronsa shi ne na maza a cikin shekarunsa na hamsin.
A China, yawan mace-mace ya kai kashi 2.8 cikin 100 ga maza da kashi 1.7 cikin 100 ga mata.
Ba a san ainihin dalilin bambancin jinsi ba, amma ana iya danganta shi ga ƙwayoyin halitta da kuma halittar jini.
Bisa ga binciken kimiyya, ƙarancin shan taba sigari a cikin mata da kuma karuwar cututtukan da ke tattare da cutar a cikin maza, kamar hawan jini a cikin ƙuruciya, na iya haifar da mutuwar da ya fi girma a cikin maza.
A Turai, maza sun kai kashi 57 cikin 100 na masu kamuwa da cutar, kuma kashi 72 cikin 100 na waɗanda suka mutu sanadiyyar COVID-19 maza ne.
A watan Afrilu na 2020, gwamnatin Amurka ba ta ba da bayanan da suka shafi jinsi ba game da cutar COVID-19.
Bincike ya nuna cewa cututtukan ƙwayar cuta kamar Ebola, mura da SARS suna shafar maza da mata daban.
Ma'aikatan kiwon lafiya mata da ma'aikatan jinya sun fi yawa, kuma suna da damar kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar na yau da kullun shine "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO alama ce ta COVID-19, VI ta cutar, da kuma 19 lokacin da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi sunan ne don kauce wa nuna wani yanki na musamman (misali China) ......
WHO ta fi amfani da "COVID-19 virus" a matsayin "kwayar cutar da ke haifar da COVID-19" a cikin tattaunawar jama'a.
Ba abin farin ciki bane kuma ba kwayar cuta ba ce, wanda aka fi sani da "coronavirus".
A lokacin farkon barkewar cutar a Wuhan, China, ana kiran cutar da cutar "coronavirus" da "Wuhan coronavirus".
A cikin Janairu 2020, WHO ta ba da shawarar cewa 2019-nCov da 2019-corona sun zama sunaye biyu na yau da kullun don cututtuka da ƙwayoyin cuta dangane da ƙa'idodin 2015 akan amfani da sunaye da sunaye.
An fitar da sunayen COVID-19 da SARS-CoV-2 a hukumance a ranar 11 ga Fabrairu, 2020.
Saboda girman girman da aka yi a cikin ma'auni na ma'auni na kasar Sin, wasu masu aikin injiniya na dijital suna buga abubuwa masu muhimmanci na kiwon lafiya kamar su ma'auni na ma'auni da kuma kayan aiki na ventilator.
A cikin wani misali, lokacin da asibitin Italiya ya buƙaci kayan aikin numfashi na gaggawa, kuma masu ba da sabis ba su iya isar da kayan aikin a cikin lokaci kamar yadda aka nema ba, an sake farawa na gida don dawo da gaggawa da gaggawa don buƙatar 100 na bukatar numfashi a cikin dare.
Tun farkon barkewar COVID-19, an yi jita-jita, jita-jita, da kuma maganganu marasa gaskiya game da tushen, ma'auni, magani, magani, da sauran fannoni na cutar, da kuma saurin yaduwar cutar ta yanar gizo.
Ana iya ganin cewa mutane na iya yada kwayar cutar zuwa wasu dabbobi.
Binciken kimiyya ya kasa gano shaidar kwayar cutar a cikin aladu, kaji da kaza.
Ba a ba da izinin magani ko allurar rigakafi don maganin cutar ba.
Binciken kasa da kasa kan allurar rigakafin COVID-19 da magungunan ana gudanar da su ta hanyar ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta fara nazarin gwajin SOLIDARITY don kimanta tasirin maganin ga magungunan ƙwayoyin cuta guda huɗu tare da alamar samun sakamako mai ban mamaki.
Babu wani maganin rigakafi, amma bangarori daban-daban suna aiki don samar da allurai.
Aikin da aka yi a baya akan SAES-CoV ya kasance mai tasiri saboda duka SARS-CoV da SARS-CoV-2 suna amfani da ƙwayoyin ACE2 don shiga cikin sel na mutum.
An gano wasu 'yan bindiga uku da suka bi shi.
Na farko. Manufar bincike ita ce samar da maganin da zai iya magance kowace cutar.
Yin amfani da kwayoyin cuta marasa rai ko kuma kwayoyin cuta da suka mutu don saurin amsawar garkuwar jiki ga sabon kamuwa da COVID-19.
Na biyu, allurar rigakafin da aka yi don samar da maganin da zai sa rigakafin jiki ya kasance mai saurin kamuwa da wasu sassan kwayar cutar.
A cikin SARS-CoV-2, waɗannan nazarin sun mai da hankali ne ga furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin ƙwayoyin ACE2.
Dabara ta uku ita ce ta amfani da nucleic acid (DNA ko RNA, sabon hanyar yin kwayar halitta).
Gwajin allurar rigakafi a cikin kowane ɗayan waɗannan dabarun yana buƙatar a gwada shi don aminci da tasiri. A ranar 16 ga Maris, 2020, an fara gwajin asibiti na farko na allurar rigakafi akan masu sa kai huɗu a Seattle.
Alurar rigakafin ta ƙunshi lambar kwayar halitta mara lahani da aka ɗauka daga kwayar cutar da ke haifar da cutar.An bayar da shawarar haɓaka haɓaka ta hanyar rigakafi a matsayin babban cikas ga ci gaban allurar rigakafin 2-SARS-CoV, amma wannan yana da matsala (ba a yarda da shi).
Sama da gwaji na asibiti 300 da aka gudanar a watan Afrilu na 2020.
An yi nazarin gwaje-gwaje bakwai kuma an amince da maganin don maganin zazzabin cizon sauro, tare da binciken huɗu na hydrochloricine ko chloroquine.
An yi hasashen cewa yawancin binciken da aka yi a China game da maganin rigakafin cutar, tare da gwaji tara na kashi na uku na redicevir a cikin wasu ƙasashe don samun rahotanni a ƙarshen Afrilu.
Ci gaban naúrar likita don nazarin motsa jiki don allurar rigakafin COVID-19 da masu neman magani suna nan, kamar yadda a cikin Afrilu 2020. Akwai wasu magungunan rigakafin cutar da aka bincika don maganin COVID-19, ciki har da remdesivir da hydrochloricoquine, lopinvir/ritonavir da lopinvir/ritonavir haɗe zuwa beta-trigger.
Akwai shaidar da za a iya samu na ɗan lokaci don tasirin Remdesivir, kamar na 5 ga watan 2020.
An sami ci gaba a cikin marasa lafiya da ke fama da raunin zuciya da aka yi wa magani na remdesivir.
An gudanar da gwajin na uku na gwajin lafiya a Amurka, China da Italiya. Chloroquine da aka yi amfani da shi a baya don maganin zazzabin cizon sauro, an gudanar da shi a China a cikin watan Fabrairun 2020 tare da sakamako mai mahimmanci.
Koyaya, akwai alaƙa da sake dubawa na binciken.
Hukumar Kula da Lafiya ta Koriya da na China sun ba da shawarar amfani da Chloroquine. Chloroquine na iya magance cutar maleriya.
Koyaya, Cibiyar Nazarin Kwayar Cutar Wuhan, yayin da take ba da shawarar cin abinci sau ɗaya a rana don gram ɗaya, ta lura cewa cin abinci sau biyu a rana yana da haɗari da haɗari.
A ranar 28 ga Mayu, 2020, FDA ta ba da sanarwar cewa akwai amfani da gaggawa na hydrochloricoquin da chloroquine a cikin shawarar likita na COVID-19 na mutane.Shirin na bakwai na jagorar na Interferon na kasar Sin, Raphavirin ko Amfifenovir don amfani da COVID-19.
Bayanai na baya sun nuna cewa cin abinci mai yawa na ribavirin yana da mahimmanci ga SARS-CoV-2 virus.
An ba da shawarar maganin Nitazoxanide don ƙarin ɓarna a cikin vivo bayan an nuna ƙarancin juriya na SARS-CoV-2.Bincike ya nuna cewa furotin na farko na furotin na iya zama mai amfani da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuwar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Gwajin gwajin chloroquine da hydroxychloroquine tare da ko ba tare da maganin rigakafi ba yana da iyakoki da yawa waɗanda suka hana likitocin likita daga amincewa da waɗannan jiyya ba tare da bincike mai zurfi ba.Oseltamivir ba ya hana SARS-CoV-2 kuma ba shi da sanannen rawar da zai taka a cikin maganin COVID-19.
Cytokine-release influx na iya zama mai saurin rikitarwa a cikin matakan COVID-19 na baya.
Akwai tabbacin cewa hydroxychloroquine na iya haifar da tasirin anti-cytokine. Tocilizumab an saka shi cikin jerin magungunan da Hukumar Lafiya ta Duniya ta tsara bayan kammala wani karamin bincike.
An yi gwajin gwaji ne na bazuwar gwaji na kasa da kasa a Italiya bayan sakamakon ya nuna cewa mutane sun kamu da cutar.
Haɗuwa da samfurin gwajin jini don ƙayyade matsalar cytokine, wannan yana nufin amsawa ga ci gaba, wanda zai iya zama sanadin mutuwa a wasu mutane masu fama da cutar.
Cytokinin-6 mai karɓar mai karɓa ya sami amincewar FDA bisa ga binciken da aka yi don magance cututtukan cututtukan steroidal na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na cututtukan cututtuka na cututtukan cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuke na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka na cututtuka.
A halin yanzu, babu wata hujja ko gwaji da ke nuna cewa tocilizumab zai iya magance CRS.
An ba da maganin rigakafin da aka tace da kuma gina shi ta tsarin garkuwar jiki na waɗanda suka warke daga COVID-19 ga mutanen da ke buƙatar magani a matsayin hanyar da ba ta da ƙarancin rigakafi.
An gwada wannan aikin don SARS ba tare da samun cikakkiyar sakamako ba.
Kwayar cutar ta haɗu ita ce hanyar da ake tsammani ta aiki wanda ƙwayoyin rigakafi masu ƙarancin magani za su iya hana rigakafin SARS-CoV-2.
Sauran hanyoyin, duk da haka, kamar su ƙwayoyin cytotoxicity-dabbatar da rigakafi ko aikin kawar da ƙwayoyin cuta na iya zama masu amfani.
Sauran nau'ikan maganin rigakafi na rigakafi, misali, amfani da maganin rigakafi na ƙwararru na monolonal, yana ci gaba.
Abubuwan da aka samar sun haɗa da ruwan jini na jini, wanda ya ƙunshi ruwan furotin na jini daga marasa lafiya da aka warkar da kuma ƙwayoyin ƙwayoyin cuta na musamman waɗanda za a iya ƙarawa don saurin yaduwa.
Cutar Koronawaira wata ƙungiya ce ta cututtuka da ke da alamomi iri ɗaya.
Li Wenliang likita ne na cibiyar asibitin Wuhan, wanda daga baya ya kamu da COVID-19 kuma ya mutu bayan ya zama sananne game da yaduwar kwayar cutar.
